TNF
Synonyms
Tumor Necrosis Factor (TNF Superfamily, Member 2), Tumor Necrosis Factor Ligand 1F, Tumor Necrosis Factor-Alpha, TNF Superfamily, Member 2, TNF, Macrophage-Derived, TNF, Monocyte-Derived, APC1 Protein, TNLG1F, DIF, ICD1, Tumor necrosis factor, NTF, TNF-a, TNF-alpha, ICD2, N-terminal fragment, TNF, Tumor necrosis factor ligand superfamily member 2, Cachectin, TNFSF2, TNFA,Description
Tumor necrosis factor α is a cell signaling protein (cytokine) involved in systemic inflammation and is one of the cytokines that make up the acute phase reaction. It is produced chiefly by activated macrophages, although it can be produced by many other cell types such as T helper cells, natural killer cells, neutrophils, mast cells, eosinophils, and neurons.TNF is a member of the TNF superfamily, consisting of various transmembrane proteins with a homologous TNF domain.Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Impairs regulatory T-cells (Treg) function in individuals with rheumatoid arthritis via FOXP3 dephosphorylation. Upregulates the expression of protein phosphatase 1 (PP1), which dephosphorylates the key 'Ser-418' residue of FOXP3, thereby inactivating FOXP3 and rendering Treg cells functionally defective . Key mediator of cell death in the anticancer action of BCG-stimulated neutrophils in combination with DIABLO/SMAC mimetic in the RT4v6 bladder cancer cell line . Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces GKAP42 protein degradation in adipocytes which is partially responsible for TNF-induced insulin resistance. Plays a role in angiogenesis by inducing VEGF production synergistically with IL1B and IL6 .The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells.
KO Status
F0
Drug Information
Launched drugs: 63
Drugs in clinical trials: 46
Latest Research Phase:Approved
Drug Name
Code
Phase
Company
Indications
Clinical Trials
Adalimumab biosimilar (Sandoz)
GP-2017
Approved
Sandoz
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Hidradenitis Suppurativa, Uveitis, Crohn Disease
NCT Number
NCT03259074
NCT02016105
NCT02744755
Intervention Type
Biological
Drug
Biological
Indications
Ankylosing Spondylitis
Plaque Type Psoriasis
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 3
Phase 3
Recruitment Status
Active, not recruiting
Completed
Completed
Infliximab (Hisun Biopharmaceutical)
IND
Hisun Biological Pharmaceutical Co Ltd
Adalimumab biosimilar (Jiangsu Zhonghe)
UBP-1211
NDA/BLA
Shanghai Junshi Biosciences Co Ltd, Jiangsu Zhonghe Pharmaceutical Technology Co Ltd
Arthritis, Rheumatoid
Etanercept biosimilar (Qilu Pharmaceutical)
QL-0902
NDA/BLA
Qilu Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing
Adalimumab biosimilar (Fujifilm Kyowa Kirin Biologics/Mylan)
FKB-327
Approved
Fujifilm Kyowa Kirin Biologics
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Colitis, Ulcerative, Arthritis, Psoriatic, Uveitis, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT02405780
NCT02260791
Intervention Type
Drug
Drug
Indications
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Study Phase
Phase 3
Phase 3
Recruitment Status
Completed
Completed
Adalimumab
D2E7, ABT-D2E7, LU-200134
Approved
Abbvie Inc
Pyoderma Gangrenosum, Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Asthma, Colitis, Ulcerative, Arthritis, Psoriatic, Osteoarthritis, Knee, Uveitis, Arthritis, Hidradenitis Suppurativa, Crohn Disease, Plaque psoriasis
NCT Number
NCT01716039
NCT02492217
NCT00216177
NCT01602302
NCT02764762
NCT01722214
NCT00233558
NCT02994836
NCT02256462
NCT00972218
NCT01609205
NCT01181570
NCT01072058
NCT00234234
NCT03221621
NCT04045782
NCT02198651
NCT02878161
NCT03739853
NCT01895764
NCT02374021
NCT01174186
NCT00808509
NCT04646187
NCT00796705
NCT01029847
NCT02852694
NCT02035800
NCT04194827
NCT00517296
NCT00291915
NCT00837434
NCT02489760
NCT03917303
NCT04132388
NCT01500278
NCT00480272
NCT01270087
NCT04131322
NCT00649922
NCT04300686
NCT02808975
NCT03619876
NCT01382160
NCT00940862
NCT03505008
NCT02132234
NCT01866592
NCT01295151
NCT03737708
NCT01793519
NCT00133315
NCT04086745
NCT00477893
NCT00234897
NCT02897115
NCT01698307
NCT01644396
NCT01893996
NCT01553058
NCT00735787
NCT01405326
NCT01185288
NCT00932113
NCT01465438
NCT02242474
NCT01548768
NCT01556672
NCT01162421
NCT02634541
NCT03059849
NCT02056184
NCT02148718
NCT00420927
NCT03220841
NCT00761514
NCT02814175
NCT01265823
NCT01604629
NCT01088165
NCT01270035
NCT02840175
NCT00408629
NCT02889796
NCT02185014
NCT01185301
NCT00233571
NCT02016105
NCT01550965
NCT00055497
NCT01243671
NCT02207244
NCT01138657
NCT00235885
NCT00939003
NCT02016482
NCT00195702
NCT03816397
NCT01764997
NCT01468207
NCT04610476
NCT02499783
NCT04088409
NCT00427362
NCT00478660
NCT03906136
NCT04230213
NCT02150473
NCT02207231
NCT00775437
NCT01870284
NCT00049751
NCT00235872
NCT02065557
NCT01958827
NCT03849404
NCT00409682
NCT01497717
NCT00566722
NCT01124838
NCT01251614
NCT00195819
NCT02533375
NCT00513370
NCT01064856
NCT00085644
NCT00195715
NCT04527380
NCT01646073
NCT00870467
NCT00338650
NCT00195676
NCT01231321
NCT01986127
NCT00195650
NCT00574249
NCT01670240
NCT00736983
NCT00647270
NCT03172325
NCT03412747
NCT00048542
NCT02065570
NCT01235689
NCT03311464
NCT00305539
NCT01635764
NCT00105300
NCT00385736
NCT00690573
NCT00929864
NCT00573794
NCT01295814
NCT00686374
NCT00427921
NCT04404517
NCT03104400
NCT00603993
NCT02632175
NCT02722044
NCT00195663
NCT01166282
NCT00235820
NCT04115748
NCT01148225
NCT00927069
NCT02196701
NCT00448383
NCT03828019
NCT01562951
NCT01629628
NCT00853099
NCT00235859
NCT02497469
NCT02629159
NCT02332356
NCT02019472
NCT00660647
NCT00234936
NCT00646178
NCT00348283
NCT02904902
NCT01808118
NCT00647920
NCT01468233
NCT03789292
NCT00077779
NCT02065622
NCT00667355
NCT01674413
NCT01114880
NCT00234845
NCT00237887
NCT01494857
NCT00409617
NCT00647400
NCT00348153
NCT03759288
NCT00445432
NCT03217734
NCT00445939
NCT00538902
NCT00647491
NCT00235105
NCT01225393
NCT03823391
NCT00646386
NCT01163617
NCT03248531
NCT00730717
NCT00645892
NCT00918255
NCT03180957
NCT02456363
NCT02349451
NCT00470509
NCT00646191
NCT00274352
NCT04588818
NCT04655807
NCT00514982
NCT00185562
NCT00298272
NCT00645814
NCT00235833
NCT02862574
NCT00311246
NCT01561313
NCT02015793
NCT02833350
NCT02706704
NCT01502423
NCT00512863
NCT04009668
NCT01136252
NCT03651518
NCT00827996
NCT02471118
NCT00731757
NCT00525902
NCT04154852
NCT01752855
NCT00690911
NCT00055523
NCT00645905
NCT00814255
NCT02141997
NCT02113904
NCT00690846
NCT02437253
NCT03153319
NCT01704599
NCT00686439
NCT03607903
NCT00193648
NCT01101555
NCT04439929
NCT02144714
NCT00650156
NCT03849313
NCT03983876
NCT02675023
NCT04514796
NCT03273192
NCT02516774
NCT00855608
NCT03254810
NCT00421642
NCT02927353
NCT02252809
NCT03955861
NCT01197144
NCT02878083
NCT01706692
NCT01012570
NCT01356758
NCT02450513
NCT04131504
NCT00650390
NCT01610947
NCT01592292
NCT03261102
NCT03681652
NCT02739828
NCT03775824
NCT00783510
NCT01736189
NCT01029613
NCT00814866
NCT01078571
NCT01613963
NCT04089514
NCT01971970
NCT03043677
NCT04378621
NCT00724672
NCT03016260
NCT02963402
NCT00963313
NCT01812954
NCT00234884
NCT04449224
NCT02330380
NCT02376478
NCT00649545
NCT03496831
NCT00497614
NCT00650026
NCT02539849
NCT01078610
NCT03561649
Intervention Type
Drug
Drug
Drug
Drug
Drug
Other;Biological
Drug
Biological;Drug
Drug
Biological
Biological
Drug
Drug
Drug
Procedure;Drug
Drug
Other;Biological
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological
Drug
Drug
Drug
Drug
Diagnostic Test;Drug
Procedure;Drug
Drug
Drug
Biological
Drug
Other;Drug
Biological;Drug
Drug
Drug
Drug
Biological
Biological
Drug
Drug
Biological
Other;Biological;Device
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological
Other
Biological
Drug
Other;Drug
Biological
Biological
Biological;Drug
Drug
Drug
Drug
Drug
Drug;Device
Biological;Drug
Other;Drug
Drug
Drug
Biological
Biological;Drug
Procedure;Drug
Drug
Biological;Drug
Biological
Drug
Other;Drug
Drug
Drug
Biological
Drug
Drug
Biological;Drug
Biological
Drug
Biological
Biological
Biological
Drug
Biological;Drug
Drug
Biological
Other;Biological
Biological;Drug
Other;Biological
Drug
Biological
Drug
Other;Biological
Drug
Drug
Drug
Other;Biological
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological
Biological
Biological
Biological
Drug
Biological
Drug
Biological;Drug
Biological
Drug
Biological
Biological
Biological
Biological
Drug
Biological
Biological;Drug
Drug
Drug
Drug
Drug
Biological
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Biological
Drug
Biological
Biological
Drug
Biological
Other;Drug
Biological
Biological
Drug
Drug
Biological
Biological
Biological;Device
Biological;Drug
Biological
Drug
Drug
Drug
Drug
Drug
Biological
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological
Drug
Biological
Biological
Biological
Biological
Drug
Other;Drug
Biological
Drug
Other;Biological
Drug
Drug
Drug
Biological
Biological
Drug
Drug
Other;Biological
Biological;Drug
Biological
Biological
Biological
Drug
Drug
Drug
Drug
Device
Other;Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug;Dietary Supplement
Drug
Biological
Drug
Drug
Biological
Biological
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Other;Drug
Drug
Drug
Drug
Other;Biological
Drug
Other;Drug
Biological
Biological
Biological
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Drug
Biological
Drug
Biological;Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Biological
Other;Drug
Drug
Biological
Drug
Drug
Drug
Biological
Drug
Other;Drug
Other;Drug
Biological
Drug
Drug
Biological
Drug;Dietary Supplement
Biological
Drug
Indications
Ulcerative Colitis
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn Disease
Psoriasis; Vascular Inflammation; Coronary Atherosclerosis
Rheumatoid Arthritis
Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis
Crohn's Disease
Spondyloarthritis; Crohn's Disease
Rheumatoid Arthritis
Psoriasis; Sleep Apnea, Obstructive
Arthritis, Rheumatoid; Spondylitis, Ankylosing
Rheumatoid Arthritis
Hidradenitis Suppurativa
Inflammatory Bowel Diseases
Rheumatoid Arthritis; Musculoskeletal and Connective Tissue Diseases
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Arthritis, Rheumatoid
Spondyloarthritis; Enterocolitis
Arthritis, Rheumatoid
Inflammatory Bowel Diseases; Crohn Disease; Colitis, Ulcerative
Rheumatoid Arthritis
Spondyloarthritis
Crohn's Disease
RheumatoId Arthritis
Rheumatoid Arthritis
Crohn Disease; Rectal Fistula
Rheumatoid Arthritis; Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Crohn Disease; Inflammatory Bowel Diseases
Hidradenitis Suppurativa
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn Disease; Ulcerative Colitis
Rheumatoid Arthritis
Takayasu Arteritis; Tocilizumab; Adalimumab; Treatment
Hidradenitis Suppurativa (HS)
Rheumatoid Arthritis; Myocardial Inflammation
Rheumatoid Arthritis
Psoriasis; Vascular Inflammation; Coronary Atherosclerosis
Rheumatoid Arthritis
Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Hypertension
Psoriasis; Cardiovascular Disease
Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Spondylarthropathies; Ankylosing Spondylitis; Psoriatic Arthritis
Rheumatoid Arthritis
Spondyloarthritis
Rheumatoid Arthritis
Axial Spondyloarthritis
Crohn's Disease
Moderate to Severe Plaque Psoriasis
Rheumatoid Arthritis; Cardiovascular Disease
Psoriasis; Cardiovascular Disease
Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Plaque Psoriasis; Crohn's Disease
Rheumatoid Arthritis
Ankylosing Spondyloarthritis
Crohn Disease; Ulcerative Colitis
Rheumatoid Arthritis; Targeted Ultrasound
Moderate to Severe Crohn's Disease
Rheumatoid Arthritis
Crohn Disease; Inflammatory Bowel Diseases; Stricture; Bowel
Rheumatoid Arthritis
Psoriatic Arthritis
Psoriasis
Spondylarthropathies
Psoriasis; Cardiovascular Diseases; Diabetes Mellitus, Type 2
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Ulcerative Colitis
Rheumatoid Arthritis
Crohn's Disease
Early Rheumatoid Arthritis
Rheumatoid Arthritis
Plaque Type Psoriasis
Ulcerative Colitis
Crohn's Disease
Intestinal Behçet's Disease
Psoriasis
Uveitis
Psoriatic Arthritis
Axial Spondyloarthritis
Nail Psoriasis; Plaque Psoriasis
Rheumatoid Arthritis
Uveitis; JIA
Rheumatoid Arthritis
Hidradenitis Suppurativa (HS)
Psoriatic Arthritis; Withdrawal; Reduction
Crohn's Disease
Uveitis
Psoriatic Arthritis
Ankylosing Spondylitis
Axial Spondyloarthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Juvenile Idiopathic Arthritis
Spondylitis, Ankylosing
Rheumatoid Arthritis
Rheumatoid Arthritis
Ulcerative Colitis
Crohn's Disease
Plaque Psoriasis
Crohn's Disease
Arthritis; Behcet
Psoriasis
Uveitis
Plaque Psoriasis
Ankylosing Spondylitis
Generalized Pustular Psoriasis (GPP); Adalimumab; Japanese
Psoriasis
Peripheral Spondyloarthritis
Ankylosing Spondylitis
Crohn's Disease
Juvenile Psoriatic Arthritis; Enthesitis Related Arthritis
Plaque Psoriasis
Rheumatoid Arthritis
Crohn's Disease
Psoriasis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Chronic Plaque Psoriasis
Ulcerative Colitis; Pouchitis
Crohn's Disease With Perianal Fistulas
Rheumatoid Arthritis
Active Rheumatoid Arthritis
Chronic Plaque Psoriasis; Moderate to Severe Plaque Psoriasis
Arthritis, Juvenile Idiopathic
Crohn's Disease
Crohn's Disease
Pyoderma Gangrenosum
Giant Cell Arteritis
Hidradenitis Suppurativa
Crohn's Disease
Ulcerative Colitis
Juvenile Rheumatoid Arthritis
Rheumatoid Arthritis
Ulcerative Colitis
Interstitial Cystitis
Crohn's Disease
Crohn's Disease
Inflammatory Bowel Diseases
Psoriatic Arthritis
Rheumatoid Arthritis
Ulcerative Colitis
Rheumatoid Arthritis
Early Rheumatoid Arthritis
Enthesitis Related Arthritis (ERA)
Psoriasis
Psoriatic Arthritis
Uveitis
Plaque Psoriasis
Psoriasis
Rheumatoid Arthritis
Uveitis
Crohn's Disease; Mucosal Inflammation
Crohn Disease
Ulcerative Colitis
Rheumatoid Arthritis
Colitis, Ulcerative
Rheumatoid Arthritis
Crohn Disease
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Rheumatoid Arthritis
Arthritis; Psoriatic
Crohn's Disease
Hidradenitis Suppurativa
Axial Spondyloarthritis
Rheumatoid Arthritis
Hidradenitis Suppurativa (HS)
Rheumatoid Arthritis
Crohn's Disease
Ulcerative Colitis (UC)
Ankylosing Spondylitis
Crohn's Disease
Ankylosing Spondylitis
Rheumatoid Arthritis
Psoriasis
Ulcerative Colitis
Crohn's Disease
Psoriasis
Uveitis
Crohn's Disease; IBD
Crohn's Disease
Psoriasis
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Arthritis; Psoriatic
Rheumatoid Arthritis
Hidradenitis Suppurativa
Pyoderma Gangrenosum
Psoriasis
Hidradenitis Suppurativa
Dupuytren's Disease
Ankylosing Spondylitis
Psoriatic Arthritis
Sciatica
Psoriasis
Sarcoidosis
Uveitis
Crohn Disease
Hermanski-Pudlak Syndrome; Colitis; Cytokines; Lymphocytes; Drug Evaluation
Osteoarthritis
Rheumatoid Arthritis
Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Sarcoidosis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Uveitis; Non-Infectious Uveitis
Rheumatoid Arthritis
Asthma
FSGS; MCD; Focal Segmental Glomerulosclerosis; Minimal Change Disease
Age-Related Macular Degeneration; Choroidal Neovascularization
Inflammatory Disease; Autoimmune Diseases
Hidradenitis Suppurativa
Osteoarthritis, Knee
Sarcoidosis; Cutaneous Sarcoidosis
Uveitis
Oligoarthritis
Rheumatoid Arthritis
Sarcoidosis
Crohn's Disease
Psoriasis
Focal Segmental Glomerulosclerosis
Rheumatoid Arthritis
Netherton Syndrome
Pyoderma Gangrenosum
Mucopolysaccharidosis Type I; Mucopolysaccharidosis Type II; Mucopolysaccharidosis Type VI
Mucopolysaccharidosis I; Mucopolysaccharidosis II
Psoriasis
Osteoarthritis
Pain; Injection Site
Focal Glomerulosclerosis
Arthritis, Rheumatoid
Healthy Participants
Healthy
Rheumatoid Arthritis
Healthy Volunteers
Plaque Psoriasis
Healthy
Healthy
Bioequivalence; Phase 1
Anaplastic Thyroid Cancers
Uveitis; Diabetic Retinopathy; Choroidal Neovascularization
Arthritis, Rheumatoid
Ulcerative Colitis
Healthy Volunteer
Innate Immunity
Psoriatic Arthritis; Psoriasis; Enthesitis
Arthritis, Rheumatoid; Pain; Fatigue
ULCERATIVE COLITIS
Psoriasis
Crohn's Disease
Psoriasis; Atopic Dermatitis; Atherosclerosis
Crohn's Disease
Crohn's Disease; IBD
Rheumatoid Arthritis
Spondyloarthritis
Rheumatoid Arthritis
Crohn Disease; Drug Monitoring; Inflammatory Bowel Diseases
Crohn Disease
Hidradenitis Suppurativa
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis; JIA
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Uveitis; Scleritis
Arthritis, Rheumatoid (RA); Axial Spondyloarthritis (axSpA); Arthritis, Psoriatic (PsA); Crohn's Disease (CD); Colitis, Ulcerative (UC)
Inflammatory Bowel Diseases
Inflammatory Bowel Disease
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Rheumatoid Arthritis
RheumatoId Arthritis
Arthritis,Rheumatoid
Psoriatic Arthritis
Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis; Inflammation
Psoriasis; Inflammatory Bowel Diseases
Rheumatoid Arthritis
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn Disease
Psoriatic Arthritis
Spondylitis, Ankylosing
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Active, not recruiting
Completed
Unknown status
Terminated
Active, not recruiting
Completed
Terminated
Active, not recruiting
Completed
Withdrawn
Completed
Completed
Unknown status
Completed
Recruiting
Recruiting
Completed
Unknown status
Recruiting
Completed
Recruiting
Completed
Completed
Not yet recruiting
Terminated
Completed
Recruiting
Unknown status
Recruiting
Completed
Unknown status
Completed
Unknown status
Recruiting
Not yet recruiting
Completed
Completed
Completed
Not yet recruiting
Completed
Recruiting
Completed
Recruiting
Completed
Completed
Active, not recruiting
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Recruiting
Unknown status
Completed
Terminated
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Unknown status
Withdrawn
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Completed
Completed
Unknown status
Unknown status
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Terminated
Completed
Not yet recruiting
Completed
Recruiting
Completed
Completed
Recruiting
Recruiting
Terminated
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Recruiting
Terminated
Unknown status
Completed
Completed
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Withdrawn
Completed
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Completed
Active, not recruiting
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Not yet recruiting
Withdrawn
Completed
Terminated
Completed
Completed
Terminated
Terminated
Completed
Completed
Completed
Unknown status
Completed
Withdrawn
Recruiting
Completed
Recruiting
Completed
Recruiting
Withdrawn
Completed
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Recruiting
Terminated
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Withdrawn
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Completed
Recruiting
Recruiting
Terminated
Completed
Unknown status
Recruiting
Approved for marketing
Completed
Completed
Recruiting
Recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Not yet recruiting
Withdrawn
Terminated
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Approved for marketing
Completed
Completed
Approved for marketing
Completed
Withdrawn
Active, not recruiting
Adalimumab biosimilar (Reliance Life Sciences)
R-TPR-021
Approved
Reliance Life Sciences
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative
Adalimumab biosimilar (Samsung Bioepis)
SB-5
Approved
Samsung Bioepis
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Hidradenitis Suppurativa, Uveitis, Crohn Disease
NCT Number
NCT04045782
NCT02167139
NCT02565810
NCT02326233
NCT02144714
NCT04089514
NCT04378621
Intervention Type
Drug
Drug
Drug
Biological
Biological
Drug
Other;Drug
Indications
Inflammatory Bowel Diseases
Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy
Healthy
Arthritis, Rheumatoid (RA); Axial Spondyloarthritis (axSpA); Arthritis, Psoriatic (PsA); Crohn's Disease (CD); Colitis, Ulcerative (UC)
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Study Phase
Phase 4
Phase 3
Phase 2
Phase 1
Phase 1
N/A
N/A
Recruitment Status
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Not yet recruiting
Infliximab biosimilar (Nichiiko Pharmaceutical/Aprogen)
GS-071, NI-071
Approved
Nichi-Iko Pharmaceutical, Aprogen
Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT02990806
NCT01927263
NCT01567358
NCT01931189
Intervention Type
Biological
Biological
Biological
Biological
Indications
Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy
Study Phase
Phase 3
Phase 3
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Infliximab biosimilar (Bionovis/The Instituto Vital Brazil)
Approved
Bionovis, The Instituto Vital Brazil
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT00902811
Intervention Type
Drug
Indications
Uncomplicated Falciparum Malaria
Study Phase
Phase 4
Recruitment Status
Unknown status
Pentoxifylline
BL-191, EHT-201, EHT-0201
Approved
U.S. Pharmaceuticals Holdings I
Hepatitis, Chronic, Peripheral Vascular Diseases, Hepatitis, Kidney Failure, Chronic, Behcet Syndrome
NCT Number
NCT01269827
NCT03859570
NCT03664414
NCT02368457
NCT01718288
NCT01542268
NCT02971306
NCT03060434
NCT03006952
NCT02008214
NCT02161653
NCT03625648
NCT01006499
NCT04391231
NCT01382303
NCT01377285
NCT00155246
NCT00770328
NCT03406169
NCT01263925
NCT01472263
NCT02485106
NCT00561093
NCT00354731
NCT00162552
NCT00354198
NCT02487225
NCT02163174
NCT03040778
NCT01214226
NCT01291433
NCT01455337
NCT00285298
NCT00632697
NCT01384578
NCT02898376
NCT00119119
NCT04152980
NCT01464242
NCT00663949
NCT02451774
NCT00267670
NCT01809132
NCT00973817
NCT04367935
NCT01381055
NCT02951299
NCT00001877
NCT01149304
NCT00022204
NCT01249092
NCT00133393
NCT01102218
NCT02230800
NCT03888846
NCT00616382
NCT01774487
NCT03731741
NCT00583700
NCT02776059
NCT00864916
NCT00188669
NCT04186559
NCT01625845
NCT02397486
NCT00590161
NCT01822405
NCT01508221
NCT03916068
NCT03830164
NCT03342950
NCT00001437
NCT00188552
NCT02530697
NCT00271336
NCT00796822
NCT02283710
NCT01871454
NCT00102453
NCT04094207
NCT00771446
NCT00243789
NCT04433988
NCT00019058
NCT02124941
NCT00000646
NCT00593658
NCT00205049
NCT03476564
NCT04417049
NCT02953275
NCT02992678
NCT01292005
NCT03800433
NCT00154661
NCT01893450
NCT00660868
NCT02123576
NCT01049633
NCT02458079
NCT01676597
NCT01144091
NCT01082003
NCT01245257
NCT00315679
NCT02592863
NCT01279434
NCT01469624
NCT02796469
NCT01337349
NCT01793272
NCT04097847
NCT00002091
NCT04570254
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological
Drug
Drug
Drug
Drug
Drug
Procedure;Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug;Behavioral
Radiation;Drug
Drug
Other;Drug
Drug;Dietary Supplement
Procedure;Drug;Dietary Supplement
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Behavioral
Radiation;Drug
Drug
Drug
Other;Biological
Drug
Drug
Radiation;Drug
Diagnostic Test;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other
Drug
Drug
Drug
Indications
Inflammation; End-stage Renal Disease; Hemodialysis
Lupus Nephritis
Chronic Kidney Disease stage3 and 4; Type 2 Diabetes Mellitus
Osteoradionecrosis
Peripheral Arterial Disease
Irritable Bowel Syndrome
Alcoholic Hepatitis
Lumbar Radiculopathy; Lumbar Disc Herniation; Lumbar Disc Disease
Diabetic Nephropathies
Hepacivirus; HIV Infections
Severe Alcoholic Hepatitis
Diabetic Kidney Disease
Sepsis of the Newborn
Hemolysis Intravascular; Acute Decompensated Heart Failure
Type 2 Diabetes
Chronic Renal Failure
Chronic Kidney Disease
Obesity
Erectile Dysfunction; Prostate Cancer
Stage II Peripheral Arterial Occlusive Disease; Intermittent Claudication Fontaine Stage II PAOD
HTLV-1; Tropical Spastic Paraparesis; Immune System Diseases; Physical Disability; Pentoxifylline
Severe Alcoholic Hepatitis
Hypoalbuminemia; Protein-energy Malnutrition; Inflammation; Oxidative Stress; Chronic Kidney Disease (CKD) Hemodialysis
Nephrotic Syndrome
Cirrhosis; Liver Failure
Glomerulonephritis
Acute Pancreatitis (AP); Gallstone Pancreatitis; Alcoholic Pancreatitis; Trauma Acute Pancreatitis; Hypertriglyceridemia Acute Pancreatitis; Idiopathic (Unknown) Acute Pancreatitis; Medication Induced Acute Pancreatitis; Cancer Acute Pancreatitis; Miscellaneous (i.e. Acute on Chronic Pancreatitis)
Neonatal Late Onset Sepsis
Medication-related Osteonecrosis of the Jaw; Bisphosphonate-related Osteonecrosis of the Jaw; Avascular Necrosis
Alcoholic Hepatitis; Alcoholic Liver Disease
Radiation Induced Brachial Plexopathy
Alcoholic Hepatitis
Kidney Failure, Chronic
Endometriosis-Associated Infertility
Non Alcoholic Steatohepatitis
Breast Carcinoma; Fibrosis
Hepatitis C, Chronic; Liver Fibrosis
Neonatal Late Onset Sepsis
Cutaneous Leishmaniasis
Diabetic Nephropathy
Acute Lymphoblastic Leukemia
Nonalcoholic Steatohepatitis; Liver Diseases
Acute Alcoholic Hepatitis
Acute On Chronic Hepatitis
Acute Coronary Syndrome
Cutaneous Leishmaniasis
Pentoxifylline; Acute Kidney Injury
Pulmonary Sarcoidosis
Colorectal Cancer; Liver Metastases; Irradiation Damage; Radiation Induced Liver Disease
Breast Cancer; Lymphedema
Primary Biliary Cirrhosis
Plasmodium Falciparum Malaria
End Stage Renal Disease
Long-term Adverse Effects of Radiotherapy for Pelvic Cancer
Behçet Disease Affecting Oral Mucosa
Patent Ductus Arteriosus
Biliary Atresia
Anemia of Chronic Kidney Disease
Fibrosis
Alcoholic Hepatitis
HIV; Vascular Diseases; Cardiovascular Diseases; Atherosclerosis; HIV Infections
Breast Neoplasms
Behcet Syndrome; Behcet Disease
Major Depressive Disorder; Depression; Depressive Symptoms; Cardiovascular Disease (CVD); Coronary Artery Disease (CAD); Heart Disease
Head and Neck Neoplasms
Nonalcoholic Steatohepatitis
Fibrosis
Brain Metastasis
Breast Cancer
Male Erectile Disorder; Prostate Adenocarcinoma; Erectile Dysfunction, CTCAE; Impotence
Neuralgia Peripheral
Fibrosis; Radiation Injuries
Wounds and Injuries
Leishmaniasis
Necrotizing Enterocolitis
HIV; Cardiovascular Diseases; Atherosclerosis
Fatty Liver
Non-small Cell Lung Cancers
Muscular Dystrophy, Duchenne
Schizophrenia
Acute Hepatitis; Chronic Hepatitis
Muscular Dystrophy, Duchenne
COVID
Brain and Central Nervous System Tumors
Cocaine Dependence; Healthy
HIV Infections
Hepatopulmonary Syndrome
Hepatitis, Alcoholic
Infertility, Female
Bipolar Depression
Crohn Disease
Pancreatitis
Acute Pancreatitis
Anemia Renal
Primary Glomerulonephritis
Graves Ophthalmopathy
Olfaction Disorders
Hepatorenal Syndrome
Type 1 Diabetes Mellitus
Alcoholic Hepatitis
Hepatopulmonary Syndrome
Contrast Induced Nephropathy; Diabetes Mellitus
Capsular Contractures
Alcoholic Hepatitis
Recurrent Aphthous Stomatitis
Dizziness; Vertigo
Non Alcoholic Steatohepatitis
Nephropathy
Alcoholic Hepatitis; Alcoholic Liver Disease
Congestive Heart Failure
Pentoxifylline Allergy
Osteoradionecrosis of Jaw
HIV Infections
Pneumonia, Viral; Covid19; ARDS; Oxidative Stress
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Not yet recruiting
Recruiting
Completed
Completed
Unknown status
Unknown status
Active, not recruiting
Completed
Unknown status
Completed
Recruiting
Unknown status
Not yet recruiting
Completed
Unknown status
Completed
Completed
Recruiting
Completed
Completed
Unknown status
Completed
Completed
Completed
Terminated
Completed
Completed
Enrolling by invitation
Completed
Completed
Unknown status
Completed
Completed
Withdrawn
Not yet recruiting
Terminated
Recruiting
Completed
Completed
Recruiting
Completed
Completed
Completed
Not yet recruiting
Completed
Unknown status
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Recruiting
Unknown status
Recruiting
Completed
Completed
Recruiting
Completed
Terminated
Not yet recruiting
Completed
Completed
Completed
Unknown status
Unknown status
Recruiting
Recruiting
Recruiting
Completed
Terminated
Recruiting
Unknown status
Completed
Completed
Recruiting
Completed
Recruiting
Completed
Completed
Not yet recruiting
Completed
Active, not recruiting
Completed
Terminated
Terminated
Unknown status
Not yet recruiting
Completed
Unknown status
Completed
Not yet recruiting
Completed
Terminated
Completed
Terminated
No longer available
Completed
Unknown status
Withdrawn
Unknown status
Completed
Completed
Enrolling by invitation
Withdrawn
Unknown status
Completed
Unknown status
Completed
Completed
Completed
Active, not recruiting
Etanercept biosimilar (Shanghai Celgen)
Approved
Shanghai Celgen Bio-Pharmaceutical Co Ltd
Psoriasis
Etanercept biosimilar (Hanwha Chemical)
HD-203, MK-8953
Approved
Hanwha Chemical
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic
NCT Number
NCT01270997
NCT01431404
NCT01894412
NCT01044836
Intervention Type
Biological
Biological
Biological
Biological
Indications
Rheumatoid Arthritis
Healthy
Healthy
Healthy
Study Phase
Phase 3
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Infliximab (dyyb)
CT-P13
Approved
Celltrion
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Urologic Neoplasms, Crohn Disease
NCT Number
NCT02452151
NCT02148640
NCT03707535
NCT02096861
NCT01217086
NCT03945019
NCT03147248
NCT04205643
NCT04438382
NCT02883452
NCT01220518
NCT01571206
NCT03729674
NCT02539368
NCT03801928
NCT03016260
NCT02605642
NCT03681652
NCT04378621
Intervention Type
Drug
Drug
Biological
Biological
Drug
Other;Biological
Biological
Other;Biological
Other;Biological;Drug
Biological
Drug
Biological
Drug
Drug
Drug
Biological
Drug
Drug
Other;Drug
Indications
Colitis, Ulcerative; Crohn's Disease
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis; Ulcerative Colitis; Crohn's Disease; Psoriasis Chronic
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Ulcerative Colitis
Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Steroid-Refractory Pneumonitis
Crohn's Disease; Ulcerative Colitis (Part 2 Only)
Ankylosing Spondylitis
Ankylosing Spondylitis
Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn's Disease
Inflammatory Bowel Disease (IBD); Crohn's Disease (CD); Ulcerative Colitis (UC)
RheumatoId Arthritis
Rheumatoid Diseases; Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Crohn Disease
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Study Phase
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 1
Phase 1
Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Unknown status
Completed
Active, not recruiting
Completed
Completed
Recruiting
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Completed
Terminated
Completed
Recruiting
Not yet recruiting
Infliximab biosimilar (Shanghai Biomabs)
CMAB-008, STI-002
NDA/BLA
Shanghai Biomabs Pharmaceuticals Co Ltd
Arthritis, Rheumatoid
Pomalidomide
CDC-394, CC-4047, IMiD-1, IMID-4047
Approved
Celgene Corp
Medulloblastoma, Lymphoma, B-Cell, Bone Marrow Neoplasms, Hodgkin Disease, Scleroderma, Systemic, Lymphoma, Large B-Cell, Diffuse, Multiple Myeloma, Central Nervous System Neoplasms, Lung Diseases, Interstitial, Prostatic Neoplasms, Sarcoma, Lymphoma, Follicular, Primary Myelofibrosis, Lymphoma, Non-Hodgkin, Carcinoma, Small Cell, Neoplasm Metastasis, Sarcoma, Kaposi, Anemia, Sickle Cell, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT01311687
NCT01712789
NCT03440411
NCT03151811
NCT04484623
NCT02990338
NCT03539744
NCT01178281
NCT02726581
NCT03651128
NCT01243944
NCT01324947
NCT04181827
NCT02916420
NCT01734928
NCT03143049
NCT03180736
NCT02576977
NCT02718833
NCT01159574
NCT01745588
NCT04287855
NCT03113942
NCT02807454
NCT04661137
NCT04584307
NCT02654132
NCT02578121
NCT03590652
NCT02244125
NCT01177735
NCT02406222
NCT01794039
NCT03713294
NCT01745640
NCT04191616
NCT03601624
NCT02046915
NCT01946477
NCT03959358
NCT01688466
NCT01319422
NCT04270175
NCT03520985
NCT01053949
NCT03910244
NCT02158702
NCT04302324
NCT03030261
NCT03170882
NCT02045017
NCT03215524
NCT01559129
NCT04176718
NCT04305444
NCT00072722
NCT04700176
NCT03841565
NCT03227432
NCT03242460
NCT00770757
NCT02176213
NCT04124497
NCT04508790
NCT03601806
NCT03756896
NCT02294357
NCT00558896
NCT03104270
NCT02612779
NCT03567616
NCT02011113
NCT00463385
NCT03683277
NCT03202628
NCT03257631
NCT02188368
NCT04577755
NCT00717522
NCT00946270
NCT01510613
NCT00949364
NCT02547662
NCT01135199
NCT01495598
NCT01212952
NCT04150965
NCT01638936
NCT01166113
NCT01464034
NCT02228512
NCT02004275
NCT03715478
NCT02548962
NCT02343042
NCT01570387
NCT02119468
NCT01997840
NCT00669578
NCT01754402
NCT01644110
NCT04094961
NCT02185820
NCT01522872
NCT00833833
NCT00540579
NCT02384083
NCT00537511
NCT01946152
NCT01665794
NCT02542657
NCT01979276
NCT02206425
NCT01421186
NCT01541332
NCT04643002
NCT01592370
NCT01432600
NCT02661022
NCT02289222
NCT02265510
NCT02029950
NCT01722305
NCT03023527
NCT02939183
NCT01568294
NCT03605719
NCT01562405
NCT03798314
NCT01707407
NCT01835561
NCT02462525
NCT04667663
NCT02431208
NCT02415153
NCT02287558
NCT02283775
NCT02189343
NCT02400242
NCT01575925
NCT02569320
NCT00482521
NCT02900716
NCT03657420
NCT01998971
NCT02168205
NCT02616640
NCT01078974
NCT04392648
NCT01889420
NCT03143985
NCT01986894
NCT02103335
NCT03424928
NCT04355039
NCT01198067
NCT03015922
NCT01728259
NCT04045795
NCT01999335
NCT01497093
NCT01522547
NCT01474330
NCT02659930
NCT01807286
NCT01537861
NCT03723096
NCT02921828
NCT02902900
NCT01632826
NCT03353545
NCT02555839
NCT02075996
NCT03288974
NCT02164955
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Behavioral
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Primary Myelofibrosis; MPN-associated Myelofibrosis
Multiple Myeloma
Multiple Myeloma
Polycythemia Vera
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapse Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma in Relapse; Multiple Myeloma, Refractory
High Grade Squamous Intra-epithelial Lesion (HSIL)
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Multiple Myeloma; First Relapse
Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Refractory Plasma Cell Myeloma
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma in Relapse; Multiple Myeloma Progression; Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Amyloidosis
Graft vs Host Disease; Graft-Versus-Host Disease
Multiple Myeloma
Amyloid; AL Amyloidosis; Refractory AL Amyloidosis
Refractory Multiple Myeloma
Multiple Myeloma
Telangiectasia, Hereditary Hemorrhagic
Multiple Myeloma; Relapse After Use of Lenalidomide and Bortezomib
Multiple Myeloma; Refractory Multiple Myeloma; Relapse Multiple Myeloma
Multiple Myeloma in Relapse
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Scleroderma, Systemic; Sclerosis, Systemic; Systemic Scleroderma; Systemic Sclerosis; Interstitial Lung Disease
Multiple Myeloma; Refractory Multiple Myeloma; Multiple Myeloma in Relapse; Relapse
Relapsed Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Diffuse Large B Cell Lymphoma; Follicular Lymphoma; Richter's Transformation
Prostate Cancer
Multiple Myeloma
Recurrent Plasma Cell Myeloma
Multiple Myeloma
Relapsed and/or refractorY Multiple Myeloma
Graft vs Host Disease
Multiple Myeloma in Relapse; Multiple Myeloma, Refractory
Multiple Myeloma; Deletion 17P Syndrome
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Human Immunodeficiency Virus 1 Positive; Skin Kaposi Sarcoma
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myelofibrosis With Myeloid Metaplasia; Myeloid Metaplasia; Myelofibrosis
Multiple Myeloma; Relapsed and Refractory Multiple Myeloma; Genetic Condition
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Central Nervous System Neoplasms; Medulloblastoma
Multiple Myeloma
Skin Kaposi Sarcoma
Soft Tissue Sarcoma
Polycythemia Vera; Thrombocythemia
Primary Amyloidosis of Light Chain Type
Myeloproliferative Neoplasms
Plasma Cell Leukemia; Plasma Cell Myeloma; Plasmacytoma
Pulmonary Fibrosis
Kaposi Sarcoma; Sarcoma, Kaposi
Refractory Multiple Myeloma
Multiple Myeloma; Relapsed Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease; Primary Effusion Lymphoma
Multiple Myeloma in Relapse
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
AL Amyloidosis
Refractory Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma
Multiple Myeloma
Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
Multiple Myeloma
Primary Myelofibrosis; Secondary Myelofibrosis; PMF; SMF; Post-PV MF; Post-ET MF
Multiple Myeloma; Multiple Myeloma in Relapse
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Pancreatic Cancer
Multiple Myeloma
Carcinoma, Small Cell
Multiple Myeloma-Light Chain Only; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Multiple Myeloma
Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma Refractory
Non-Hodgkin's Lymphoma; Hodgkin Lymphoma; Multiple Myeloma
Myeloma
Multiple Myeloma
Multiple Myeloma
Solid Tumors; Advanced Malignancies; Metastatic Cancer
Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia-2; High Risk Myelodysplastic Syndrome; Myeloproliferative Neoplasm
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma; Central Nervous System Lymphoma; Intraocular Lymphoma; Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System; Recurrent Adult Diffuse Large Cell Lymphoma; Retinal Lymphoma
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma
Multiple Myeloma
Recurrent Nervous System Lymphoma; Recurrent Primary Vitreoretinal DLBCL; Refractory Nervous System Lymphoma; Refractory Primary Vitreoretinal DLBCL
Pharmacology, Clinical; Healthy
Clinical Pharmacology, Healthy Volunteer Study
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Neurofibromatosis Type 1; Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Visual Pathway Glioma; Recurrent Primary Central Nervous System Neoplasm; Refractory Primary Central Nervous System Neoplasm
Hereditary Hemorrhagic Telangiectasia; Idiopathic Vascular Ectasia
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Renal Impairment
Recurrent Plasma Cell Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Chronic Lymphocytic Leukemia; B-Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Healthy Volunteers
Multiple Myeloma
Waldenstrom's Macroglobulinemia
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma in Relapse
Multiple Myeloma
Clinical Pharmacology, Healthy Volunteer Study
Multiple Myeloma in Relapse; Refractory Multiple Myeloma; Multiple Myeloma
Bioequivalence
Refractory Multiple Myeloma; Relapse Multiple Myeloma
Recurrent Waldenstrom Macroglobulinemia; Refractory Waldenstrom Macroglobulinemia
Multiple Myeloma
Light Chain Deposition Disease; Primary Systemic Amyloidosis
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Anemia, Sickle Cell
Healthy
Kaposi Sarcoma
Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapse/Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Completed
Terminated
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Recruiting
Completed
Completed
Recruiting
Unknown status
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Not yet recruiting
Active, not recruiting
Withdrawn
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Recruiting
Completed
Recruiting
Recruiting
Completed
Recruiting
Recruiting
Completed
Completed
Not yet recruiting
Active, not recruiting
Completed
Recruiting
Unknown status
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Not yet recruiting
Recruiting
Completed
Not yet recruiting
Recruiting
Withdrawn
Completed
Completed
Completed
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Not yet recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Terminated
Completed
Completed
Completed
Active, not recruiting
Withdrawn
Active, not recruiting
Completed
Recruiting
Completed
Active, not recruiting
Completed
Withdrawn
Active, not recruiting
Recruiting
Terminated
Recruiting
Completed
Unknown status
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Unknown status
Completed
Completed
Completed
Terminated
Terminated
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Completed
Unknown status
Recruiting
Active, not recruiting
Completed
Completed
Terminated
Terminated
Completed
Completed
Terminated
Active, not recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Completed
Completed
Terminated
Not yet recruiting
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Suspended
Completed
Completed
Withdrawn
Active, not recruiting
Completed
Active, not recruiting
Terminated
Withdrawn
Terminated
Recruiting
Completed
Completed
Completed
Withdrawn
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Terminated
Terminated
No longer available
Active, not recruiting
Active, not recruiting
Approved for marketing
Completed
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recombinant chimeric anti-TNFα antibody (Hisun Pharma)
HS-626
NDA/BLA
Zhejiang Hisun Pharmaceutical Co Ltd
Psoriasis
Etanercept biosimilar (AryoGen Biopharma)
Approved
Aryogen Biopharma
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
Adalimumab-adbm
BI-695501
Approved
C.H. Boehringer Sohn Ag & Co. Kg
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Colitis, Ulcerative, Arthritis, Psoriatic, Uveitis, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT03210259
NCT02850965
NCT02871635
NCT02137226
NCT02640612
NCT02636907
NCT01505491
NCT02606903
NCT02045979
NCT02899338
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Psoriasis
Psoriasis
Crohn Disease
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Healthy
Healthy
Healthy
Healthy
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Etanercept biosimilar (Shanghai Fudan-Zhangjiang Bio-Pharmaceutical)
NDA/BLA
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Arthritis, Rheumatoid
Luminol sodium
MP-1032
Approved
Selvim, Metrio
Immune System Diseases, Psoriasis
NCT Number
NCT02908347
NCT03706209
Intervention Type
Drug
Drug
Indications
Psoriasis; Plaque Psoriasis
Psoriasis
Study Phase
Phase 2
Phase 2
Recruitment Status
Completed
Completed
Recombinant human TNF-α monoclonal antibody(SL Pharma/Combio)
KM113
IND
Beijing Sl Pharmaceutical Co Ltd, Beijing Kangming Bio New Drug Development Co Ltd
Autoimmune Diseases
Etanercept-szzs
GP-2015
Approved
Clariant Produkte (Schweiz) Ag
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
NCT Number
NCT02638259
NCT03729674
Intervention Type
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
Study Phase
Phase 3
N/A
Recruitment Status
Completed
Recruiting
Adalimumab biosimilar (Amgen)
ABP-501
Approved
Amgen Inc
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT04131322
NCT01970475
NCT01970488
NCT02114931
NCT04378621
Intervention Type
Drug
Biological
Biological
Biological
Other;Drug
Indications
Crohn Disease; Ulcerative Colitis
Arthritis, Rheumatoid
Psoriasis
Arthritis, Rheumatoid
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Study Phase
Phase 4
Phase 3
Phase 3
Phase 3
N/A
Recruitment Status
Not yet recruiting
Completed
Completed
Completed
Not yet recruiting
Adalimumab biosimilar (Fresenius Kabi)
MSB-11022
Approved
Merck Serono, Fresenius Kabi
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Uveitis, Hidradenitis Suppurativa, Crohn Disease
NCT Number
NCT02660580
NCT03052322
NCT04018599
NCT03014947
Intervention Type
Drug
Drug
Drug
Drug
Indications
Psoriasis; Plaque Type Psoriasis; Moderate to Severe Plaque Psoriasis
Moderate to Severe Rheumatoid Arthritis
Rheumatoid Arthritis; Polyarticular Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Crohn Disease; Ulcerative Colitis; Plaque Psoriasis; Pediatric Plaque Psoriasis; Pediatric Crohns Disease; Hidradenitis Suppurativa; Non-infectious Uveitis
Healthy Subjects
Study Phase
Phase 3
Phase 3
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Certolizumab pegol
PHA-738144, CDP-870, CZP
Approved
Ucb
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Spondylarthropathies, Multiple Sclerosis, Psoriasis, Arthritis, Psoriatic, Osteoarthritis, Spine, Crohn Disease, Plaque psoriasis
NCT Number
NCT02597829
NCT00580840
NCT01602302
NCT02242474
NCT01696942
NCT03020992
NCT02451748
NCT01500278
NCT01548768
NCT00993668
NCT01443364
NCT01295151
NCT01147341
NCT02714634
NCT02353780
NCT01024647
NCT01255761
NCT01491815
NCT02466581
NCT00308581
NCT00152490
NCT01590966
NCT00850343
NCT00160602
NCT02505542
NCT00160641
NCT00152386
NCT01087788
NCT00307931
NCT01235598
NCT02319642
NCT00354367
NCT00152425
NCT00851318
NCT00544154
NCT00160693
NCT03368664
NCT04123795
NCT00674362
NCT02552212
NCT01521923
NCT00552344
NCT01519791
NCT00356408
NCT03357471
NCT00358683
NCT01817972
NCT04610476
NCT02346240
NCT01374971
NCT02151851
NCT00333788
NCT02497976
NCT00160524
NCT00297648
NCT02326272
NCT01197066
NCT04643483
NCT01213017
NCT00993317
NCT00843778
NCT01451203
NCT00717236
NCT02586246
NCT00791921
NCT00753454
NCT00548834
NCT01087762
NCT01292265
NCT01864265
NCT01550003
NCT02326298
NCT00160706
NCT00552058
NCT00175877
NCT00349752
NCT03051217
NCT00791999
NCT01190410
NCT00291668
NCT03215277
NCT00245765
NCT02430909
NCT00329550
NCT03152058
NCT01090154
NCT00329420
NCT02293590
NCT00329303
NCT00899678
NCT02806219
NCT02120807
NCT02154425
NCT02365948
NCT00813774
NCT01091220
NCT00845663
NCT02019602
NCT04163016
NCT04378621
NCT01288287
NCT01691014
NCT02073526
NCT01526434
NCT01577264
NCT03559686
NCT01625650
NCT01053559
NCT01764321
NCT01095393
NCT01582568
NCT01098201
NCT02354105
NCT01069419
NCT03266471
NCT02714881
NCT03062865
NCT02775656
NCT02619552
NCT00844285
NCT02620189
NCT03955861
NCT04053881
NCT03559660
NCT04569890
NCT01773681
NCT03016260
NCT01489384
NCT01797224
Intervention Type
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Drug
Biological;Drug
Drug
Other;Biological
Biological
Biological;Drug
Drug
Drug
Drug
Biological
Biological
Biological;Drug
Biological;Drug
Other;Biological
Drug
Drug
Drug
Drug
Other;Biological
Biological
Drug
Other;Biological
Biological
Other;Biological
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Other;Biological
Biological
Biological
Other;Biological
Biological
Drug
Drug
Biological;Drug
Drug
Other;Biological
Procedure;Drug
Other;Biological;Drug
Biological
Biological;Drug
Biological
Biological
Other;Biological
Drug
Drug
Drug
Drug
Biological
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Biological
Biological
Drug
Drug
Other;Biological
Biological
Other;Biological
Biological
Other;Biological
Other;Drug
Drug
Drug
Other;Biological
Other;Drug
Other;Drug
Other;Biological
Biological
Drug
Drug
Biological
Drug
Drug
Drug
Device
Drug
Procedure;Biological
Other;Biological
Biological
Biological
Drug
Procedure;Biological
Drug
Other;Drug
Other
Drug
Drug
Drug
Drug
Drug
Diagnostic Test;Other
Radiation;Drug
Other
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug;Device
Biological
Indications
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Axial Spondyloarthritis (axSpA); Anterior Uveitis (AU)
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis; Insufficient Response to Methotrexate.
Rheumatoid Arthritis (RA)
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Crohn's Disease
Axial and Peripheral Spondyloarthritis; Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Axial Spondyloarthrithis; Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Arthritis, Psoriatic
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn Disease
Crohn's Disease
Rheumatoid Arthritis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Multiple Sclerosis
Moderate Chronic Plaque Psoriasis; Severe Chronic Plaque Psoriasis; Mixed Guttate/Plaque Psoriasis
Rheumatoid Arthritis
Axial Spondyloarthritis; Nonradiographic Axial Spondyloarthritis; Nr-axSpA
Rheumatoid Arthritis
Crohn Disease
Rheumatoid Arthritis
Crohn's Disease
Moderate and Severe Active Rheumatoid Arthritis; Active Psoriatic Arthritis; Active Ankylosing Spondylitis; Moderately to Severely Active Crohn's Disease
Crohn's Disease
Crohn's Disease
Psoriatic Arthritis; Withdrawal; Reduction
Psoriasis; Plaque Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Cystitis, Interstitial
Crohn's Disease
Crohn's Disease
Psoriasis; Plaque Psoriasis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Active Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Spondyloarthropathies
Rheumatoid Arthritis
Rheumatoid Arthritis
Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
Psoriasis; Plaque Psoriasis
Crohn's Disease
Crohn Disease
Rheumatoid Arthritis
Crohn's Disease
Moderate to Severe Psoriasis; Generalized Pustular Psoriasis and Erythrodermic Psoriasis
Rheumatoid Arthritis
Crohn's Disease
Crohn's Disease
Ankylosing Spondylitis
Chronic Plaque Psoriasis
Rheumatoid Arthritis
Crohn's Disease
High Risk Pregnancy; Pregnancy Complications; Antiphospholipid Syndrome in Pregnancy; Lupus Anticoagulant Disorder
Ulcerative Colitis
Crohn's Disease
Rheumatoid Arthritis
Psoriasis
Crohn's Disease
Healthy
Stage IV Lung Adenocarcinoma
Axial Spondyloarthritis (AxSpA); Non-radiographic Evidence-AxSpA; Ankylosing Spondylitis; Crohn's Disease; Psoriatic Arthritis; Rheumatoid Arthritis
Healthy Subjects
Bioavailability Study on Healthy Volunteers
Sperm Quality
Healthy
Axial Spondyloarthritis (AxSpA); Non-radiographic Evidence-AxSpA; Ankylosing Spondylitis; Crohn's Disease; Psoriatic Arthritis; Rheumatoid Arthritis
Rheumatoid Arthritis; Psoriatic Arthritis; Crohn's Disease; Axial Spondyloarthritis; Plaque Psoriasis
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Arthritis,Rheumatoid
Rheumatoid Arthritis (RA)
Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis
Rheumatoid Arthritis
Rheumatoid Arthritis; Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohns Disease
Rheumatoid Arthritis
Axial Spondyloarthritis
Rheumatoid Arthritis
Inflammatory Bowel Diseases
Rheumatoid Arthritis; Cardiovascular Disease
RheumatoId Arthritis
Rheumatoid Arthritis (RA); Crohn's Disease (CD); Psoriatic Arthritis (PsA); Axial Spondyloarthritis and Ankylosing Spondylitis
Crohn's Disease; IBD
Crohn's Disease
Rheumatoid Arthritis
Psoriatic Arthritis; Psoriasis; Enthesitis
Plaque Psoriasis
Crohn's Disease
Rheumatoid Arthritis; Pregnancy Related
Rheumatoid Arthritis
RheumatoId Arthritis
Rheumatoid Arthritis
Crohn's Disease; Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis; Psoriasis
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Unknown status
Completed
Terminated
Unknown status
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Terminated
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Unknown status
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Active, not recruiting
Completed
Completed
Completed
Terminated
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Not yet recruiting
Completed
Terminated
Completed
Completed
Terminated
Available
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Enrolling by invitation
Recruiting
Recruiting
Terminated
Completed
Completed
Unknown status
Recruiting
Recruiting
Available
Not yet recruiting
Completed
Terminated
Unknown status
Recruiting
Etanercept biosimilar (Mylan)
YLB-113
Approved
Mylan Nv, Lupin Ltd
Arthritis, Rheumatoid, Spondylarthropathies, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
Adalimumab biosimilar (HEC Pharma)
IND
Guangdong Dongyangguang Pharmaceutical Co Ltd
Arthritis, Rheumatoid
Etanercept biosimilar (Amega Biotech)
Approved
Amega Biotech
Arthritis, Rheumatoid
NCT Number
NCT03332719
NCT03403140
Intervention Type
Biological;Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Study Phase
Phase 3
Phase 3
Recruitment Status
Completed
Unknown status
Adalimumab biosimilar (AXXO)
Approved
Axxo
Arthritis, Rheumatoid, Arthritis, Psoriatic
Adalimumab biosimilar (Shanghai Henlius Biotech)
HLX-03
Approved
Shanghai Henlius Biotech Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis
NCT Number
NCT03316781
NCT03357939
Intervention Type
Drug
Drug
Indications
Plaque Psoriasis
Immune System Disorder
Study Phase
Phase 3
Phase 1
Recruitment Status
Unknown status
Completed
Golimumab
rTNV148B, CNTO-148
Approved
Janssen Global Services Llc
Diabetes Mellitus, Type 1, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Colitis, Ulcerative, Arthritis, Psoriatic, Asthma
NCT Number
NCT01212653
NCT02092285
NCT03253796
NCT01804166
NCT02687724
NCT02242474
NCT03669029
NCT01602302
NCT02155335
NCT01604629
NCT03733925
NCT01668004
NCT01548768
NCT01718951
NCT02758782
NCT02186886
NCT03124121
NCT01295151
NCT02318667
NCT02425865
NCT00488631
NCT00264550
NCT02277444
NCT02065713
NCT02437162
NCT00264537
NCT01863771
NCT04108468
NCT02438787
NCT03270501
NCT01426815
NCT00727987
NCT03596645
NCT01871649
NCT01453725
NCT00973479
NCT04610476
NCT00265083
NCT02181673
NCT01004432
NCT01230827
NCT01248793
NCT02186873
NCT00771251
NCT00487539
NCT01715896
NCT04218565
NCT03182166
NCT02456363
NCT01988961
NCT02846545
NCT01217814
NCT00955279
NCT02862574
NCT00207740
NCT01526174
NCT03298542
NCT01900574
NCT01288157
NCT03632759
NCT04188249
NCT03016260
NCT02011386
NCT03043677
NCT01313858
NCT03945903
NCT03955861
NCT04531423
NCT01610947
NCT01081717
NCT03729349
NCT03496831
NCT02414984
NCT03775824
NCT02841176
NCT04378621
NCT04200833
Intervention Type
Other;Drug
Drug
Other;Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Biological
Drug
Biological
Drug
Drug
Drug
Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Other;Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological
Biological
Diagnostic Test;Biological;Drug
Biological;Drug
Biological
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Biological
Drug
Drug
Biological
Other;Drug
Drug
Other;Biological;Drug
Biological
Drug
Biological
Drug
Other;Biological
Other;Drug
Drug
Indications
Ankylosing Spondylitis(AS)
Ulcerative Colitis
Spondyloarthritis
Hepatosplenic T-Cell Lymphoma
Colitis
Rheumatoid Arthritis
Colitis, Ulcerative
Rheumatoid Arthritis
Ulcerative Colitis
Spondylarthropathies
Spondylitis, Ankylosing; Arthritis, Psoriatic
Ankylosing Spondylitis
Rheumatoid Arthritis
Spondyloarthropathy
Ankylosing Spondylitis
Ulcerative Colitis
Ulcerative Colitis
Rheumatoid Arthritis
Colitis, Ulcerative
ULCERATIVE COLITIS
Colitis, Ulcerative
Rheumatoid Arthritis
Arthritis, Juvenile
Psoriatic Arthritis
Axial Spondyloarthritis
Rheumatoid Arthritis
Colitis, Ulcerative
Psoriatic Arthritis
Axial Spondyloarthritis
Axial Spondyloarthritis
Peripheral Spondylarthritis
Rheumatoid Arthritis
Colitis, Ulcerative
Psoriatic Arthritis
Spondylitis, Ankylosing
Arthritis, Rheumatoid
Psoriatic Arthritis; Withdrawal; Reduction
Spondylitis, Ankylosing
Arthritis, Psoriatic
Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases
Juvenile Idiopathic Arthritis
Ankylosing Spondylitis
Ankylosing Spondylitis
Rheumatoid Arthritis
Colitis, Ulcerative
Rheumatoid Arthritis
Behcet Syndrome; Uveitis
Ulcerative Colitis
Ankylosing Spondylitis
Colitis, Ulcerative
Diabetes Mellitus, Type 1
Rheumatoid Arthritis
Sarcoidosis
Rheumatoid Arthritis
Asthma
Autoimmune Inner Ear Disease
Pre-Symptomatic Type 1 Diabetes
Colitis, Ulcerative
Healthy Adult Chinese Males
Type 1 Diabetes Mellitus
Arthritis, Rheumatoid
RheumatoId Arthritis
Axial Spondyloarthritis
Inflammatory Bowel Disease
Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing
Diabetes Mellitus, Type 1
Psoriatic Arthritis; Psoriasis; Enthesitis
Major Depressive Disorder
Spondyloarthritis
Rheumatoid Arthritis; Arthritis, Psoriatic; Ankylosing Spondylitis
Arthritis, Rheumatoid
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriatic Arthritis
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
JIA Associated Uveitis
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Completed
Active, not recruiting
Completed
Unknown status
Unknown status
Unknown status
Terminated
Completed
Completed
Recruiting
Completed
Completed
Completed
Active, not recruiting
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Completed
Recruiting
Terminated
Recruiting
Completed
Completed
Recruiting
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Unknown status
Completed
Active, not recruiting
Terminated
Completed
Terminated
Completed
Terminated
Recruiting
Active, not recruiting
Completed
Recruiting
Recruiting
Terminated
Completed
Completed
Completed
Available
Recruiting
Not yet recruiting
Completed
Completed
Recruiting
Completed
Terminated
Completed
Terminated
Not yet recruiting
Active, not recruiting
Adalimumab biosimilar (Innovent Biologics)
IBI-303
Approved
Innovent Biologics (Suzhou) Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis
NCT Number
NCT02893254
Intervention Type
Drug
Indications
AS
Study Phase
Phase 3
Recruitment Status
Completed
PG-201
PG-201
Approved
Viromed
Osteoarthritis, Knee, Osteoarthritis
NCT Number
NCT02049606
NCT01768468
NCT01576419
NCT01122485
Intervention Type
Drug
Drug
Drug
Other
Indications
Osteoarthritis of the Knee
Osteoarthritis of the Knee
Osteoarthritis of the Knee
Osteoarthritis of the Knee
Study Phase
Phase 4
Phase 4
Phase 3
Phase 2
Recruitment Status
Completed
Completed
Completed
Completed
Adalimumab biosimilar (Bio-Thera Solutions)
BAT-1406
Approved
Bio-Thera Solutions Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Uveitis, Crohn Disease
NCT Number
NCT04135508
Intervention Type
Drug
Indications
Ankylosing Spondylitis
Study Phase
Phase 3
Recruitment Status
Completed
Adalimumab (Beijing Science Sun)
K-3, K3
Preclinical
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Colitis, Ulcerative, Plaque psoriasis
Etanercept biosimilar (Intas Biopharmaceuticals)
Approved
Intas Biopharmaceuticals
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
Lenalidomide
IMiD-3, CC-5013, CDC-501, CDC-5013, ENMD-0997, IMID-5013
Approved
Celgene Corp
Lymphoma, B-Cell, Marginal Zone, Recurrence, Hematologic Diseases, Leukemia, Myeloid, Lymphoma, B-Cell, HIV Infections, Lymphoma, T-Cell, Peripheral, Anemia, Paraproteinemias, Blood Protein Disorders, Myelodysplastic Syndromes, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, Large B-Cell, Diffuse, Smoldering Multiple Myeloma, Multiple Myeloma, Lymphoma, Follicular, Lymphoma, Mantle-Cell, Radiculopathy, Prostatic Neoplasms, Reflex Sympathetic Dystrophy, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Waldenstrom Macroglobulinemia, Thrombocytopenia, Leukemia, Myeloid, Acute, Neoplasm Metastasis, Melanoma, Leukemia, Lymphocytic, Chronic, B-Cell, Carcinoma, Non-Small-Cell Lung, Crohn Disease, Complex Regional Pain Syndromes
NCT Number
NCT01198054
NCT03416374
NCT03934684
NCT01731886
NCT04152577
NCT04038411
NCT03908138
NCT04348006
NCT01408199
NCT04361643
NCT04040491
NCT03173092
NCT04217967
NCT03829371
NCT02076009
NCT02112175
NCT04680052
NCT02659293
NCT03729804
NCT00111319
NCT02252172
NCT04071457
NCT02215980
NCT02579863
NCT00114101
NCT01650701
NCT00843882
NCT03941860
NCT01239797
NCT03617731
NCT03720041
NCT04084626
NCT03859427
NCT00988208
NCT04224493
NCT01335399
NCT03948035
NCT01208766
NCT04270409
NCT00179647
NCT01021423
NCT00179621
NCT01564537
NCT00522392
NCT04287660
NCT03652064
NCT02128061
NCT01208662
NCT01916252
NCT02544308
NCT02516423
NCT01554852
NCT02495922
NCT00166452
NCT01243944
NCT01476787
NCT00093028
NCT01530594
NCT00480363
NCT01091831
NCT01191060
NCT00478777
NCT00056160
NCT01093196
NCT00420849
NCT04096066
NCT01080391
NCT00424047
NCT00572169
NCT00689936
NCT02575144
NCT01122472
NCT00551928
NCT03651128
NCT03993912
NCT04288765
NCT00405756
NCT02354313
NCT03937635
NCT03901963
NCT03319667
NCT04483739
NCT04298372
NCT00928486
NCT01659658
NCT01863550
NCT01109004
NCT00644228
NCT01850524
NCT01621672
NCT01685814
NCT01243476
NCT00064038
NCT01996865
NCT00602641
NCT01029262
NCT02516696
NCT00774345
NCT00891384
NCT01169337
NCT02406144
NCT02285062
NCT02322320
NCT00098475
NCT01098656
NCT00622336
NCT04404283
NCT03710603
NCT01891643
NCT01938001
NCT02155634
NCT04566328
NCT00057616
NCT00430365
NCT03952091
NCT00910910
NCT01865110
NCT04490707
NCT00055562
NCT00120120
NCT02419118
NCT03428373
NCT01197560
NCT02145598
NCT02633137
NCT02219178
NCT00179686
NCT00675441
NCT00883623
NCT00759603
NCT01936532
NCT01036399
NCT00628238
NCT01415752
NCT00786851
NCT01393756
NCT00812968
NCT02928419
NCT01553149
NCT00067743
NCT01496976
NCT00109005
NCT01241786
NCT00535873
NCT03333746
NCT04032626
NCT00403169
NCT02897830
NCT01206205
NCT01459211
NCT01617213
NCT02272803
NCT03000634
NCT02720510
NCT02471820
NCT02619682
NCT04329130
NCT02294357
NCT01199575
NCT00695786
NCT01782963
NCT00065156
NCT03490344
NCT04063189
NCT00466921
NCT02060656
NCT00445692
NCT00267059
NCT01402284
NCT00238238
NCT02188368
NCT02871219
NCT01830478
NCT02802943
NCT03837873
NCT01939327
NCT00538733
NCT00848328
NCT00378209
NCT04174196
NCT00925821
NCT01858558
NCT03605056
NCT02420860
NCT01647165
NCT01556477
NCT01472562
NCT03367143
NCT01718379
NCT02523040
NCT01133275
NCT00874978
NCT03004287
NCT03376477
NCT03289299
NCT03669445
NCT03054532
NCT04480099
NCT00305812
NCT00742560
NCT02460276
NCT00091260
NCT02538965
NCT03544281
NCT02232516
NCT01133665
NCT02874742
NCT03003520
NCT00602836
NCT04094142
NCT01919619
NCT00996931
NCT01374217
NCT00907348
NCT00717756
NCT00963105
NCT00179673
NCT01401322
NCT04268498
NCT03188172
NCT00899431
NCT02389517
NCT01216683
NCT02986451
NCT03168100
NCT00691704
NCT01548573
NCT04129710
NCT01919086
NCT03673826
NCT01729091
NCT02880228
NCT02371590
NCT00482911
NCT01270932
NCT02193698
NCT00227591
NCT00840827
NCT01772420
NCT01379274
NCT00744536
NCT03290950
NCT01481194
NCT01351896
NCT01271283
NCT03412565
NCT04009109
NCT02371577
NCT02955823
NCT00352794
NCT01754870
NCT00546897
NCT01572480
NCT02309515
NCT01269203
NCT01032291
NCT03730740
NCT02126553
NCT00684242
NCT01675141
NCT01215344
NCT03477539
NCT01358734
NCT01054144
NCT03012880
NCT03641456
NCT01559935
NCT01779167
NCT00617591
NCT04025593
NCT02253316
NCT00096525
NCT00474188
NCT01133743
NCT00287287
NCT00619684
NCT02538198
NCT00607581
NCT03785184
NCT01702831
NCT04622579
NCT03411031
NCT00977132
NCT01553357
NCT03031483
NCT00833534
NCT00974233
NCT03697356
NCT04544059
NCT01342692
NCT02843074
NCT01924169
NCT01375140
NCT01611259
NCT02446457
NCT01816620
NCT04518982
NCT01194791
NCT04140162
NCT01178814
NCT02225275
NCT04460248
NCT02719613
NCT01442714
NCT01754857
NCT01723839
NCT00885508
NCT02331368
NCT01556035
NCT01307605
NCT00860457
NCT02903381
NCT01701076
NCT02441686
NCT00179660
NCT04404088
NCT00166413
NCT00478218
NCT01501370
NCT00961467
NCT00445484
NCT02532257
NCT02765854
NCT01775553
NCT01301820
NCT01518465
NCT01737177
NCT01055301
NCT03556332
NCT01127542
NCT01246076
NCT01724177
NCT00179738
NCT01816971
NCT01553786
NCT00418665
NCT01545804
NCT03269669
NCT04214626
NCT02917941
NCT00478959
NCT01116193
NCT00410605
NCT01673308
NCT01956695
NCT00087672
NCT04497961
NCT00360672
NCT00074282
NCT03495960
NCT00772915
NCT01282047
NCT00439231
NCT03212807
NCT04481815
NCT01419795
NCT04635189
NCT00424229
NCT00044382
NCT03409432
NCT00843310
NCT00142168
NCT02728102
NCT03959358
NCT03224507
NCT03815279
NCT01121757
NCT00867308
NCT04627753
NCT02906332
NCT03118466
NCT00352365
NCT01460940
NCT00847639
NCT00446433
NCT01011894
NCT00540007
NCT02636322
NCT00908232
NCT01160107
NCT01373294
NCT02005289
NCT00784927
NCT00779922
NCT01522976
NCT00322985
NCT00540644
NCT01380106
NCT04151667
NCT00765245
NCT00761449
NCT00957385
NCT01264315
NCT00751296
NCT01743859
NCT02353468
NCT03715309
NCT02472691
NCT01600053
NCT00044018
NCT01349569
NCT00923663
NCT03891355
NCT01132989
NCT00602459
NCT01316523
NCT00783367
NCT00567229
NCT01465230
NCT00799513
NCT01729338
NCT04352205
NCT00737529
NCT01160484
NCT04430894
NCT02128230
NCT01651039
NCT03232307
NCT03606577
NCT03809780
NCT01463670
NCT02399085
NCT00875667
NCT00902915
NCT01123356
NCT03252600
NCT01053806
NCT00109772
NCT02916771
NCT02969837
NCT04052880
NCT03863184
NCT00051116
NCT00654186
NCT01002755
NCT02415413
NCT02405364
NCT02086552
NCT00942578
NCT04277845
NCT00460031
NCT03733691
NCT01794039
NCT01450215
NCT01237249
NCT00720850
NCT00665652
NCT03746223
NCT01446133
NCT00679367
NCT00538824
NCT00655668
NCT00807599
NCT00482261
NCT01245673
NCT01307592
NCT01698801
NCT02203643
NCT02041325
NCT01639898
NCT01125176
NCT00064974
NCT00968331
NCT00553644
NCT00165477
NCT01088373
NCT03949062
NCT01497496
NCT00151203
NCT03019640
NCT00632359
NCT01706666
NCT03314636
NCT00837031
NCT01856192
NCT00564889
NCT03376672
NCT02206503
NCT02159365
NCT00609869
NCT04231370
NCT00065351
NCT01145495
NCT03104842
NCT01274533
NCT00971685
NCT00096044
NCT04223661
NCT04065789
NCT01593410
NCT02279394
NCT01718743
NCT01222195
NCT03184194
NCT02921893
NCT03500445
NCT02375555
NCT04002401
NCT00413036
NCT03413800
NCT01081431
NCT02348528
NCT00112827
NCT01079936
NCT02213913
NCT01038635
NCT02937571
NCT01002703
NCT02802163
NCT02343042
NCT01111903
NCT00396045
NCT00778752
NCT02180711
NCT02057640
NCT01303965
NCT02898259
NCT02561273
NCT02911142
NCT02733042
NCT02589145
NCT02631577
NCT02206425
NCT02075021
NCT03015792
NCT01368757
NCT01421186
NCT01057121
NCT00829647
NCT02983097
NCT01995669
NCT01412307
NCT01155583
NCT02963610
NCT01582776
NCT00699842
NCT01355705
NCT01638936
NCT02685826
NCT04539236
NCT01054196
NCT02529852
NCT00348595
NCT00975806
NCT00890929
NCT01583283
NCT04423926
NCT01060384
NCT01383928
NCT00294632
NCT02302469
NCT00507442
NCT03191981
NCT01788189
NCT00972842
NCT00831766
NCT01016600
NCT01531998
NCT00915408
NCT03980171
NCT01003769
NCT00352001
NCT02875067
NCT00670358
NCT00477750
NCT04257448
NCT01208051
NCT04607772
NCT00179751
NCT02281279
NCT01547260
NCT01019174
NCT04446962
NCT00901615
NCT01035463
NCT04663347
NCT01127386
NCT03011814
NCT02038153
NCT01703364
NCT02077166
NCT00966693
NCT00981708
NCT03100877
NCT00738829
NCT01241734
NCT01217957
NCT01049945
NCT02142049
NCT01348919
NCT00790842
NCT02341014
NCT04432714
NCT00621400
NCT01502085
NCT00378105
NCT01403246
NCT01076543
NCT01166035
NCT02077959
NCT00963534
NCT00179712
NCT01297764
NCT01029054
NCT00536341
NCT01615029
NCT01755975
NCT00306813
NCT02389543
NCT00910858
NCT01246557
NCT01668719
NCT02340936
NCT04120350
NCT00633594
NCT00727415
NCT01075321
NCT01180569
NCT01484626
NCT00939510
NCT01744912
NCT01010243
NCT02628405
NCT03015896
NCT01575860
NCT00987493
NCT01704781
NCT01342172
NCT01558167
NCT01142232
NCT00903630
NCT00724568
NCT01881789
NCT01093183
NCT00179725
NCT01686386
NCT02265510
NCT01460420
NCT01555281
NCT01352338
NCT01750983
NCT00840931
NCT01056679
NCT00398515
NCT00560391
NCT03150316
NCT01429025
NCT00031941
NCT01711671
NCT00884546
NCT04661007
NCT00923234
NCT01718899
NCT01644799
NCT01246622
NCT00933426
NCT02481934
NCT02335983
NCT00525447
NCT00412581
NCT01998971
NCT01578954
NCT01604031
NCT01965353
NCT01202890
NCT02426723
NCT00100880
NCT03591744
NCT01766583
NCT01542918
NCT00735930
NCT03373305
NCT01038388
NCT01954784
NCT01042704
NCT01732861
NCT01829568
NCT01629082
NCT00687674
NCT02721043
NCT03302728
NCT01681537
NCT01955499
NCT01886859
NCT00091624
NCT04196491
NCT01200004
NCT03984097
NCT01645930
NCT03208218
NCT01729104
NCT01904643
NCT02018523
NCT00153933
NCT03283046
NCT04519476
NCT03523975
NCT00502112
NCT01615042
NCT00642954
NCT00729638
NCT02160015
NCT02036502
NCT02312102
NCT00495872
NCT01749969
NCT01373229
NCT00415064
NCT01005979
NCT02334865
NCT03070327
NCT01562405
NCT00543114
NCT03701711
NCT03223610
NCT01218555
NCT02568553
NCT00864942
NCT04091126
NCT01045928
NCT04447716
NCT01088048
NCT04134936
NCT02521714
NCT04447027
NCT04609046
NCT04635683
NCT01985477
NCT04246086
NCT00580242
NCT01421927
NCT01619761
NCT02431208
NCT03015922
NCT02705638
NCT03031730
NCT01838434
NCT02697344
NCT00415116
NCT02513186
NCT01126450
NCT01712828
NCT01185262
NCT00179699
NCT00466895
NCT00046735
NCT01155505
NCT00179608
NCT02370888
NCT04326296
NCT00828802
NCT02280525
NCT00698776
NCT00839059
NCT01433965
NCT03558750
NCT01132586
NCT02918331
NCT04436107
NCT04272775
NCT02086604
NCT01034592
NCT02992522
NCT00104962
NCT01207921
NCT03703167
NCT01062152
NCT01750762
NCT02655458
NCT01348503
NCT02600897
NCT02446236
NCT00603447
NCT01183663
NCT01440582
NCT01169298
NCT00671801
NCT01254617
NCT01378091
NCT01742793
NCT00555100
NCT02255162
NCT01116154
NCT02573896
NCT01711554
NCT03506802
NCT02954406
NCT01254578
NCT01393964
NCT02200848
NCT00419250
NCT01352962
NCT01241292
NCT00729118
NCT04301076
NCT03702725
NCT00253344
NCT02492750
NCT01359657
NCT00532675
NCT03359460
NCT01400685
NCT01217203
NCT03110822
NCT02030483
NCT04578600
NCT01953692
NCT03113695
NCT00991562
NCT02886065
NCT01222754
NCT00036894
NCT03050450
NCT00434239
NCT01861340
NCT01537861
NCT04049864
NCT00704691
NCT00907452
NCT03001804
NCT02692339
NCT03903406
NCT02856438
NCT03433001
NCT02537808
NCT01430546
NCT02164955
NCT03098589
NCT03065790
NCT02387879
NCT00633945
NCT02608515
NCT02525250
NCT02863458
NCT02368301
NCT01927718
NCT00899080
NCT01081028
NCT04109872
NCT01347944
NCT04319601
NCT01947309
NCT04036448
NCT02666209
NCT04432402
NCT04435743
NCT02528838
NCT02921815
NCT00890552
NCT02279654
NCT02921802
NCT01752075
NCT02922543
NCT02733224
NCT03715296
NCT02556905
NCT00911105
NCT00792077
NCT01268774
NCT01827137
NCT03647124
NCT01649791
NCT02341781
NCT02741544
NCT02075996
NCT03106324
Intervention Type
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Procedure;Other;Drug
Drug
Other;Biological;Drug
Other;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug;Combination Product
Biological;Drug
Other;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Procedure
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Other;Drug
Other;Drug
Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Radiation;Drug
Procedure;Drug
Biological;Drug
Drug
Other;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Other;Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Procedure;Drug;Genetic
Procedure;Drug
Drug
Drug
Drug
Drug
Procedure;Other;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug;Behavioral
Drug
Biological;Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Other;Procedure;Drug
Drug;Device
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Radiation;Biological;Drug;Genetic
Procedure;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Drug
Drug
Drug
Procedure;Drug
Drug
Drug;Dietary Supplement
Drug
Other;Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Other;Biological;Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Behavioral
Drug
Drug
Other;Drug
Drug
Biological;Drug
Other;Biological;Drug;Genetic
Drug
Drug
Other;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Biological;Drug
Other;Drug
Other;Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Procedure;Biological;Radiation;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug;Genetic
Drug
Drug
Other;Biological;Drug
Drug
Drug
Other;Biological;Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Other;Drug
Biological;Drug
Drug
Drug
Other;Drug
Other;Drug
Drug
Other;Procedure;Radiation;Drug
Other;Drug
Drug
Other;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug;Genetic
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Other;Biological;Radiation;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug;Behavioral
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug;Genetic
Other;Drug
Biological;Drug
Other;Biological;Drug
Procedure;Other;Biological;Radiation;Drug
Drug
Other;Drug
Biological;Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological
Drug;Combination Product
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Diagnostic Test
Drug
Procedure
Drug
Drug;Behavioral
Other;Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Other;Procedure;Drug
Drug
Indications
AML
Relapsed and/or Refractory Multiple Myeloma
Relapsed Refractory Multiple Myeloma
Multiple Myeloma
Lymphoma, B-Cell
NK/T Cell Lymphoma
Hematologic Neoplasms; Multiple Myeloma; Efficacy; Safety
Newly Diagnosed Multiple Myeloma
Cutaneous Lupus
COVID-19
Peripheral T-cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Follicular Lymphoma; Marginal Zone Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma
Follicular Lymphoma
Anemia; Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome
Plasma Cell Myeloma
Lymphoma; Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
EBV Infection
Relapsed or Refractory Multiple Myeloma
Prostate Cancer
Relapsed/Refractory Follicular Lymphoma
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma
Myelodysplastic Syndromes
Relapsed Multiple Myeloma; Refractory Multiple Myeloma
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Plasmacytoma
Solitary Osseous Plasmacytoma
Multiple Myeloma
Multiple Myeloma
Complex Regional Pain Syndrome, Type 1
Polycythemia Vera
Follicular Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; New Diagnosis Tumor
Relapsed Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphoma; Diffuse Large B-cell Lymphoma
Multiple Myeloma; Newly Diagnosed Patients
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
MANTLE CELL LYMPHOMA
Smoldering Plasma Cell Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Amyloidosis Cardiac
Multiple Myeloma
Relapsed or Refractory Systemic Light Chain Amyloidosis
Plasma Cell Myeloma
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Previously Untreated Symptomatic Multiple Myeloma
Myelodysplastic Syndrome
Multiple Myeloma; Plasma Cell Neoplasm
Lymphoma, Non-Hodgkin
Plasma Cell Myeloma
Anemia
Multiple Myeloma
B-cell Chronic Lymphocytic Leukemia
Multiple Myeloma
Light Chain Deposition Disease; Smoldering Plasma Cell Myeloma
Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Lymphoma
Multiple Myeloma
Diffuse Large B-cell Lymphoma
Multiple Myeloma
Newly Diagnosed, Previously Untreated Multiple Myeloma
Lymphoma, Non-Hodgkin
Multiple Myeloma; Neoplasms; Plasma Cells; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Therapeutic Uses
Plasma Cell Myeloma; RISS Stage I Plasma Cell Myeloma; RISS Stage II Plasma Cell Myeloma
Melanoma; Neoplasm Metastasis
Myeloma
Multiple Myeloma in Relapse; Refractory Multiple Myeloma
B-Cell Chronic Lymphocytic Leukemia
Mantle Cell Lymphoma
Acute Myeloid Leukemia in Remission
Melanoma; Neoplasm Metastasis
Radiculopathy
Multiple Myeloma
Multiple Myeloma in Relapse; Multiple Myeloma Progression; Multiple Myeloma Stage II; Multiple Myeloma Stage I; Multiple Myeloma With Failed Remission; Multiple Myeloma Stage III
Diffuse Large B-cell Lymphoma
Multiple Myeloma
Mantle Cell Lymphoma; Untreated
Multiple Myeloma
Non-Small Cell Lung Cancer
Graft-versus-Host Disease
Primary Amyloidosis
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Newly Diagnosed Multiple Myeloma
Peripheral T-cell Lymphoma
Chronic Lymphocytic Leukemia; CLL; Untreated; Front-line; First-Line; Initial Therapy
Lymphoma; Neurotoxicity; Therapy-related Toxicity
MANTLE CELL LYMPHOMA
Follicular Lymphoma
Myelodysplastic Syndromes
Myelodysplastic Syndromes
Neurofibromatosis Type 1; Recurrent Childhood Pilocytic Astrocytoma; Recurrent Childhood Visual Pathway Glioma
Complex Regional Pain Syndrome (RSD)
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Melanoma
Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
Leukemia; CLL; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Cognitive Impairment, Mild; Cognitive Dysfunction; Amyloid Plaque; Neurodegeneration; Inflammation, Brain
Kidney Cancer
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma; Transplant-Related Carcinoma
Relapsed or Refractory Peripheral T-cell Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia; CLL
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma in Relapse
Lymphoma
Diffuse Large B-Cell Lymphoma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Chronic Lymphocytic Leukemia; Leukemia
Multiple Myeloma
Lymphoma
Multiple Myeloma
Ann Arbor Stage II Grade 1 Follicular Lymphoma; Ann Arbor Stage II Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Bulky Disease; Fatigue; Fever; Grade 3a Follicular Lymphoma; Night Sweats; Splenomegaly; Weight Loss
Indolent Non Hodgkin Lymphoma
Leukemia, Chronic Lymphatic
Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Transformed Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Lymphoma
Multiple Myeloma
Plasmacytoma; Plasmacytoma of Bone; Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Hematopoietic Cell Transplantation Recipient; Plasma Cell Myeloma
Multiple Myeloma
Myelodysplastic Syndrome; Acute Myelogenous Leukemia
Mantle Cell Lymphoma
Diffuse Large B-Cell Lymphoma Refractory
Myelodysplastic Syndromes
Langerhans Cell Histiocytosis (LCH); Histiocytoses Erdheim-chester Disease; Histiocytic Sarcoma (HS)
Myelodysplastic Syndrome; MDS
Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma
Smoldering Multiple Myeloma
Multiple Myeloma
LYMPHOMA
Peripheral T-cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Hematologic Cancer
Relapsed/Refractory Mantle Cell Lymphoma
Multiple Myeloma
Leukemia, Myeloid
Multiple Myeloma
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome
Squamous Cell Carcinoma
Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse
Leukemia; Lymphoma
Non-hodgkin Lymphoma,B Cell
B-Cell Non-Hodgkin Lymphoma; Hematopoietic and Lymphoid Cell Neoplasm; Leukemia; Lymphoma; Plasma Cell Myeloma; T-Cell Non-Hodgkin Lymphoma
Autism
Multiple Myeloma
Non Hodgkin Lymphoma; Follicular Lymphoma
Liver Cancer
Relapsed or Refractory Chronic Lymphocytic Leukemia
Non-Hodgkins Lymphoma
Leukemia; Relapsed Adult Acute Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Plasma Cell Myeloma; Residual Disease
Lymphoma
Relapse/Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)
Multiple Myeloma (MM)
Smouldering Myeloma
Plasma Cell Leukemia; Plasma Cell Myeloma
Plasma Cell Myeloma
Chronic Lymphocytic Leukemia
Intraocular Melanoma; Malignant Conjunctival Neoplasm
Renal Failure; Multiple Myeloma
POEMS Syndrome
Essential Thrombocythemia; Polycythemia Vera; Primary Myelofibrosis
Myelodysplastic Syndrome
Adult Myelodysplastic Syndrome; Anemia; Chronic Myelomonocytic Leukemia
MDS
Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Angiogenesis
Multiple Myeloma
Multiple Myeloma
Ann Arbor Stage I Small Lymphocytic Lymphoma; Ann Arbor Stage II Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene; Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Multiple Myeloma
Myeloma, Multiple
Chronic Lymphocytic Leukemia (CLL)
Diffuse Large B-cells Non-Hodgkin Lymphoma
Myelofibrosis
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
Leukemia, Myeloid, Acute
Multiple Myeloma
Monoclonal B-Cell Lymphocytosis; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma
Multiple Myeloma
Colorectal Cancer
Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma
Alkylating Agent-Related Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia
Advanced Cancer; Pain
Multiple Myeloma
Multiple Myeloma
Minimal Residual Disease; Plasma Cell Myeloma
Acute Myeloid Leukemia; Acute Myelogenous Leukemia
Multiple Myeloma
Plasma Cell Myeloma
Myeloma; Newly Diagnosed; High Risk
Multiple Myeloma
Waldenstrom Macroglobulinemia
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Kidney Cancer
Diffuse Large B-cell Lymphoma
Chronic Lymphocytic Leukemia
Thyroid Neoplasms
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Plasma Cell Myeloma
Amyloidosis
Multiple Myeloma
Multiple Myeloma
Diffuse Large B Cell Lymphoma; Age Over 80 Years
Multiple Myeloma
Myelodysplastic Syndrome MDS
Primary Plasma Cell Leukemia
Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
Leukemia; Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Waldenström's Macroglobulinemia
Diffuse Large B Cell Lymphoma
MDS
Multiple Myeloma
Hematologic Disorder
Myeloproliferative Diseases
Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma
POEMS Syndrome
CAEBV
Primary Systemic Amyloidosis
Multiple Myeloma
Myelodysplastic Syndrome
Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS)
Lymphoid Leukemia; Small Lymphocytic Lymphoma; Lymphoma, Non-Hodgkin
Chronic Lymphocytic Leukemia (CLL)
Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Acute Myeloid Leukemia
Multiple Myeloma
Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)
Lymphoma
Chronic Lymphocytic Leukemia
Smoldering Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Non-Hodgkins Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Amyloidosis
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; CD20 Positive; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Relapse Multiple Myeloma; Refractory Multiple Myeloma
Acute Myeloid Leukemia
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Mantle Cell Lymphoma
Multiple Myeloma; Plasma Cell Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukaemia
Myelodysplastic Syndromes
Adult T-Cell Leukemia-Lymphoma
Prostate Cancer
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
T-cell Lymphoma
Myelodysplastic Syndromes; Thrombocytopenia
Liver Cancer
Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Refractory Follicular Lymphoma
Diffuse Large B Cell Lymphoma
Relapsed and/or Refractory Multiple Myeloma
Hodgkin Disease
Leukemia, Lymphoid; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Multiple Myeloma in Relapse; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myelodysplastic Syndrome
Lymphoma; Relapse
Myelofibrosis
Multiple Myeloma
Acute Myelogenous Leukemia; Myelodysplastic Syndrome
Leukemia
Primary Central Nervous System Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
HIV Infection Associated Kaposi Disease
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma
EBV Related Non-Hodgkin's Lymphoma; Primary CNS Lymphoma; Primary Testicular Lymphoma
PCNSL
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia
Multiple Myeloma
Myelodysplastic Syndromes
Myelodysplastic Syndrome
Lymphomatoid Papulosis; Primary Cutaneous Anaplastic Large Cell Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma
Multiple Myeloma
Waldenstrom's Macroglobulinemia
Multiple Myeloma
Multiple Myeloma; Amyloidosis
Multiple Myeloma
Multiple Myeloma; Smoldering Multiple Myeloma
Follicular Lymphoma; Marginal Zone Lymphoma
Myelodysplastic Syndrome
Primary CNS Lymphoma
Multiple Myeloma
AML
Adult Acute Basophilic Leukemia; Adult Acute Eosinophilic Leukemia; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia
Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma
Multiple Myeloma
Crohn's Disease
Chronic Lymphocytic Leukemia; Leukemia
Hodgkin Disease
Diffuse Large B-Cell Lymphoma Unclassifiable
Multiple Myeloma
Multiple Myeloma
Bladder Cancer
Contiguous Stage II Small Lymphocytic Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma
Lymphoma
Multiple Myeloma; Impaired Renal Function
Chronic Myelomonocytic Leukemia; Chronic Myelomonocytic Leukemia-1; Chronic Myelomonocytic Leukemia-2; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Excess Blasts-1; Myelodysplastic Syndrome With Excess Blasts-2
T-cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphoma
MDS; AML
Acute Myeloid Leukemia
Multiple Myeloma
Chronic Lymphocytic Leukaemia
Acute Myeloid Leukemia
Refractory Plasma Cell Myeloma
Follicular Lymphoma
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic
Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
MALT Lymphoma
Mantle Cell Lymphoma
Cutaneous T Cell Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Non Hodgkin's Lymphoma
Follicular Lymphoma; Marginal Zone B-Cell Lymphoma; MALT Lymphoma; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Lymphocytic; Waldenstrom Macroglobulinemia; Mantle-Cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma
Multiple Myeloma
Plasma Cell Myeloma; Renal Failure
Mantle Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
CCND1 Positive; CD20-Positive Neoplastic Cells Present; Mantle Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Diffuse Large B-cell Lymphoma
Mantle Cell Lymphoma; Lymphoma, Mantle-Cell
Multiple Myeloma Light Chain Induced Renal Insufficiency
Chronic Lymphocytic Leukemia
Recurrent Primary Amyloidosis
Myelodysplastic Syndrome
Complex Regional Pain Syndrome, Type I
Smoldering Multiple Myeloma
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
Mantle Cell Lymphoma
Multiple Myeloma
Prostate Cancer
Chronic Lymphocytic Leukemia; Fatigue; Fever; Hypogammaglobulinemia; Lymphadenopathy; Lymphocytosis; Night Sweats; Paraproteinemia; Small Lymphocytic Lymphoma; Thrombocytopenia
Smoldering Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Metastatic Prostate Cancer
Multiple Myeloma
Prostate Cancer
Newly Diagnosed Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndromes; Acute Myelogenous Leukemia
Neuropathy; Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
Primary Intraocular Lymphoma
Leukemia; Lymphoma
Multiple Myeloma
Multiple Myeloma
T-cell Non-Hodgkin's Lymphoma
Multiple Myeloma
Multiple Myeloma
Myeloma
Lymphoma
Multiple Myeloma
MULTIPLE MYELOMA (MM)
Plasma Cell Disorder
POEMS Syndrome
Chronic Lymphocytic Leukemia
Myelodysplastic Syndromes
Diffuse Large B-cell Lymphoma
Recurrent Mantle Cell Lymphoma
Glioblastoma; Gliosarcoma; Malignant Gliomas
Myelodysplastic Syndromes
Diffuse Large B Cell Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Multiple Myeloma
Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myeloma
Metastatic Pancreatic Cancer
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphocytic Leukemia; Mantle Cell Lymphoma
NK/T Cell Lymphoma Nos
Multiple Myeloma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Multiple Myeloma
Adult T Cell Leukemia/Lymphoma
POEMS Syndrome
Leukemia
Multiple Myeloma
Myeloma Multiple; Myeloma, Plasma-Cell; Myeloma-Multiple; Plasma Cell Myeloma
Multiple Myeloma
Smoldering Myeloma; Smoldering Multiple Myeloma
Hematopoietic Cell Transplantation Recipient; Plasma Cell Myeloma
Leukemia
Myeloma
Plasmacytoma; POEMS Syndrome
Myeloma; Multiple Myeloma
Multiple Myeloma
Refractory Large B-cell Lymphoma
Lymphoma, Non-Hodgkin's
Relapsed Hematologic Malignancy; Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Refractory Multiple Myeloma; Smoldering Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myeloma; Stem Cell Transplantation
Adult Grade III Lymphomatoid Granulomatosis; B-cell Chronic Lymphocytic Leukemia; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Progressive Hairy Cell Leukemia, Initial Treatment; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage 0 Chronic Lymphocytic Leukemia; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Testicular Lymphoma; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia
Leukemia
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Ovarian Cancer Recurrent
Multiple Myeloma
Multiple Myeloma
Non Hodgkin Lymphoma
Multiple Myeloma; Kahler Disease; Plasma-Cell Myeloma; Myelomatosis
Multiple Myeloma
B Cell Lymphoma; Lymphoma
Anaplastic Large Cell Lymphoma, ALK-Negative; Anaplastic Large Cell Lymphoma, ALK-Positive; Hepatosplenic T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Stage II Angioimmunoblastic T-cell Lymphoma; Stage II Enteropathy-Associated T-Cell Lymphoma; Stage III Angioimmunoblastic T-cell Lymphoma; Stage III Enteropathy-Associated T-Cell Lymphoma; Stage IV Angioimmunoblastic T-cell Lymphoma; Stage IV Enteropathy-Associated T-Cell Lymphoma
Primary Effusion Lymphoma; B-Cell Neoplasm
Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell
Lymphoma
Lymphoma, Follicular
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Chronic Myelomonocytic Leukemia
Multiple Myeloma
AIDS-Related Kaposi Sarcoma; Recurrent Kaposi Sarcoma
Chronic Lymphocytic Leukemia; Leukemia
Diffuse Large B-cell Lymphoma (DLBCL); Follicular Lymphoma Grade III (FL III°); Mantle Cell Lymphoma (MCL), Blastoid Variant; Burkitt Lymphoma (BL); Aggressive Marginal Zone Lymphoma (MZL)
Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Follicular Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Small Lymphocytic Lymphoma
Recurrent Adult Hodgkin Lymphoma
Refractory Multiple Myeloma
Relapsed or Refractory Solid Tumors; Nonsmall Cell Lung Cancer
Follicular Lymphoma Patients (Phase IB); Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
Myelodysplastic Syndrome; MDS; Low to Intermediate-1 MDS; Non-deletion 5q
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Lymphoma
Prostate Cancer
Renal Cell Carcinoma
Acute Myeloid Leukemia (AML); Adult Acute Myeloblastic Leukemia
Multiple Myeloma
PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATL
Non-Hodgkin's Lymphoma
Multiple Myeloma
Lymphoma
Waldenstrom Macroglobulinemia
Multiple Myeloma
Myeloma Multiple
B-cell Lymphoma
Peripheral T-Cell Non-Hodgkin's Lymphoma
Myelodysplastic Syndrome; Acute Myeloid Leukemia
Leukemia, Myeloid, Acute
Myeloma
Multiple Myeloma
Follicular Lymphoma
Recurrent Chronic Lymphocytic Leukemia
Leukemia; Myelodysplastic Syndromes
Relapsed Hodgkin Lymphoma; Relapsed Non-Hodgkin Lymphoma
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Pancreas Cancer; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma
Refractory Differentiated Thyroid Gland Carcinoma; Refractory Thyroid Gland Follicular Carcinoma; Refractory Thyroid Gland Hurthle Cell Carcinoma; Refractory Thyroid Gland Papillary Carcinoma; Unresectable Thyroid Gland Carcinoma
Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Pancreatic Cancer
B-cell Adult Acute Lymphoblastic Leukemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Pancreatic Carcinoma.
Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse; Central Nervous System Neoplasms, Primary
Lymphoma, Large B-Cell, Diffuse; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma
Anaplastic Large Cell Lymphoma, ALK-Negative; Recurrent Anaplastic Large Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma; Follicular Lymphoma
Cancer Cachexia Syndrome
Folliculotropic Mycosis Fungoides; Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified; Sezary Syndrome; Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia in Remission
CLL; Chronic Lymphocytic Leukemia
Relapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Amyloidosis
Plasma Cell Leukemia in Remission; Plasma Cell Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell
Diffuse Large B-cell Lymphoma.
Multiple Myeloma
Refractory Multiple Myeloma
Diffuse Large B Cell Lymphoma Relapsed; Diffuse Large B Cell Lymphoma Refractory
Multiple Myeloma
Multiple Myeloma; Plasma Cell Neoplasm
T-cell Lymphomas; Relapsed or Refractory
DLBCL; Untreated; MYC Gene Rearrangement
Amyloidosis
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
AIDS-Related Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Waldenstrom Macroglobulinemia
Solid Tumors
Multiple Myeloma
Mantle Cell Lymphoma
Ovarian Cancer
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma; Non-Hodgkin's Lymphoma
Relapse; Refractory Multiple Myeloma
Multiple Myeloma
Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)
Chronic Lymphatic Leukemia
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Diffuse Large B-cell Lymphoma
Primary Central Nervous System Lymphoma
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
Lymphoma; Follicular Lymphoma
Multiple Myeloma
Prostate Cancer
Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B-cell Lymphomas; Marginal Zone Lymphoma; Mantle Cell Lymphoma; Waldenstrom's Macroglobulinemia
Multiple Myeloma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma
Grade 3a Follicular Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma
Lymphoma
Lymphoma
HIV-1 Infection
Urinary Bladder Neoplasms
Chronic Lymphocytic Leukemia
Multiple Myeloma
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Multiple Myeloma
Multiple Myeloma
Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer
Ovarian Cancer
Multiple Myeloma
Solid Tumors; Advanced Malignancies; Metastatic Cancer
Hematologic Malignancies; Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Advanced Cancers
Leukemia
Hodgkin Lymphoma
Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma
Myeloma, Multiple
Refractory/Relapsed Indolent Non-Hodgkin Lymphoma
Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Multiple Myeloma
Advanced Cancer, Various, NOS
Non Hodgkins Lymphoma; Diffuse Large B-cell Lymphoma
Myelodysplastic Syndromes; Acute Myelogenous Leukemia
Smoldering Multiple Myeloma
Recurrent Follicular Lymphoma
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Recurrent Adult Acute Myeloid Leukemia
Prostate Cancer
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Melanoma
Multiple Myeloma
Acute Myeloid Leukemia
B-cell Chronic Lymphocytic Leukemia
Multiple Myeloma in Relapse
Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Carcinoma; Primary Peritoneal Carcinoma
Multiple Myeloma
Childhood Atypical Teratoid/Rhabdoid Tumor; Childhood Central Nervous System Germ Cell Tumor; Childhood Choroid Plexus Tumor; Childhood Craniopharyngioma; Childhood Ependymoblastoma; Childhood Grade I Meningioma; Childhood Grade II Meningioma; Childhood Grade III Meningioma; Childhood High-grade Cerebellar Astrocytoma; Childhood High-grade Cerebral Astrocytoma; Childhood Infratentorial Ependymoma; Childhood Low-grade Cerebellar Astrocytoma; Childhood Low-grade Cerebral Astrocytoma; Childhood Medulloepithelioma; Childhood Mixed Glioma; Childhood Oligodendroglioma; Childhood Supratentorial Ependymoma; Recurrent Childhood Brain Tumor; Recurrent Childhood Cerebellar Astrocytoma; Recurrent Childhood Cerebral Astrocytoma; Recurrent Childhood Ependymoma; Recurrent Childhood Medulloblastoma; Recurrent Childhood Pineoblastoma; Recurrent Childhood Subependymal Giant Cell Astrocytoma; Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor; Recurrent Childhood Visual Pathway and Hypothalamic Glioma
Plasma Cell Leukemia
Relapsed/Refractory B-cell Lymphoma
Recurrent/Refractory CNS; Intraocular Lymphoma
Anemia; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Thrombocytopenia
CD30-Positive Neoplastic Cells Present; Folliculotropic Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Sezary Syndrome
Multiple Myeloma
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myeloma
Leukemia Lymphocytic Chronic B-Cell
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Myeldysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia; Bone Marrow Diseases; Neutropenia; Acute Myeloid Leukemia (AML)
Multiple Myeloma and Plasma Cell Neoplasm
Solid Tumors
Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Hodgkin Lymphoma
Acute Myelogenous Leukemia
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma
Recurrent B-Cell Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory B-Cell Prolymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Multiple Myeloma
Multiple Myeloma
Advanced Cancers
Multiple Myeloma
Multiple Myeloma
Healthy, Male
Lymphoma
Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia
Carcinoma, Non-Small-Cell Lung
Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic; Multiple Myeloma
Refractory Multiple Myeloma
Mantle Cell Lymphoma
Myelodysplastic Syndrome (MDS)
Acute Leukemia
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Multiple Myeloma
Myelodysplastic Syndrome; Acute Myeloid Leukemia
Solid Tumors
Plasma Cell Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell
Multiple Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell; Chronic Lymphocytic Leukemia; Lymphoma, Small Lymphocytic
Partial Response of Multiple Myeloma or Plasma Cell Leukemia; Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia
Demyelinating Sensorimotor Neuropathy
Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Burkitt Lymphoma
Solid Organ Malignancies; Adenoidcystic Carcinoma; Neuroendocrine Tumors
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Grade 3b Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mediastinal Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Mediastinal Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma
Multiple Myeloma
Adult Non-Hodgkin Lymphoma; Adult Grade III Lymphomatoid Granulomatosis; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
Indolent Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma
Diffuse Large B-cell Lymphoma
Healthy Volunteers
Relapsed/Refractory T-cell Malignancies; Cutaneous T-Cell Lymphoma; Mature T-cell Malignancies; Peripheral T-Cell Lymphoma
Central Nervous System Lymphoma; Diffuse Large B-Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Nodal Marginal Zone Lymphoma; Recurrent Splenic Marginal Zone Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Follicular Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Nodal Marginal Zone Lymphoma; Refractory Splenic Marginal Zone Lymphoma; Refractory Waldenstrom Macroglobulinemia
Myeloma
Follicular Lymphoma
Myelodysplasia
Multiple Myeloma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Multiple Myeloma
Multiple Myeloma
Immunoglobulin G Subclass 4 Related Disease; IgG4-related Disease; Autoimmune Pancreatitis; IgG4-related Sclerosing Cholangitis; Retroperitoneal Fibrosis
Plasmacytoma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Relapsed/Refractory Mantle Cell Lymphoma
Recurrent Plasma Cell Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Plasma Cell Myeloma
Colon Cancer; Rectal Cancer
Healthy
Chronic Lymphocytic Leukemia
Non-Small Cell Lung Cancer
Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Lymphocytic Leukemia
Neoplasms
Advanced Solid Tumors
Malignant Melanoma
Leukemia, Myeloid; Myelodysplastic Syndromes
Colorectal Neoplasms
Myelodysplastic Syndromes
Leukemia
Myeloma
Acute Myeloid Leukemia
Acute Myeloid Leukemia; Myelodysplastic Syndrome
Recurrent Central Nervous System Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Refractory Central Nervous System Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL; Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA; Alkylating Agent-Related Acute Myeloid Leukemia; de Novo Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome; Recurrent Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndrome; Untreated Adult Acute Myeloid Leukemia
Multiple Myeloma
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Relapsed and/or Refractory Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse
Anemia; Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS)
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Transformed Recurrent Non-Hodgkin Lymphoma
Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ringed Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Secondary Myelodysplastic Syndromes; Unspecified Childhood Solid Tumor, Protocol Specific
Hodgkin Disease
Primary Central Nervous System Lymphoma (PCNSL); Secondary Central Nervous System Lymphoma (SCNSL)
Myelodysplastic Syndrome
Multiple Myeloma; Lymphoma
Multiple Myeloma
Hepatocellular Carcinoma
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Mantle Cell Lymphoma
Relapsed Multiple Myeloma
Advanced Cancers
Myeloma
Adult T-cell Leukemia-Lymphoma; Peripheral T-cell Lymphoma
Malignant Gliomas
Recurrent Colon Carcinoma; Recurrent Hypopharyngeal Squamous Cell Carcinoma; Recurrent Laryngeal Squamous Cell Carcinoma; Recurrent Laryngeal Verrucous Carcinoma; Recurrent Lip and Oral Cavity Squamous Cell Carcinoma; Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary; Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma; Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma; Recurrent Oral Cavity Verrucous Carcinoma; Recurrent Oropharyngeal Squamous Cell Carcinoma; Recurrent Rectal Carcinoma; Recurrent Salivary Gland Carcinoma; Salivary Gland Squamous Cell Carcinoma; Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary; Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7; Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7; Stage IVA Colon Cancer AJCC v7; Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVA Laryngeal Verrucous Carcinoma AJCC v7; Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVA Major Salivary Gland Cancer AJCC v7; Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVA Oral Cavity Cancer AJCC v6 and v7; Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7; Stage IVA Rectal Cancer AJCC v7; Stage IVB Colon Cancer AJCC v7; Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVB Laryngeal Verrucous Carcinoma AJCC v7; Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVB Major Salivary Gland Cancer AJCC v7; Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVB Oral Cavity Cancer AJCC v6 and v7; Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7; Stage IVB Rectal Cancer AJCC v7; Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVC Laryngeal Verrucous Carcinoma AJCC v7; Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVC Major Salivary Gland Cancer AJCC v7; Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVC Oral Cavity Cancer AJCC v6 and v7; Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7; Tongue Carcinoma
Prostate Cancer
Hodgkin's Lymphoma; Mature T-cell Lymphoma; Multiple Myeloma
Multiple Myeloma
Acute Myeloid Leukemia (AML); Acute Myelocytic Leukemia; Acute Myelogenous Leukemia; Acute Granulocytic Leukemia; Acute Non-Lymphocytic Leukemia
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Neuroblastoma
Recurrent Neuroblastoma; Refractory Neuroblastoma
HLA-A*0201 Positive Cells Present; NY-ESO-1 Positive Tumor Cells Present; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Lymphoma, Non-Hodgkin
Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A; Adult Acute Promyelocytic Leukemia With PML-RARA; Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-Cell Lymphoma; Alkylating Agent-Related Acute Myeloid Leukemia; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma; Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Hepatosplenic T-Cell Lymphoma; Intraocular Lymphoma; Lymphomatous Involvement of Non-Cutaneous Extranodal Site; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Nodal Marginal Zone Lymphoma; Post-Transplant Lymphoproliferative Disorder; Primary Cutaneous B-Cell Non-Hodgkin Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Non-Hodgkin Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Richter Syndrome; Small Intestinal Lymphoma; Splenic Marginal Zone Lymphoma; T-Cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Multiple Myeloma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia; Leukemia, B-Cell, Chronic
Urethral Neoplasms; Neoplasms, Urethral; Cancer of the Urethra; Urethral Cancer
Multiple Myeloma
Multiple Myeloma; Plasma Cell Neoplasm
Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection
Refractory Multiple Myeloma; Multiple Myeloma in Relapse; Multiple Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Indolent Plasma Cell Myeloma; Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome; Refractory High Risk Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Therapy-Related Myelodysplastic Syndrome
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B Chronic Lymphocytic Leukemia
Patients With Multiple Myeloma Experiencing a; First or Second Relapse
Multiple Myeloma
Multiple Myeloma
Indolent B-Cell Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Mucosa-Associated Lymphoid Tissue Lymphoma; Recurrent Follicular Lymphoma; Recurrent Hairy Cell Leukemia; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Mucosa-Associated Lymphoid Tissue Lymphoma; Refractory Follicular Lymphoma; Refractory Hairy Cell Leukemia; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Small Lymphocytic Lymphoma
Myelodysplastic Syndrome; Multiple Myeloma; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Primary Mediastinal B-Cell Lymphoma
Richter's Syndrome; CLL
Multiple Myeloma
Smoldering Multiple Myeloma
Diffuse Intrinsic Pontine Glioma; Anaplastic Astrocytoma; High Grade Glioma
Brain and Central Nervous System Tumors
Central Nervous System Tumors
Myelodysplasia
Myeloma
Multiple Myeloma
Relapsed Neuroblastoma
Peripheral T-cell Lymphomas; Adult T-cell Leukemia; Adult T-cell Lymphoma; Peripheral T-cell Lymphoma Unspecified; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large Cell Lymphoma; T/Null Cell Systemic Type; Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease
Myeloma
Multiple Myeloma
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Cutaneous Lupus Erythematosus (CLE)
Relapsed/Refractory Multiple Myeloma
Acute Myeloid Leukemia or Myelodysplasic Syndrome
Acute Myeloid Leukemia; Myelodysplastic Syndromes
Multiple Myeloma
Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Mantle Cell Lymphoma
Myelodysplastic Syndrome
Angioimmunoblastic T-cell Lymphoma; Chemotherapy Effect; Chemotherapeutic Toxicity
Multiple Myeloma
Myelodysplastic Syndromes; Lymphoma, Mantle-Cell
Multiple Myeloma in Relapse; Multiple Myeloma
Diffuse Large B Cell Lymphoma
Non-hodgkin Lymphoma,B Cell
Multiple Myeloma
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute
Leukemia; Amyloidosis
Myelodysplastic Syndrome
Multiple Myeloma; Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma
Patient Non-adherence
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Leukemia; CLL
Multiple Myeloma
Multiple Myeloma; Minimal Residual Disease; High-Risk Cancer
Lymphoma, Mantle-Cell
B-cell Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia
Lymphoma, Mantle-Cell
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Terminated
Active, not recruiting
Recruiting
Completed
Recruiting
Recruiting
Recruiting
Recruiting
Completed
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Terminated
Completed
Active, not recruiting
Terminated
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Unknown status
Recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Withdrawn
Recruiting
Completed
Completed
Recruiting
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Terminated
Active, not recruiting
Completed
Completed
Terminated
Completed
Completed
Active, not recruiting
Terminated
Unknown status
Active, not recruiting
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Active, not recruiting
Completed
Terminated
Completed
Terminated
Recruiting
Completed
Terminated
Completed
Completed
Terminated
Active, not recruiting
Withdrawn
Terminated
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Unknown status
Recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Completed
Completed
Not yet recruiting
Active, not recruiting
Withdrawn
Unknown status
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Recruiting
Completed
Terminated
Unknown status
Completed
Completed
Completed
Terminated
Recruiting
Recruiting
Terminated
Suspended
Active, not recruiting
Withdrawn
Withdrawn
Completed
Terminated
Recruiting
Active, not recruiting
Recruiting
Recruiting
Completed
Withdrawn
Terminated
Completed
Completed
Completed
Terminated
Recruiting
Terminated
Completed
Active, not recruiting
Completed
Active, not recruiting
Withdrawn
Active, not recruiting
Not yet recruiting
Withdrawn
Active, not recruiting
Completed
Withdrawn
Completed
Recruiting
Completed
Withdrawn
Terminated
Recruiting
Recruiting
Terminated
Terminated
Completed
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Terminated
Completed
Recruiting
Active, not recruiting
Completed
Terminated
Completed
Completed
Completed
Active, not recruiting
Completed
Withdrawn
Active, not recruiting
Recruiting
Recruiting
Terminated
Completed
Active, not recruiting
Withdrawn
Completed
Recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Terminated
Completed
Completed
Recruiting
Completed
Recruiting
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Active, not recruiting
Unknown status
Completed
Completed
Active, not recruiting
Completed
Suspended
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Withdrawn
Completed
Completed
Active, not recruiting
Recruiting
Completed
Completed
Terminated
Completed
Withdrawn
Recruiting
Terminated
Completed
Completed
Terminated
Unknown status
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Terminated
Completed
Withdrawn
Recruiting
Terminated
Not yet recruiting
Unknown status
Completed
Recruiting
Terminated
Terminated
Active, not recruiting
Recruiting
Recruiting
Enrolling by invitation
Terminated
Terminated
Recruiting
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Terminated
Recruiting
Completed
Terminated
Completed
Completed
Unknown status
Recruiting
Unknown status
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Terminated
Unknown status
Terminated
Recruiting
Completed
Completed
Recruiting
Active, not recruiting
Completed
Withdrawn
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Unknown status
Completed
Recruiting
Unknown status
Terminated
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Not yet recruiting
Completed
Recruiting
Completed
Completed
Completed
Terminated
Terminated
Recruiting
Active, not recruiting
Completed
Terminated
Terminated
Completed
Unknown status
Completed
Unknown status
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Completed
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Completed
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Recruiting
Completed
Active, not recruiting
Recruiting
Completed
Unknown status
Completed
Not yet recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Terminated
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Active, not recruiting
Unknown status
Withdrawn
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Terminated
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Active, not recruiting
Terminated
Suspended
Unknown status
Completed
Completed
Withdrawn
Terminated
Active, not recruiting
Unknown status
Completed
Terminated
Active, not recruiting
Terminated
Completed
Completed
Active, not recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Completed
Terminated
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Terminated
Completed
Completed
Completed
Completed
Recruiting
Terminated
Completed
Terminated
Active, not recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Terminated
Withdrawn
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Recruiting
Terminated
Completed
Active, not recruiting
Completed
Unknown status
Withdrawn
Completed
Unknown status
Completed
Completed
Completed
Terminated
Terminated
Active, not recruiting
Recruiting
Completed
Unknown status
Active, not recruiting
Terminated
Completed
Unknown status
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Withdrawn
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Withdrawn
Terminated
Completed
Completed
Unknown status
Recruiting
Recruiting
Active, not recruiting
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Terminated
Terminated
Unknown status
Terminated
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Not yet recruiting
Terminated
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Active, not recruiting
Terminated
Completed
Completed
Withdrawn
Completed
Completed
Completed
Withdrawn
Active, not recruiting
Terminated
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Terminated
Recruiting
Completed
Completed
Terminated
Terminated
Terminated
Completed
Withdrawn
Not yet recruiting
Recruiting
Completed
Terminated
Completed
Completed
Active, not recruiting
Terminated
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Terminated
Recruiting
Active, not recruiting
Active, not recruiting
Terminated
Recruiting
Recruiting
Completed
Recruiting
Completed
Recruiting
Terminated
Recruiting
Completed
Active, not recruiting
Completed
Recruiting
Not yet recruiting
Not yet recruiting
Terminated
Recruiting
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
Completed
Terminated
Completed
Completed
Unknown status
Completed
Terminated
Not yet recruiting
Completed
Active, not recruiting
Completed
Terminated
Active, not recruiting
Terminated
Completed
Completed
Recruiting
Terminated
Active, not recruiting
Terminated
Suspended
Completed
Active, not recruiting
Recruiting
Completed
Terminated
Completed
Terminated
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Terminated
Terminated
Recruiting
Active, not recruiting
Withdrawn
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Terminated
Recruiting
Completed
Recruiting
Completed
Recruiting
Completed
Completed
Suspended
Unknown status
Completed
Terminated
Recruiting
Terminated
Completed
Recruiting
Recruiting
Not yet recruiting
Available
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Approved for marketing
Terminated
Completed
Active, not recruiting
Recruiting
Completed
Recruiting
Terminated
Not yet recruiting
No longer available
Recruiting
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Recruiting
Terminated
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Adalimumab biosimilar (CTTQ Pharma)
NDA/BLA
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Arthritis, Rheumatoid
Adalimumab-afzb
PF-06410293
Approved
Pfizer Pharmaceuticals Ltd (China)
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Hidradenitis Suppurativa, Uveitis, Crohn Disease
NCT Number
NCT04230213
NCT02480153
NCT02237729
NCT02572245
NCT01870986
Intervention Type
Drug
Biological
Biological
Device
Biological
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy Subjects
Healthy Subjects
Healthy
Study Phase
Phase 3
Phase 3
Phase 1
Phase 1
Phase 1
Recruitment Status
Recruiting
Completed
Completed
Completed
Completed
Infliximab
TA-650
Approved
Janssen Global Services Llc
Giant Cell Arteritis, Spondylitis, Ankylosing, Arthritis, Rheumatoid, Sarcoidosis, Pediatric Crohn's disease, Mucocutaneous Lymph Node Syndrome, Psoriasis, Pediatric ulcerative colitis, Arthritis, Psoriatic, Colitis, Ulcerative, Parapsoriasis, Uveitis, Pulmonary Disease, Chronic Obstructive, Crohn Disease, Behcet Syndrome
NCT Number
NCT03937609
NCT00688636
NCT02743390
NCT00779012
NCT00507403
NCT00686595
NCT01802593
NCT01346826
NCT02425852
NCT00554710
NCT01752790
NCT01638715
NCT01282528
NCT00574470
NCT01880307
NCT00779935
NCT00432432
NCT01308255
NCT00462072
NCT00896168
NCT00714493
NCT03004443
NCT02242474
NCT01144143
NCT00396747
NCT02994836
NCT00752622
NCT02177071
NCT00936143
NCT00794898
NCT02566889
NCT01604629
NCT01000441
NCT02517684
NCT02353780
NCT01793519
NCT02878161
NCT01548768
NCT01148901
NCT02770040
NCT00133315
NCT00764725
NCT00463580
NCT01793831
NCT00589628
NCT01804166
NCT00686894
NCT00246064
NCT01408810
NCT04530877
NCT02412085
NCT03679546
NCT01295151
NCT00542152
NCT01442025
NCT00908089
NCT04150770
NCT01072058
NCT00726804
NCT02829424
NCT01817426
NCT01602302
NCT02453776
NCT01181765
NCT02770794
NCT02132234
NCT00778869
NCT04646187
NCT00216177
NCT00636142
NCT02714634
NCT00851565
NCT00432406
NCT00132691
NCT02332356
NCT00439283
NCT00040885
NCT01571219
NCT00796250
NCT00094458
NCT00385086
NCT00051623
NCT01217086
NCT01532570
NCT03596645
NCT02096861
NCT00527072
NCT00336492
NCT00236028
NCT03112603
NCT02298062
NCT04610476
NCT00760435
NCT00367237
NCT00207662
NCT00269841
NCT00805766
NCT00984568
NCT00254982
NCT01190839
NCT01962974
NCT00095147
NCT00571337
NCT00521924
NCT00036439
NCT01936181
NCT02505568
NCT03371095
NCT00096655
NCT00237484
NCT01585155
NCT00844805
NCT03162432
NCT00202852
NCT00207675
NCT01177800
NCT00202865
NCT00443651
NCT01724268
NCT03478111
NCT00505947
NCT00317538
NCT04593940
NCT04535518
NCT03065244
NCT00269867
NCT01551290
NCT00394589
NCT00732875
NCT00004941
NCT01559142
NCT02136069
NCT00132899
NCT00207766
NCT03088293
NCT01580670
NCT00833053
NCT00036374
NCT02771457
NCT00207701
NCT03147248
NCT00056264
NCT01423591
NCT01680159
NCT00537316
NCT00687401
NCT02779114
NCT00106834
NCT01661257
NCT00251641
NCT00036387
NCT03704610
NCT00106847
NCT00691028
NCT01596335
NCT00629772
NCT01548014
NCT00073437
NCT00686686
NCT00358670
NCT00443222
NCT02532738
NCT00368264
NCT00591201
NCT00521963
NCT00269854
NCT02457585
NCT00823641
NCT00074074
NCT04305145
NCT00753103
NCT00687362
NCT00230529
NCT00523354
NCT01313520
NCT00006292
NCT02363738
NCT01485055
NCT00512278
NCT00795574
NCT00201799
NCT00372723
NCT00076726
NCT00244179
NCT04114188
NCT02763761
NCT00278083
NCT00112749
NCT04438382
NCT03269695
NCT00304954
NCT00060502
NCT00207714
NCT04564001
NCT02251041
NCT03684278
NCT01355614
NCT00175266
NCT00283712
NCT01216631
NCT00033891
NCT00514982
NCT00029042
NCT02403232
NCT00244192
NCT04425538
NCT02495077
NCT00604864
NCT02126020
NCT00958906
NCT00325078
NCT01256489
NCT02638701
NCT01846026
NCT00111917
NCT02620618
NCT00959725
NCT00271570
NCT01886443
NCT00695682
NCT01844804
NCT03293784
NCT02359903
NCT02883452
NCT03446976
NCT01571206
NCT01971814
NCT01220518
NCT03006393
NCT02987686
NCT00075075
NCT00583232
NCT01567358
NCT01261286
NCT00228839
NCT03819296
NCT01630850
NCT00553176
NCT00705471
NCT03266471
NCT01361542
NCT00207688
NCT00725452
NCT01625650
NCT00779675
NCT00840957
NCT01356758
NCT01706692
NCT00658827
NCT00819663
NCT01850121
NCT01692899
NCT01543594
NCT02075697
NCT02707341
NCT01605175
NCT00661284
NCT00760669
NCT02332460
NCT01753245
NCT03452501
NCT03358693
NCT03340519
NCT02356445
NCT00988832
NCT03308357
NCT03325582
NCT00224562
NCT01657513
NCT03108326
NCT00948610
NCT04131504
NCT04156425
NCT03681652
NCT01685918
NCT03775824
NCT02293681
NCT00725543
NCT00639821
NCT01490528
NCT02330458
NCT02322008
NCT00724529
NCT00725296
NCT03331393
NCT04655729
NCT03192878
NCT01436019
NCT00307593
NCT00818168
NCT01233583
NCT02557308
NCT01299545
NCT02088944
NCT02922192
NCT02694588
NCT03209232
NCT02170714
NCT02522169
NCT03445624
NCT01848028
NCT02998398
NCT00818272
NCT00748826
NCT00901550
NCT01981473
NCT01349920
NCT00237419
NCT01438151
NCT00261976
NCT01617018
NCT03818516
NCT00723905
NCT01787786
NCT01083563
NCT00508547
NCT01971970
NCT00749398
NCT01759017
NCT01610947
NCT01666535
NCT00724958
NCT00755937
NCT00705289
NCT01338740
NCT00705614
NCT01613963
NCT01245361
NCT01137838
NCT00745329
NCT02073526
NCT00586807
NCT03370601
NCT02799615
NCT00705484
NCT02376478
NCT04378621
NCT01605188
NCT02675153
NCT01219257
NCT02852850
NCT01402661
NCT02868398
NCT00676988
NCT00606346
NCT02619552
NCT02711202
NCT00252369
NCT01266785
NCT02060318
NCT00955123
NCT03496831
NCT00213564
NCT01691014
NCT00273390
NCT02453607
NCT00561548
NCT00727298
NCT02728934
NCT03062865
NCT02027727
NCT03006198
NCT03393247
NCT01915537
NCT00724672
NCT01812954
NCT01881464
NCT01286545
NCT00380796
NCT03397108
NCT00741104
NCT02134054
NCT00897312
NCT02847884
NCT03729674
NCT03765450
NCT02057016
NCT01592292
NCT03043677
NCT00741793
NCT00724243
NCT03016260
NCT00791557
NCT02693340
NCT02438410
NCT03056924
NCT00725621
Intervention Type
Drug
Drug
Other;Biological
Biological
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Drug
Drug;Dietary Supplement
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Biological;Drug
Biological
Drug
Drug
Biological
Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure
Drug
Drug
Procedure;Drug
Drug
Drug
Biological;Dietary Supplement
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological
Drug
Drug
Biological
Biological
Drug
Biological
Drug
Procedure
Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological
Biological
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological
Biological;Drug
Biological
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological;Drug
Biological
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Dietary Supplement
Drug
Biological
Biological
Drug
Other;Biological;Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological
Drug
Procedure;Biological;Drug
Biological
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Other;Biological
Other;Biological;Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Procedure;Drug
Other;Drug
Drug
Drug
Drug
Drug
Procedure;Device
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological
Combination Product
Drug
Biological
Biological
Biological
Drug
Drug
Other;Drug
Drug
Drug
Drug
Biological
Drug
Drug
Other;Procedure;Biological;Drug
Procedure;Biological
Other
Biological
Diagnostic Test;Other
Drug
Drug
Biological
Biological
Biological
Drug
Biological;Drug
Other
Drug
Drug
Drug
Drug
Device
Other
Biological
Diagnostic Test
Drug
Drug
Biological
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Biological
Procedure
Biological
Biological
Biological
Other
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Other
Drug
Drug
Other
Biological
Biological
Drug
Other
Drug
Drug
Drug
Drug
Other
Biological
Biological
Drug
Biological
Biological
Other
Biological
Drug
Biological
Drug
Drug
Other
Drug
Other
Drug
Drug
Biological;Drug
Other;Drug
Other;Drug
Drug
Biological
Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Other
Drug
Drug
Procedure
Biological
Biological
Other
Other
Drug
Drug
Drug
Drug
Drug;Device
Drug
Drug
Other;Biological;Drug
Biological
Drug
Drug
Drug
Biological
Drug
Biological
Drug
Biological
Biological
Biological
Indications
Colitis, Ulcerative
Crohn's Disease
Hypertension
Spondylitis, Ankylosing
Ankylosing Spondylitis
Psoriasis
Crohn's Disease
Crohn's Disease; Ulcerative Colitis
Ulcerative Colitis
Crohn's Disease
Pediatric Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis; Ultrasonography; Infliximab
Graft vs Host Disease
Crohn's Disease
Spondylitis, Ankylosing
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis; Psoriatic Arthritis; Psoriasis; Crohn's Disease
Arthritis, Rheumatoid
Rheumatoid Arthritis
Depression
Rheumatoid Arthritis
Osteoarthritis of the Knee
Rheumatoid Arthritis
Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis
Crohn's Disease
Crohn's Disease
Spondylitis
Arthritis, Rheumatoid
Inflammatory Bowel Diseases
Spondylarthropathies
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Ulcerative Colitis
Spondylarthropathies; Ankylosing Spondylitis; Psoriatic Arthritis
Rheumatoid Arthritis
Depression
Crohn's Diseases; Inflammatory Bowel Disease
Chronic Uveitis
Hepatosplenic T-Cell Lymphoma
Spondylitis, Ankylosing; SpA
Arthritis, Rheumatoid
Ulcerative Colitis
Crohn's Disease; Exclusive Enteral Nutrition; Infliximab; Mucosal Healing
Colitis, Ulcerative
Ulcerative Colitis
Rheumatoid Arthritis
Ulcerative Colitis; Steroid Refractory
Crohn's Disease
Rheumatoid Arthritis
Uveitis; Infliximab
Arthritis, Rheumatoid; Spondylitis, Ankylosing
SPONDYLOARTHRITIS
Psoriasis
Crohn Disease
Rheumatoid Arthritis
Inflammatory Bowel Disease
Crohn's Disease
Arthritis, Rheumatoid
Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Hypertension
Spondylitis, Ankylosing
Inflammatory Bowel Diseases; Crohn Disease; Colitis, Ulcerative
Rheumatoid Arthritis
Obesity; Insulin Resistance; Metabolic Syndrome
Rheumatoid Arthritis; Insufficient Response to Methotrexate.
Crohn's Disease
Psoriatic Arthritis
Uveitis
Crohn Disease
Ankylosing Spondylitis
Anorexia; Cachexia; Fatigue; Lung Cancer
Rheumatoid Arthritis
Crohn's Disease
Crohn Disease
Post Operative Sciatica by Lumbar Spinal Fibrosis
Arthritis, Psoriatic
Rheumatoid Arthritis
Behcet's Disease; Behcet Syndrome; Neuro-Behcet's Disease
Colitis, Ulcerative
Crohn's Disease
Psoriasis
Ulcerative Colitis
Rheumatoid Arthritis
Graft-versus-host Disease (GVHD)
Kawasaki Disease
Psoriatic Arthritis; Withdrawal; Reduction
Kawasaki Disease
Arthritis, Psoriatic
Crohn Disease
Crohn Disease
Crohn's Disease
Colitis, Ulcerative
Psoriasis
Crohn's Disease
Arthritis, Rheumatoid
Rheumatoid Arthritis
Crohn Disease
Rheumatoid Arthritis
Ulcerative Colitis
Rheumatoid Arthritis
Behcet Disease
Behcet's Disease; Vasculitis
Ulcerative Colitis
Hepatitis C, Chronic
Pediatric Ulcerative Colitis
Ankylosing Spondylitis; Axial Spondyloarthritis
IBD; Ulcerative Colitis; Crohn Disease
Arthritis, Rheumatoid
Crohn Disease
Psoriasis
Spondylitis, Ankylosing
Rheumatoid Arthritis
RHEUMATOID ARTHRITIS
Rheumatoid Arthritis
Diabetic Macular Edema; Visual Acuity; Diabetic Retinopathy
Rheumatoid Arthritis
Covid19
Kawasaki Disease
Mucocutaneous Lymph Node Syndrome
Rheumatoid Arthritis
Ulcerative Colitis
Rheumatoid Arthritis
Arthritis, Rheumatoid
Crohn's Disease
Crohn Disease
Ulcerative Colitis
Crohn's Disease
Crohn Disease
Idiopathic Refractory Scleritis
Pediatric Crohn's Disease
Psoriasis
Rheumatoid Arthritis, Juvenile
Inflammatory Bowel Disease
Ankylosing Spondylitis
Rheumatoid Arthritis
Chronic Obstructive Pulmonary Disease; COPD
Polymyalgia Rheumatica
Plaque Psoriasis; Psoriatic Arthritis; Pustular Psoriasis (Excluding a Localized); Psoriatic Erythroderma
Ulcerative Colitis
Psoriasis
Rheumatoid Arthritis
Psoriasis
Crohn's Disease
Psoriasis
Arthritis, Rheumatoid
Extrathoracic Sarcoidosis
Psoriasis; Parapsoriasis
Rheumatoid Arthritis
Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
Palmoplantar Psoriasis
Crohn's Disease
Sarcoidosis
Psoriasis
Psoriasis
Refractory Myositis
Crohn's Disease
Lupus Erythematosus, Systemic; Lupus Nephritis
Spondylarthropathies
Arthritis
Crohn Disease
Takayasu's Arteritis
HTLV-I-associated Myelopathy
Myelodysplastic Syndromes
Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
Wegener's Granulomatosis; Renal Limited Vasculitis; Microscopic Polyangiitis
Psoriasis
Psoriasis
Esophagitis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Bipolar Depression
Graft Versus Host Disease; Steroid Refractory GVHD; Acute GVH Disease
Hepatitis C
Hidradenitis Suppurativa
Graft-Versus-Host Disease
Toxic Epidermal Necrolysis
Giant Cell Arteritis
Reactive Arthritis
Renal Transplant Rejection
Renal Cell Carcinoma; Melanoma; Lung Cancer
Asthma
Breast Cancer; Fatigue
Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Steroid-Refractory Pneumonitis
Ulcerative Colitis
Age-Related Macular Degeneration; Choroidal Neovascularization
Cachexia; Pancreatic Neoplasms
Rheumatoid Arthritis
Takayasu Arteritis
Reperfusion Injury
Acute Pancreatitis
Crohn's Disease
Type 1 Diabetes
Pemphigus
Spondylarthropathies
Dermatomyositis; Polymyositis
Hermanski-Pudlak Syndrome; Colitis; Cytokines; Lymphocytes; Drug Evaluation
Juvenile Rheumatoid Arthritis
Perianal Fistula; Crohn Disease
COPD; Cachexia
COVID-19
Kidney Transplant
Endometriosis
Stevens-Johnson Syndrome; Toxic Epidermal Necrolysis (Lyell) Syndrome; Mucous Membrane Pemphigoid
Uveitic Macular Edema; Intraocular Inflammation
Chronic Granulomatous Disease; Crohn'S-like IBD; Inflammatory Bowel Disease (IBD)
Stevens-Johnson Syndrome; Corneal Blindness
Aneurysm; Stroke; Vasculitis; Tumor Necrosis Factor-alpha
Ulcerative Colitis
Berylliosis; Beryllium Disease
Behçet's Disease; Uveitis
Diabetic Macular Edema
Kawasaki Disease
Reperfusion Injury
Diabetic Retinopathy; Macular Degeneration
Healthy
Melanoma
Ankylosing Spondylitis
Crohn's Disease; Ulcerative Colitis (Part 2 Only)
Health, Subjective
Ankylosing Spondylitis
Ulcerative Colitis (UC); Inflammatory Bowel Disease
Ankylosing Spondylitis
Depression
Sterile Corneal Melt
Scleritis
Crohn's Disease; Protein Metabolism; Energy Metabolism
Rheumatoid Arthritis
Crohn's Disease
Graft vs Host Disease
Clinical Stage 0 Cutaneous Melanoma AJCC v8; Clinical Stage I Cutaneous Melanoma AJCC v8; Clinical Stage IA Cutaneous Melanoma AJCC v8; Clinical Stage IB Cutaneous Melanoma AJCC v8; Clinical Stage II Cutaneous Melanoma AJCC v8; Clinical Stage IIA Cutaneous Melanoma AJCC v8; Clinical Stage IIB Cutaneous Melanoma AJCC v8; Clinical Stage IIC Cutaneous Melanoma AJCC v8; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Colitis; Diarrhea; Malignant Genitourinary System Neoplasm; Pathologic Stage 0 Cutaneous Melanoma AJCC v8; Pathologic Stage I Cutaneous Melanoma AJCC v8; Pathologic Stage IA Cutaneous Melanoma AJCC v8; Pathologic Stage IB Cutaneous Melanoma AJCC v8; Pathologic Stage II Cutaneous Melanoma AJCC v8; Pathologic Stage IIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIC Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IIID Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8
Diabetes Mellitus, Type 1
Crohn's Disease
Crohn Disease
Inflammatory Bowel Diseases
Ankylosing Spondylitis
Ulcerative Colitis
Psoriasis
Rheumatoid Arthritis
Psoriasis
Rheumatoid Arthritis
Psoriasis; Atopic Dermatitis; Atherosclerosis
Psoriasis
Inflammatory Bowel Disease
Crohn's Disease
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Psoriasis
Inflammatory Bowel Disease
Rheumatoid Arthritis
Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic
Chronic Inflammatory Disease
Psoriasis Vulgaris; Metabolic Syndrome
Inflammatory Bowel Diseases; Crohn Disease; Fistulizing Crohn's Disease; Ulcerative Colitis
Atopic Dermatitis; Psoriasis
Crohn Disease
Sarcoidosis
Crohn's Disease
Inflammatory Bowel Diseases
Perianal Fistula
Rheumatoid Arthritis; Crohn's Disease; Ankylosing Spondylitis; Psoriasis
Psoriasis
Crohn Disease
Rheumatoid Arthritis
Crohn's Disease; IBD
Major Depressive Disorder
Crohn Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Spondylitis, Ankylosing
Spondylitis, Ankylosing
Inflammatory Bowel Diseases
Pediatric Inflammatory Bowel Disease
Inflammatory Bowel Disease; Crohn's Disease
Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease
Crohn's Disease; Ankylosing Spondylitis
Arthritis, Psoriatic
Rheumatoid Arthritis
Crohn Disease
Takayasu Arteritis
Juvenile Idiopathic Arthritis
Wegener's Granulomatosis; Churg-Strauss Syndrome; Microscopic Polyangiitis
Spondylitis, Ankylosing
Psoriasis
Ankylosing Spondylitis
Rheumatoid Arthritis
Serological C Reactive Protein or Erythrocyte Sedimentation Rate
Rheumatoid Arthritis; Inflammatory Bowel Disease; Psoriasis; Psoriatic Arthritis; Ankylosing Spondylitis
IBD
Ulcerative Colitis
Pediatric Acute Severe Colitis
Pediatric Crohns Disease
Inflammatory Bowel Diseases
Psoriasis; Psoriatic-arthritis
Rheumatoid Arthritis; Spondyloarthritis; Crohn's Disease; Uveitis
Crohn's Disease
Arthritis, Rheumatoid
Rheumatoid Arthritis
Rheumatoid Arthritis
Crohn Disease
Ankylosing Spondylitis
Crohn's Disease
Arthritis, Rheumatoid; Crohn Disease; Psoriasis
Psoriasis
Schizophrenia
Crohn Disease; Arthritis, Rheumatoid
Crohn's Disease; Ulcerative Colitis
Rheumatoid Arthritis
Psoriasis
Inflammatory Bowel Diseases
Psoriasis
Crohn's Disease
Spondyloarthritis
Inflammatory Bowel Disease
Crohn's Disease
Crohn's Disease
Rheumatoid Arthritis
Crohn's Disease
Crohn's Disease
Uveitis; Scleritis
Undifferentiated Arthritis
Rheumatoid Arthritis
Crohn's Disease; Ulcerative Colitis
Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis
Ulcerative Colitis; Protein Metabolism; Energy Expenditure
Inflammatory Bowel Diseases
Colitis, Ulcerative; Bowel Diseases, Inflammatory
Ulcerative Colitis
Psoriasis; Inflammatory Bowel Diseases
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Inflammatory Bowel Disease
Crohn's Diseases
Spondyloarthritis; Ultrasonography
Ulcerative Colitis
Rheumatoid Arthritis
Ulcerative Colitis
Crohn's Disease
Crohn's Disease; Ulcerative Colitis; Indeterminate Colitis; Inflammatory Bowel Diseases
Crohn's Disease; IBD
Kidney Transplantation
Crohn's Disease
Crohn's Disease
Crohn Disease
Inflammatory Bowel Diseases
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Uveitis
Inflammatory Bowel Disease; Crohn's Disease
Crohn Disease
Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Psoriasis; Crohn's Disease
Arthritis, Rheumatoid
RheumatoId Arthritis
Inflammatory Bowel Diseases
Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Colitis, Ulcerative
Crohn Disease
Rheumatoid Arthritis（RA）
Rheumatoid Arthritis
Psoriasis
Crohn's Disease
Ankylosing Spondylitis
COPD; Pulmonary Disease, Chronic Obstructive
Crohn's Disease; Ulcerative Colitis; Healthy Controls
Rheumatoid Arthritis
Inflammatory Bowel Disease
Melanoma
Inflammatory Bowel Disease; Crohn's Disease
Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
Ulcerative Colitis
Crohn's Disease; Ulcerative Colitis
Rheumatoid Arthritis
Inflammatory Bowel Disease
Arthritis, Rheumatoid; Spondyloarthritis, Axial; Arthritis, Psoriatic
Rheumatoid Arthritis
RheumatoId Arthritis
Pyoderma Gangrenosum; Crohn's Disease; Ulcerative Colitis; Inflammatory Bowel Disease
Inflammatory Bowel Disease
Colitis, Ulcerative; Inflammatory Bowel Disease; IBD
Inflammatory Bowel Diseases
Rheumatoid Arthritis
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Withdrawn
Completed
Unknown status
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Unknown status
Completed
Completed
Active, not recruiting
Terminated
Active, not recruiting
Completed
Completed
Terminated
Completed
Unknown status
Active, not recruiting
Terminated
Recruiting
Unknown status
Completed
Withdrawn
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Completed
Terminated
Completed
Completed
Not yet recruiting
Unknown status
Recruiting
Completed
Completed
Completed
Unknown status
Active, not recruiting
Unknown status
Terminated
Recruiting
Unknown status
Terminated
Completed
Completed
Unknown status
Unknown status
Completed
Not yet recruiting
Unknown status
Completed
Unknown status
Unknown status
Completed
Completed
Recruiting
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Terminated
Terminated
Completed
Completed
Terminated
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Terminated
Completed
Recruiting
Not yet recruiting
Recruiting
Completed
Completed
Terminated
Completed
Completed
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Terminated
Completed
Withdrawn
Completed
Completed
Completed
Unknown status
Completed
Terminated
Completed
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Terminated
Completed
Unknown status
Terminated
Completed
Withdrawn
Completed
Unknown status
Terminated
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Terminated
Completed
Completed
Completed
Withdrawn
Terminated
Unknown status
Recruiting
Withdrawn
Completed
Terminated
Recruiting
Active, not recruiting
Completed
Completed
Completed
Not yet recruiting
Completed
Suspended
Completed
Completed
Completed
Terminated
Completed
Withdrawn
Terminated
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Completed
Withdrawn
Withdrawn
Terminated
Withdrawn
Recruiting
Withdrawn
Terminated
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Recruiting
Completed
Terminated
Enrolling by invitation
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Enrolling by invitation
Completed
Completed
Completed
Active, not recruiting
Unknown status
Active, not recruiting
Recruiting
Recruiting
Unknown status
Completed
Unknown status
Unknown status
Unknown status
Unknown status
Recruiting
Completed
Recruiting
Not yet recruiting
Recruiting
Unknown status
Completed
Terminated
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Active, not recruiting
Recruiting
Unknown status
Unknown status
Completed
Completed
Completed
Recruiting
Terminated
Unknown status
Unknown status
Unknown status
Recruiting
Completed
Unknown status
Recruiting
Recruiting
Unknown status
Completed
Completed
Completed
Completed
Completed
Unknown status
Terminated
Completed
Recruiting
Recruiting
Completed
Withdrawn
Terminated
Recruiting
Completed
Completed
Terminated
Completed
Completed
Completed
Terminated
Completed
Unknown status
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Terminated
Terminated
Completed
Completed
Completed
Not yet recruiting
Completed
Recruiting
Completed
Unknown status
Enrolling by invitation
Completed
Completed
Active, not recruiting
Completed
Completed
Terminated
Withdrawn
Completed
Completed
Completed
Completed
Terminated
Completed
Unknown status
Terminated
Completed
Completed
Recruiting
Unknown status
Completed
Unknown status
Unknown status
Withdrawn
Completed
Unknown status
Unknown status
Completed
Recruiting
Completed
Active, not recruiting
Terminated
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Unknown status
Completed
Completed
Completed
Recombinant human tumor necrosis factor-α (hTNF-α) monoclonal antibody (Shanghai Humanized Bio-tech)
IND
Shanghai Humanized Bio-tech Ltd
Infliximab biosimilar (Amgen)
ABP-710
Approved
Amgen Inc
Arthritis, Rheumatoid, Pediatric Crohn's disease, Spondylitis, Ankylosing, Pediatric ulcerative colitis, Colitis, Ulcerative, Arthritis, Psoriatic, Crohn Disease
NCT Number
NCT02937701
NCT04305145
Intervention Type
Biological
Drug
Indications
Arthritis, Rheumatoid
Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
Study Phase
Phase 3
Phase 2
Recruitment Status
Completed
Recruiting
Etanercept biosimilar (Mochida)
LBEC-0101
Approved
Mochida
Arthritis, Rheumatoid, Arthritis, Juvenile
Adalimumab biosimilar (Hisun Pharma)
HS-016
Approved
Zhejiang Hisun Pharmaceutical Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid
Etanercept biosimilar (Hisun-Pfizer Pharmaceuticals)
Approved
Hisun-Pfizer
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic
NCT Number
NCT04077957
NCT03636984
Intervention Type
Drug
Drug
Indications
Ankylosing Spondylitis; Spondyloarthritis
Rheumatoid Arthritis; Ankylosing Spondylitis
Study Phase
Phase 4
N/A
Recruitment Status
Not yet recruiting
Not yet recruiting
Etanercept biosimilar (Mycenax Biotech/TSH Biopharm)
ENIA-11, E-11
Approved
Mycenax Biotech Inc, Tsh Biopharm
Spondylitis, Ankylosing, Arthritis, Rheumatoid
NCT Number
NCT01787149
NCT01709760
NCT02685904
Intervention Type
Drug
Drug
Biological
Indications
Combination With DMARDs
Rheumatoid Arthritis
Ankylosing Spondylitis
Study Phase
Phase 3
Phase 3
Phase 3
Recruitment Status
Unknown status
Unknown status
Terminated
Etanercept
TNR-001
Approved
Pfizer Pharmaceuticals Ltd (China), Amgen Inc
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Pulmonary Fibrosis, Psoriasis, Asthma, Arthritis, Psoriatic, Inflammation, Plaque psoriasis
NCT Number
NCT00110981
NCT00581165
NCT00523692
NCT00848354
NCT01132235
NCT02144857
NCT01053819
NCT01783015
NCT02489760
NCT00706797
NCT00132418
NCT02713997
NCT02878161
NCT00111124
NCT02509026
NCT00252668
NCT01548768
NCT00913458
NCT02364479
NCT00420238
NCT00444340
NCT02353780
NCT04485325
NCT00783536
NCT01543204
NCT01313208
NCT00245960
NCT00247962
NCT00654368
NCT01602302
NCT00858780
NCT01578850
NCT00967538
NCT00833729
NCT03636373
NCT02749370
NCT01072058
NCT01793519
NCT00581555
NCT04086745
NCT02374021
NCT03649061
NCT00195494
NCT00458185
NCT00873730
NCT01295151
NCT01875991
NCT02242474
NCT01372930
NCT00565409
NCT00420303
NCT00837434
NCT00127842
NCT00688103
NCT00115219
NCT02132234
NCT00133315
NCT00832364
NCT00099554
NCT01934933
NCT00161655
NCT00094341
NCT00410046
NCT00432406
NCT00791765
NCT02433184
NCT00640393
NCT01298531
NCT00663052
NCT02638896
NCT01971346
NCT01927757
NCT01009879
NCT03976245
NCT00992394
NCT00796705
NCT00195507
NCT00910273
NCT01604629
NCT01303874
NCT00936065
NCT03504072
NCT00259610
NCT00581100
NCT00768053
NCT00546533
NCT02915354
NCT02092467
NCT00421915
NCT01235442
NCT01936688
NCT01421069
NCT00356590
NCT00111111
NCT00421174
NCT00357903
NCT00121615
NCT00443950
NCT00012506
NCT00393471
NCT00141921
NCT00116181
NCT00484237
NCT03728478
NCT00111449
NCT00353119
NCT00413452
NCT00356356
NCT00110903
NCT00078806
NCT04079374
NCT02373813
NCT00726375
NCT02346240
NCT02840175
NCT00418717
NCT01764997
NCT03781375
NCT00078819
NCT00111436
NCT00249041
NCT02986139
NCT03332719
NCT02115750
NCT04610476
NCT00524381
NCT01270997
NCT03451851
NCT00333034
NCT01901185
NCT00962741
NCT00421980
NCT01313221
NCT02987257
NCT00434811
NCT00317499
NCT01729754
NCT02378506
NCT01258738
NCT00434044
NCT01690299
NCT00418548
NCT00445770
NCT01001208
NCT00468117
NCT00789997
NCT01030120
NCT00127387
NCT00005007
NCT03780959
NCT00111956
NCT00035958
NCT00141791
NCT02464878
NCT00841789
NCT00797784
NCT00063869
NCT02862574
NCT00001954
NCT00001955
NCT01289730
NCT00639717
NCT00509600
NCT01289743
NCT00520572
NCT00789308
NCT00034060
NCT01730495
NCT01989689
NCT00048373
NCT00141726
NCT00107991
NCT00309907
NCT00135720
NCT01068353
NCT00134368
NCT00006070
NCT00329823
NCT00001862
NCT00434850
NCT02656082
NCT00001901
NCT00285779
NCT00001893
NCT00224874
NCT00224393
NCT04066348
NCT00298272
NCT03193957
NCT00141739
NCT00293202
NCT02464033
NCT00678782
NCT00447265
NCT00031551
NCT00141713
NCT02456363
NCT00888628
NCT02821026
NCT00118287
NCT00730392
NCT00201682
NCT03160001
NCT00093366
NCT03182426
NCT02586831
NCT00201838
NCT01894412
NCT00361634
NCT01716637
NCT01276847
NCT03273088
NCT00201812
NCT01294397
NCT02799498
NCT03193203
NCT04254627
NCT04255498
NCT01145950
NCT00091741
NCT04585711
NCT01865630
NCT04559412
NCT00502879
NCT00705042
NCT00112385
NCT01725620
NCT00802815
NCT00965666
NCT01356758
NCT01558089
NCT02330380
NCT00195364
NCT01592292
NCT04378621
NCT04398732
NCT01613963
NCT00405275
NCT03775824
NCT00825344
NCT02031211
NCT00195403
NCT00544557
NCT00195377
NCT01932372
NCT00477191
NCT00293709
NCT01170715
NCT01411215
NCT04582084
NCT00708708
NCT01706692
NCT01421303
NCT02376478
NCT01557322
NCT01432249
NCT00949546
NCT01230177
NCT03327454
NCT00503503
NCT01812954
NCT01793285
NCT01100034
NCT00121056
NCT02722811
NCT01145352
NCT03100734
NCT03016260
NCT01623752
NCT00276029
NCT01646385
NCT02202850
NCT02258282
NCT04507763
NCT00078793
NCT04449224
NCT04428424
NCT01276314
NCT00409318
NCT03496831
NCT03729674
NCT00683384
NCT00116727
NCT00293722
NCT02202837
NCT00413400
NCT00116272
NCT01188655
NCT03178955
NCT03955861
NCT04267614
NCT02322580
NCT00484809
NCT01610947
NCT04428502
NCT04507776
NCT00195416
NCT02766439
NCT04428411
NCT00322439
NCT00488475
NCT00195338
NCT00931957
NCT00503139
NCT02486302
NCT00245934
NCT02722772
Intervention Type
Drug;Device
Drug
Drug
Biological;Drug
Biological
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Biological;Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug;Device
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Other;Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Biological;Drug
Other;Drug
Drug
Biological
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Other;Biological
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological
Biological;Drug;Dietary Supplement
Drug;Device
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological
Drug
Biological;Dietary Supplement
Drug
Drug
Drug
Drug
Other;Drug;Device
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Device
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Other;Drug
Biological;Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Biological
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Indications
Psoriasis
Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Psoriasis
Psoriasis; Melanoma; Non-melanoma Skin Cancer
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Pancreatitis, Chronic; Diabetes; Transplant
Rheumatoid Arthritis
Psoriasis
Spondylitis, Ankylosing
Rheumatoid Arthritis
Rheumatoid Arthritis
Active Rheumatoid Arthritis; Arthritis, Rheumatoid; Rheumatoid Arthritis
Spondyloarthritis
Ankylosing Spondylitis
Ankylosing Spondylitis
Rheumatoid Arthritis (RA)
Rheumatic Arthritis
Rheumatoid Arthritis
Psoriasis
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Plaque Psoriasis
Gout Attack
Plaque Psoriasis
Arthritis, Rheumatoid; Spondylitis, Ankylosing
Rheumatoid Arthritis
Psoriasis
Rheumatoid Arthritis
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Rheumatoid Arthritis
Ankylosing Spondylitis
Ankylosing Spondylitis
Rheumatoid Arthritis
Rheumatoid Arthritis; Plaque Psoriasis
Rheumatoid Arthritis
Myocardial Infarction
Arthritis, Rheumatoid
Spondylarthropathies, Enthesitis
Rheumatoid Arthritis
Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Hypertension
Spondylarthropathies; Ankylosing Spondylitis; Psoriatic Arthritis
Plaque Psoriasis
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriasis; Arthritis, Psoriatic
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis
Psoriasis
Rheumatoid Arthritis
Psoriasis Vulgaris
Axial Spondyloarthritis
Plaque Psoriasis; Psoriasis
Ankylosing Spondylitis
Psoriasis
Moderate to Severe Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriasis
Rheumatoid Arthritis
Psoriasis
Ankylosing Spondylitis
Spondylarthropathies
Rheumatoid Arthritis; Inflammatory Arthritis
Moderate to Severe Psoriasis
Spondyloarthritis
Rheumatoid Arthritis
Nail Psoriasis; Plaque Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Spondylitis, Ankylosing; Recurrence
Arthritis, Rheumatoid
Ankylosing Spondylitis
Psoriasis
Plaque-type Psoriasis
Juvenile Idiopahtic Arthritis
Rheumatoid Arthritis
Psoriasis
Pneumonia; Idiopathic Pneumonia Syndrome
Rheumatoid Arthritis
Inflammation; Psoriasis
Arthritis, Rheumatoid
Uveitis; Arthritis, Juvenile Rheumatoid
Active Rheumatoid Arthritis
Pediatric Plaque Psoriasis
Psoriasis
Rheumatoid Arthritis
Oligoarthritis, Juvenile; Polyarthritis, Juvenile, Rheumatoid Factor Negative
Psoriasis
Palmoplantaris Pustulosis
Rheumatoid Arthritis
Ankylosing Spondylitis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Acute Graft Versus Host Disease
Psoriasis; Plaque Psoriasis
Juvenile Idiopathic Arthritis
Arthritis, Rheumatoid
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Psoriasis
Psoriasis
Rheumatoid Arthritis
Arthritis, Rheumatoid; Arthritis, Psoriatic
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriatic Arthritis; Withdrawal; Reduction
Polymyalgia Rheumatica
Rheumatoid Arthritis
Psoriasis
Psoriasis
Rheumatoid Arthritis; Psoriatic Arthritis
Arthritis, Juvenile Idiopathic
Ankylosing Spondylitis
Psoriasis
Stevens-Johnson Syndrome; Toxic Epidermal Necrolyses
Type 1 Diabetes Mellitus
Psoriatic Arthritis; Psoriasis
Plaque Psoriasis
Arthritis, Rheumatoid
Spondylitis, Ankylosing
Ankylosing Spondylitis
Psoriasis; Psoriatic Arthritis
Ankylosing Spondylitis
Arthritis, Rheumatoid
Psoriasis
Type 1 Diabetes Mellitus
COPD Exacerbation
Chronic Idiopathic Urticaria
Lung Cancer; Prostate Cancer; Neoplasm Metastasis; Bone Cancer
Wegener's Granulomatosis
Juvenile Rheumatoid Arthritis
Metabolic Syndrome X
Dermatomyositis
Asthma
Kidney Transplant; Type 1 Diabetes
Mucocutaneous Lymph Node Syndrome; Kawasaki Disease
Discoid Lupus Erythematosus (DLE)
Pulmonary Fibrosis
Rheumatoid Arthritis
Sjogren's Syndrome
Temporomandibular Joint Disorder
Spondyloarthritis
Graft Versus Host Disease
Leukemia
Ankylosing Spondylitis
Rheumatoid Arthritis
Diabetes Mellitus, Type I
Rheumatoid Arthritis; Healthy
Chronic Fatigue Syndrome; Myalgic Encephalomyelitis
PSORIASIS
Histiocytosis, Langerhans-Cell
Lung Injury, Acute; Respiratory Distress Syndrome, Adult; Bronchiolitis Obliterans
Hidradenitis Suppurativa
Accelerated Phase Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Disseminated Neuroblastoma; Juvenile Myelomonocytic Leukemia; Previously Treated Childhood Rhabdomyosarcoma; Previously Treated Myelodysplastic Syndromes; Pulmonary Complications; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Neuroblastoma; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Recurrent/Refractory Childhood Hodgkin Lymphoma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes
Pemphigus Vulgaris
Alzheimer's Disease
Vitiligo
Healthy; Inflammation
Hidradenitis Suppurativa
Juvenile Rheumatoid Arthritis; Uveitis
Diabetes Mellitus, Type 1
Lupus Erythematosus, Discoid; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Chronic Cutaneous
Vasculitis; Wegener's Granulomatosis
Lichen Planus
Asthma
Graft vs Host Disease; Immune System Disorders
Primary Systemic Amyloidosis
Tinnitus, Noise Induced
Rheumatoid Arthritis
Rheumatoid Arthritis
Graft-Versus-Host Disease
End Stage Renal Disease
Diabetes Mellitus, Type 1
Persistent Knee Joint Synovitis
Lupus Nephritis
Stomatitis
Graft-Versus-Host Disease
Ankylosing Spondylitis
Diabetes Mellitus, Type I
Type 1 Diabetes
de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Secondary Myelodysplastic Syndromes
Type 1 Diabetes
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Rheumatoid Arthritis (RA)
Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 1; Hypoglycemia; Autoimmune Diseases; Diabetes Mellitus
Pancreatic Neoplasms; Adenocarcinoma
Healthy
Rheumatoid Arthritis
Alzheimer's Disease
Psoriasis
Phase 1; Bioequivalence
Tumors
Postmenopausal; Osteopenia; Rheumatoid Arthritis; Osteoporosis
Healthy Men and Women
Healthy
Gulf War Illness
Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases
Healthy
HIV Infection
Juvenile Idiopathic Arthritis; Rheumatoid Arthritis; Obesity
Subarachnoid Hemorrhage, Aneurysmal
Rheumatoid Arthritis
Healthy
Healthy Subjects
Dermatomyositis
Healthy
Inclusion Body Myositis
Fanconi Anemia
Psoriasis; Atopic Dermatitis; Atherosclerosis
Rheumatoid Arthritis
Psoriasis; Inflammation
Rheumatoid Arthritis; Inflammation
Rheumatoid Arthritis
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
Plaque Psoriasis
Uveitis; Scleritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Inguinal Hernia; Postoperative Pain
CRPS; Chronic Regional Pain Syndrome
Rheumatoid Arthritis
Ankylosing Spondylitis
Arthritis, Psoriatic; Arthritis, Rheumatoid
Rheumatoid Arthritis
Psoriasis; Metabolic Syndrome; Hyperlipidemia; Obesity; Hypertension
Arthritis, Psoriatic; Psoriasis; Skin Diseases, Papulosquamous
Psoriasis
Rheumatoid Arthritis; Ankylosing Spondylitis
Rheumatoid Arthritis; Ankylosing Spondylitis; Psoriatic Arthritis
Psoriasis
Psoriasis
Ankylosing Spondylitis
Psoriasis; Inflammatory Bowel Diseases
Rheumatoid Arthritis
Pediatric Psoriasis
Hidradenitis Suppurativa
Arthritis; Rheumatoid
Rheumatoid Arthritis; Spondyloarthropathies
Rheumatoid Arthritis
Psoriasis
Ankylosing Spondylitis
Psoriasis
Rheumatoid Arthritis
Osteoarthritis Of Knee
Juvenile Idiopathic Arthritis
Rheumatoid Arthritis; Axial Spondyloarthritis
RheumatoId Arthritis
Rheumatoid Arthritis; Psoriasis Arthritis
Asthma
Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriasis
Ankylosing Spondylitis
Juvenile Rheumatoid Arthritis
Rheumatoid Arthritis
Arthritis, Rheumatoid
Drug Hypersensitivity
Metabolic Syndrome
Rheumatoid Arthritis; Spondyloarthritis; Psoriatic Arthritis
Rheumatoid Arthritis; Ankylosing Spondylitis; Ulcerative Colitis; Crohn's Disease
Arthritis, Psoriatic
Rheumatoid Arthritis
Arthritis, Psoriatic; Psoriasis; Skin Diseases, Papulosquamous
Rheumatoid Arthritis
Metabolic Syndrome
Pregnancy
Spondylitis, Ankylosing
Rheumatoid Arthritis
Psoriatic Arthritis; Psoriasis; Enthesitis
Arthritis Rheumatoid
Psoriasis
Rheumatoid Arthritis
Spondyloarthritis
Psoriatic Arthritis
Spondyloarthrosis
Ankylosing Spondylitis
Rhupus Syndrome, Etanercept
Plaque Psoriasis
Psoriasis
Rheumatoid Arthritis
Rheumatoid Arthritis
Behcet Syndrome; Uveal Disease
Rheumatoid Arthritis
Rheumatoid Arthritis; Psoriatic Arthritis; Axial Spondyloarthritis; Plaque Psoriasis
Rheumatoid Arthritis
Osteoarthritis of Knee
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Completed
Unknown status
Completed
Unknown status
Recruiting
Completed
Terminated
Unknown status
Terminated
Completed
Active, not recruiting
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Recruiting
Withdrawn
Terminated
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Suspended
Completed
Unknown status
Recruiting
Completed
Recruiting
Recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Terminated
Withdrawn
Recruiting
Completed
Terminated
Completed
Terminated
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Terminated
Completed
Completed
Completed
Terminated
Completed
Recruiting
Unknown status
Unknown status
Completed
Terminated
Completed
Completed
Unknown status
Completed
Terminated
Unknown status
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Suspended
Not yet recruiting
Terminated
Completed
Completed
Terminated
Completed
Completed
Terminated
Terminated
Completed
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Recruiting
Recruiting
Completed
Completed
Not yet recruiting
Withdrawn
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Unknown status
Completed
Completed
Completed
Withdrawn
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Completed
Terminated
Completed
Completed
Recruiting
Completed
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Withdrawn
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Unknown status
Etanercept biosimilar (Nanogen Biopharmaceutical)
Approved
Nanogen Biopharmaceutical Co
Arthritis, Rheumatoid, Psoriasis
Infliximab biosimilar (Reliance Life Sciences)
BOW-015, R-TPR-015
Approved
Epirus Biopharmaceuticals
Arthritis, Rheumatoid
NCT Number
NCT02683564
Intervention Type
Drug
Indications
Rheumatoid Arthritis
Study Phase
Phase 3
Recruitment Status
Unknown status
Thalidomide
K-17, NSC-66847, NSC-527179
Approved
Celgene
HIV Infections, Spondylitis, Ankylosing, Myelodysplastic Syndromes, Multiple Myeloma, HIV Wasting Syndrome, Erythema Nodosum, Leprosy, Lepromatous, Carcinoma, Hepatocellular
NCT Number
NCT02559154
NCT04612582
NCT02844361
NCT01664975
NCT01249690
NCT00314665
NCT02401971
NCT02844309
NCT01640639
NCT02778893
NCT01638078
NCT03122431
NCT00652041
NCT03777930
NCT00390247
NCT02858804
NCT00111319
NCT01659658
NCT01539083
NCT03402295
NCT00217438
NCT03221166
NCT00004859
NCT00910897
NCT01134484
NCT00432458
NCT00083551
NCT00225290
NCT00461747
NCT00038233
NCT03318835
NCT01070862
NCT00033332
NCT00028886
NCT00075829
NCT00734877
NCT00098475
NCT00572169
NCT00083915
NCT00644306
NCT00215943
NCT00097981
NCT00222053
NCT00061919
NCT00573391
NCT00443235
NCT02203253
NCT00207805
NCT00452569
NCT00041080
NCT00367185
NCT00416897
NCT00305552
NCT03016000
NCT00005966
NCT00529633
NCT02085655
NCT00633542
NCT00602511
NCT00892346
NCT00057564
NCT00507416
NCT00111748
NCT02248428
NCT00050843
NCT00083876
NCT00218855
NCT01063179
NCT02707484
NCT00600028
NCT02748772
NCT00921531
NCT00787436
NCT00033254
NCT00005834
NCT00720538
NCT01971658
NCT00232934
NCT01532856
NCT01554852
NCT00004635
NCT01858571
NCT00934154
NCT00049673
NCT00256776
NCT00205751
NCT02387086
NCT02532738
NCT01438450
NCT00934739
NCT00657488
NCT04453345
NCT00728078
NCT00038090
NCT01094340
NCT03062800
NCT00165451
NCT00320476
NCT00871013
NCT00053001
NCT00769587
NCT00747123
NCT02410694
NCT00053287
NCT00075023
NCT00450008
NCT00792142
NCT00379353
NCT01891019
NCT00319865
NCT00006358
NCT00400517
NCT00009984
NCT00040937
NCT00890188
NCT00089544
NCT03273452
NCT00226980
NCT00020046
NCT02447679
NCT00026533
NCT00287872
NCT00083382
NCT01849783
NCT02022033
NCT00201357
NCT00083408
NCT00039468
NCT00006226
NCT04680195
NCT00083005
NCT00001599
NCT00112502
NCT00003894
NCT02501291
NCT00054158
NCT01548573
NCT00577512
NCT03341494
NCT00521482
NCT00019747
NCT00378755
NCT00250796
NCT00017316
NCT00505635
NCT00104988
NCT00038181
NCT00015990
NCT00281827
NCT00165217
NCT03980002
NCT00151281
NCT00027664
NCT02891811
NCT00083577
NCT00019123
NCT00083681
NCT00025220
NCT02424851
NCT01632150
NCT01756989
NCT00114192
NCT00438841
NCT02995707
NCT00072345
NCT00047294
NCT00140452
NCT00003754
NCT00025467
NCT01551641
NCT04273581
NCT00033709
NCT00079092
NCT00019539
NCT00953615
NCT00049374
NCT00083902
NCT00209014
NCT00006016
NCT00284505
NCT02128230
NCT00227682
NCT00961467
NCT01779167
NCT00124813
NCT01526694
NCT00121563
NCT01114048
NCT03140943
NCT00008242
NCT00310076
NCT00349115
NCT00358020
NCT00025285
NCT00193544
NCT00003850
NCT00301405
NCT00445900
NCT01527032
NCT00090870
NCT00357500
NCT00276705
NCT00046826
NCT03043105
NCT00027638
NCT00412542
NCT03896737
NCT00006890
NCT00450801
NCT00307294
NCT02201043
NCT00538733
NCT00053430
NCT00182663
NCT00016224
NCT00455910
NCT00001680
NCT00142116
NCT03004287
NCT00469703
NCT03393273
NCT00004276
NCT04352205
NCT04120519
NCT00064337
NCT00276744
NCT03608501
NCT00002127
NCT00047879
NCT00112879
NCT00001524
NCT00006200
NCT02966522
NCT00238329
NCT00000790
NCT00389935
NCT00222105
NCT00964496
NCT02879526
NCT00083538
NCT00274820
NCT00231140
NCT00058487
NCT03069326
NCT00384800
NCT01125176
NCT01274403
NCT00006198
NCT00081939
NCT00869232
NCT00053300
NCT00958854
NCT01328236
NCT00083694
NCT00026416
NCT00004876
NCT00165230
NCT00015821
NCT00531453
NCT02586038
NCT00193102
NCT00089609
NCT00458705
NCT00025519
NCT00006006
NCT00049361
NCT00519688
NCT02733380
NCT00004088
NCT00251511
NCT00001446
NCT00179881
NCT00030550
NCT00777998
NCT01976195
NCT01485224
NCT00670631
NCT04382300
NCT00026520
NCT00083707
NCT00047281
NCT02649101
NCT00856804
NCT00162760
NCT00538824
NCT01341262
NCT01356290
NCT00022581
NCT02507336
NCT00723658
NCT03335098
NCT02754960
NCT00523848
NCT00025506
NCT00072163
NCT03208413
NCT02301949
NCT00577668
NCT03184844
NCT00113932
NCT01775553
NCT01055301
NCT00373646
NCT00006005
NCT04273529
NCT00098865
NCT00089167
NCT00124579
NCT00022607
NCT00015912
NCT00263484
NCT01242267
NCT00966693
NCT00155272
NCT00971126
NCT01057225
NCT00406978
NCT00277017
NCT02545907
NCT00005815
NCT00081757
NCT01061866
NCT00096018
NCT02145715
NCT00038246
NCT01661400
NCT00083460
NCT00014443
NCT00000812
NCT01420432
NCT00052416
NCT00002104
NCT02467647
NCT00251797
NCT00049296
NCT02870036
NCT01998971
NCT00062127
NCT01937442
NCT00258245
NCT00418132
NCT00527657
NCT01028781
NCT02956538
NCT01537861
NCT00577096
NCT00907452
NCT00002157
NCT00002174
NCT02998827
NCT01697839
NCT01927718
NCT00002392
NCT01924624
NCT00899080
NCT00004450
NCT03601871
NCT01268774
NCT02293681
NCT00023530
NCT03723083
NCT03089411
Intervention Type
Drug
Drug
Other
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug;Genetic
Drug
Radiation;Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Procedure;Drug;Behavioral
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure
Drug
Other;Drug
Drug
Procedure;Drug
Drug
Other;Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Procedure
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Radiation;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other;Procedure;Drug;Genetic
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Procedure;Biological;Drug
Drug
Procedure;Other;Radiation;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Procedure;Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Procedure;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Procedure;Drug
Drug
Biological;Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Biological;Drug
Procedure;Biological;Drug
Drug
Drug
Biological;Drug
Procedure;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Drug
Drug
Drug
Procedure;Drug
Other;Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Procedure;Biological;Radiation;Drug
Biological;Drug
Radiation;Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Procedure
Drug
Drug
Combination Product
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Drug
Procedure
Drug
Other;Procedure;Drug;Genetic
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Biological;Drug;Behavioral
Drug
Drug
Drug
Other;Drug
Drug;Behavioral
Drug
Drug
Other;Genetic
Drug
Drug
Drug
Procedure;Drug
Drug
Indications
Multiple Myeloma
Immunoglobulin Light-Chain Amyloidosis
Waldenström Macroglobulinemia
Peripheral T-cell Lymphoma
Multiple Myeloma
Uveitis
Gastric Cancer
Waldenström Macroglobulinemia
Congestive Heart Failure
NSCLC
Coronary Artery Disease
Systemic Lupus Erythematosus (SLE); Juvenile SLE; Cutaneous Lupus
Multiple Myeloma
Cancer, Therapy-Related
Peritoneal Dialysis; Malnutrition
Mantle Cell Lymphoma
Multiple Myeloma
Relapsed or Refractory Systemic Light Chain Amyloidosis
Multiple Myeloma
Multiple Myeloma; Effects of Chemotherapy
Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Crohn Disease
Lung Cancer
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Carcinoma, Hepatocellular
Multiple Myeloma
Multiple Myeloma
Thalidomide
Multiple Myeloma de Novo Treatment
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Newly Diagnosed, Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lung Cancer
Multiple Myeloma
Multiple Myeloma
Neoplasms
Multiple Myeloma
Multiple Myeloma
Fallopian Tube Cancer; Primary Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm; Renal Failure
Sarcoidosis
Lymphoma, Large B-Cell, Diffuse
Kidney Cancer
Hypoalbuminemia
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Gastrointestinal Vascular Malformation
Idiopathic Pulmonary Fibrosis; Cough
Colorectal Neoplasms
Hepatocellular Carcinoma
Gastrointestinal Hemorrhage; Portal Hypertension
Tumors Metastatic to Brain
Multiple Myeloma
Inflammatory Bowel Diseases; Crohn's Disease; Ulcerative Colitis
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Prostate Cancer
Malignant Childhood Neoplasm
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
NSCLC
Crohn's Disease
Hepatocellular Carcinoma
Oral Cavity Cancer
Multiple Myeloma
T-LGL Leukemia; Clpd-Nk
Hepatocellular Carcinoma; Liver Cancer
Multiple Myeloma
Alzheimer's Disease
Advanced Nsclc
Neoplasms
Multiple Myeloma
Myeloma
Anemia; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Non Neoplastic Condition; Precancerous Condition
Multiple Myeloma
Multiple Myeloma
Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Graft-versus-Host Disease; Stomatitis
Prostatic Neoplasms
Multiple Myeloma and Plasma Cell Neoplasm; Neurotoxicity
Advanced Cancers
Psoriasis, Plaque-type
Multiple Myeloma
Brain and Central Nervous System Tumors
Prostate Cancer
Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia
Multiple Myeloma
Colon Cancer
Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma AJCC v7; Stage II Adult Soft Tissue Sarcoma AJCC v7; Stage III Adult Soft Tissue Sarcoma AJCC v7
Angioimmunoblastic T-cell Lymphoma
Kidney Neoplasms
Stage IV Prostate Cancer; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
Adult Hepatocellular Carcinoma; Recurrent Hepatocellular Carcinoma; Adverse Reaction to Drug; Vascular Endothelial Growth Factor Overexpression
Head and Neck Cancer
Multiple Myeloma
Multiple Myeloma
Extramedullary Plasmacytoma; Isolated Plasmacytoma of Bone; Light Chain Deposition Disease; Primary Systemic Amyloidosis; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Pancreatic Cancer
Hormone-refractory Prostate Cancer
Multiple Myeloma
Brain and Central Nervous System Tumors
B-cell Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia
Chronic Radiation Proctitis
Prostate Cancer
Sjogren's Syndrome; Xerostomia
Brain and Central Nervous System Tumors
Graft Versus Host Disease; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Crohn's Disease
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
NSCLC Stage IV; Chemotherapy Effect
Glioblastoma
Colorectal Cancer
Multiple Myeloma
Liver; Cancer
Melanoma (Skin)
Melanoma
Melanoma (Skin)
Prostate Cancer
Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Ringed Sideroblasts; Secondary Myelodysplastic Syndromes
Lung Cancer
Colorectal Adenocarcinoma
Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Kidney Cancer
Multiple Myeloma
Multiple Myeloma
Sarcoma
Multiple Myeloma
Recurrent Uterine Corpus Sarcoma; Uterine Corpus Leiomyosarcoma
Multiple Myeloma; Chronic Kidney Disease
Relapsed and/or Refractory Multiple Myeloma
Brainstem Glioma
Lung Cancer
Multiple Myeloma and Plasma Cell Neoplasm
Thalassemia
Intraocular Melanoma; Melanoma (Skin)
Brain and Central Nervous System Tumors
Amyotrophic Lateral Sclerosis; ALS
Unspecified Childhood Solid Tumor, Protocol Specific
Endometrial Adenoacanthoma; Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Recurrent Endometrial Carcinoma
Esophageal Cancer
COVID-19 Thalidomide
Sarcoma
Brain and Central Nervous System Tumors
Stage IV Renal Cell Cancer; Recurrent Renal Cell Cancer
Primary Sclerosing Cholangitis
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
B-Cell Lymphoma; Hodgkin's Disease
Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer
Arachnoiditis
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Waldenstrom Macroglobulinemia
Multiple Myeloma
Multiple Myeloma
Pain
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Carcinoma of the Appendix; Colorectal Cancer
Multiple Myeloma
Multiple Myeloma
Lung Cancer
Multiple Myeloma
Head and Neck Cancer
Chronic Prostatitis; Pelvic Pain
Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
Amyloidosis
Kidney Cancer
Central Nervous System Tumor, Pediatric; Leukemia; Lymphoma; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
Liver Cancer
Prostate Cancer
Multicentric Castleman Disease
Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome
Glioblastoma Multiforme; Glioma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Lymphoma
Prostate Cancer
Ankylosing Spondylitis
Multiple Myeloma
HIV Infections
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Ovarian Cancer
Myelodysplastic Syndromes
Discoid Lupus Erythematosus
Waldenstrom's Macroglobulinemia; Lymphoplasmacytic Lymphoma
Multiple Myeloma
Chronic Pancreatitis
Multiple Myeloma
HIV Infections; Mycobacterium Infections; Tuberculosis
Plasma Cell Myeloma; Renal Failure
Langerhans Cell Histiocytosis
Multiple Myeloma; Plasma Cell Myeloma
Pancreatic Cancer
Multiple Myeloma
HIV Infections; HIV Wasting Syndrome
Glioma
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
Acquired Immunodeficiency Syndrome; Burning Mouth Syndrome; HIV Infection
Melanoma
Cardiac Amyloidosis
Intraocular Melanoma; Melanoma (Skin)
HIV Infections; Stomatitis, Aphthous
Arteriovenous Malformation; Hereditary Hemorrhagic Telangiectasia; Hematochezia; Melena
Multiple Myeloma
Obscure Gastrointestinal Bleeding; Angiodysplasia; Gastric Antral Vascular Ectasia; Thalidomide
Relapse/Refratory Peripheral T Cell Lymphoma
Multiple Myeloma
Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Amyotrophic Lateral Sclerosis (ALS)
Liver Cancer
Myelofibrosis
Carcinoma, Hepatocellular
Chronic Lymphocytic Leukemia
Multiple Myeloma
Liver Cancer
Multiple Myeloma
Multiple Myeloma
Lung Cancer
Lymphoma
Plasma Cell Leukemia; Multiple Myeloma
Leukemia
Sarcoma
Ovarian Cancer
Neuroendocrine Tumor
Primary Myelofibrosis
Multiple Myeloma
Multiple Myeloma
Breast Cancer
Prostatic Neoplasms
Multiple Myeloma and Plasma Cell Neoplasm
Kidney Cancer
Liver Cancer
Brain and Central Nervous System Tumors; Unspecified Adult Solid Tumor, Protocol Specific
Hepatocellular Carcinoma
Diffuse Large B-cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndrome
Prostatic Neoplasm
Brain Stem Neoplasms, Primary; Neoplasms, Brain Stem
Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Multiple Myeloma
Immune Thrombocytopenia
Hereditary Hemorrhagic Telangiectasia; Epistaxis
Multiple Myeloma
Non-small Cell Lung Cancer
Melanoma (Skin)
Waldenstrom Macroglobulinemia
Brain and Central Nervous System Tumors
Metastatic Breast Cancer
Hepatitis C
Idiopathic Pulmonary Fibrosis (IPF)
Multiple Myeloma
Multiple Myeloma
Medulloblastoma Recurrent; Ependymoma Recurrent; ATRT Recurrent
Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Small Lymphocytic Lymphoma
Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma
Lymphoma
Waldenstrom Macroglobulinemia; Lymphoplasmacytic Lymphoma
Gastrointestinal Hemorrhage; Vascular Malformation
Multiple Myeloma and Plasma Cell Neoplasm
Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
Recurrent Melanoma; Stage IV Melanoma; Tumors Metastatic to Brain
Radiation Injuries
Gastrointestinal Bleeding of Unknown Origin; Gastrointestinal Vascular Malformation; Thalidomide Efficiency
Multiple Myeloma
Thalassemia
Multiple Myeloma
Relapse Multiple Myeloma; Refractory Multiple Myeloma
Multiple Myeloma; Plasma Cell Myeloma
MALT Lymphoma
Endometrial Cancer; Sarcoma
COVID-19 Thalidomide
Central Nervous System Tumor, Pediatric; Neuroblastoma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma
Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Hepatocellular Carcinoma
Hepatocellular Carcinoma
Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma
Kidney; Cancer
Amyloidosis
Intraocular Melanoma; Melanoma (Skin)
Multiple Myeloma
Refractory Epilepsy
Leukemia
Multiple Myeloma
Prostate Cancer
Glioma; Neuroectodermal Tumors, Primitive; Wilms Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Osteosarcoma; Retinoblastoma
Multiple Myeloma
Brain and Central Nervous System Tumors
HIV Infections
Ankylosing Spondylitis
Leukemia; Lymphoma
Mycobacterium Avium-Intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection
Multiple Myeloma
Brain and Nervous System; Cancer
Cancer
Advanced Solid Tumor; Advanced/Metastatic Colorectal Cancer
Multiple Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Scleroderma, Systemic
Brain Neoplasms; Melanoma
Endometriosis
Crohn Disease
Multiple Myeloma
Multiple Myeloma
Myeloma
HIV Infections; HIV Wasting Syndrome
HIV Infections
Crohn Disease
Multiple Myeloma; Peripheral Neuropathy
Myeloma
HIV Infections
Hepatocellular Carcinoma; Recurrence
Multiple Myeloma and Plasma Cell Neoplasm
Adrenoleukodystrophy
Chemotherapy-induced Nausea and Vomiting
Multiple Myeloma
Spondylitis, Ankylosing
Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Graft vs Host Disease
Dermatologic; Other
Myeloma Multiple
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Unknown status
Recruiting
Unknown status
Completed
Unknown status
Terminated
Unknown status
Unknown status
Unknown status
Unknown status
Unknown status
Recruiting
Completed
Not yet recruiting
Withdrawn
Unknown status
Completed
Active, not recruiting
Completed
Completed
Completed
Terminated
Terminated
Unknown status
Unknown status
Completed
Completed
Terminated
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Terminated
Terminated
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Terminated
Active, not recruiting
Completed
Completed
Suspended
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Completed
Unknown status
Unknown status
Withdrawn
Completed
Terminated
Completed
Completed
Completed
Unknown status
Active, not recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Unknown status
Unknown status
Unknown status
Terminated
Completed
Recruiting
Unknown status
Completed
Unknown status
Recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Completed
Completed
Unknown status
Completed
Completed
Terminated
Completed
Unknown status
Terminated
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Recruiting
Unknown status
Terminated
Unknown status
Completed
Completed
Terminated
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
Unknown status
Not yet recruiting
Unknown status
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Active, not recruiting
Terminated
Completed
Terminated
Unknown status
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Unknown status
Completed
Active, not recruiting
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Terminated
Withdrawn
Completed
Recruiting
Recruiting
Completed
Terminated
Withdrawn
Completed
Completed
Withdrawn
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Terminated
Completed
Recruiting
Unknown status
Active, not recruiting
Completed
Unknown status
Completed
Active, not recruiting
Completed
Unknown status
Unknown status
Completed
Unknown status
Completed
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Completed
Withdrawn
Completed
Completed
Completed
Recruiting
Completed
Terminated
Completed
Completed
Completed
Unknown status
Withdrawn
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Unknown status
Unknown status
Completed
Terminated
Completed
Recruiting
Completed
Active, not recruiting
Withdrawn
Recruiting
Withdrawn
Completed
Completed
Completed
Recruiting
Withdrawn
Withdrawn
Unknown status
Completed
Completed
Withdrawn
Completed
Completed
Not yet recruiting
Completed
Completed
Terminated
Completed
Terminated
Completed
Completed
Completed
Unknown status
Terminated
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Unknown status
Completed
Recruiting
Completed
Unknown status
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Completed
Recruiting
Active, not recruiting
Completed
Completed
Completed
Terminated
Completed
Terminated
Unknown status
Terminated
Completed
Completed
Completed
Completed
Unknown status
Completed
Terminated
Completed
Unknown status
Completed
Completed
Recruiting
Completed
Terminated
Completed
No longer available
Unknown status
Infliximab biosimilar (AXXO)
Approved
Axxo
Autoimmune Diseases, Crohn Disease
Adalimumab biosimilar (Biocad)
BCD-057
Approved
Biocad
Psoriasis
NCT Number
NCT02762955
NCT02395055
Intervention Type
Biological
Drug
Indications
Psoriasis
Healthy
Study Phase
Phase 3
Phase 1
Recruitment Status
Unknown status
Completed
Adalimumab biosimilar (Zydus Cadila)
Approved
Zydus Cadila
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Arthritis, Psoriatic
Adalimumab biosimilar (Mylan/Biocon)
BMO-2, MYL-1401-A
Approved
Biocon
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease, Plaque psoriasis
NCT Number
NCT02714322
NCT02472912
Intervention Type
Biological
Biological
Indications
Psoriasis; Arthritis, Psoriatic
Healthy Volunteers
Study Phase
Phase 3
Phase 1
Recruitment Status
Completed
Completed
Infliximab-qbtx
GP-1111, PF-6438179, PF-06438179
Approved
Pfizer Pharmaceuticals Ltd (China)
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT02222493
NCT04305145
NCT01844804
NCT03885037
NCT03885089
NCT03884439
Intervention Type
Biological
Drug
Biological
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
Healthy
Rheumatoid Arthritis
Psoriasis Vulgaris; Psoriasis Arthropathica; Pustular Psoriasis; Erythrodermic Psoriasis
Crohn's Disease; Ulcerative Colitis
Study Phase
Phase 3
Phase 2
Phase 1
N/A
N/A
N/A
Recruitment Status
Completed
Recruiting
Completed
Recruiting
Recruiting
Recruiting
Infliximab (ABDA)
SB-2
Approved
Samsung Bioepis, Merck & Co Inc
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT01936181
NCT04305145
NCT01922336
NCT03662919
NCT04378621
NCT03016260
Intervention Type
Drug
Drug
Biological
Drug
Other;Drug
Biological
Indications
Rheumatoid Arthritis
Melanoma Stage III; Melanoma Stage IV; Side Effect of Drug; Colitis
Healthy
Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Crohn's Disease; Colitis, Ulcerative
Rheumatoid Arthritis; Pain; Fatigue; Cognitive Decline; Depression; Brain Diseases; Hand Rheumatism
RheumatoId Arthritis
Study Phase
Phase 3
Phase 2
Phase 1
N/A
N/A
N/A
Recruitment Status
Completed
Recruiting
Completed
Recruiting
Not yet recruiting
Terminated
Anti-tumour necrosis factor-alpha antibody
Approved
Materia Medica Holding Research And Production Company
Arthritis, Rheumatoid, Osteoarthritis
Etanercept biosimilar (Samsung Bioepis)
SB-4
Approved
Samsung Bioepis
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Arthritis, Psoriatic
NCT Number
NCT03813771
NCT01895309
NCT03193957
NCT01865552
NCT03100734
NCT03327454
Intervention Type
Drug
Drug
Drug;Device
Biological
Biological
Biological
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy
Rheumatoid Arthritis; Axial Spondyloarthritis
Rheumatoid Arthritis; Spondyloarthropathies
Study Phase
Phase 4
Phase 3
Phase 2
Phase 1
N/A
N/A
Recruitment Status
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
SCT-640A
SCT-640A, SCT640A
Preclinical
Shenzhou Cell Engineering Co Ltd
Arthritis, Rheumatoid, Psoriasis
Etanercept biosimilar (PROBIOMED)
Approved
Probiomed
Arthritis, Rheumatoid
CMAB815
CMAB815
IND
Shanghai Biomabs Pharmaceuticals Co Ltd, Sinomab Bioscience Ltd
Arthritis, Rheumatoid
Etanercept biosimilar (Shanghai CP Guojian Pharmaceutical)
301S
Approved
Shanghai Cp Guojian Pharmaceutical Co Ltd, Cipla Gmbh
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis
NCT Number
NCT02960035
NCT02364479
NCT03411798
NCT04345458
NCT01394913
NCT03589833
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Spondyloarthropathy
Spondyloarthritis
Ankylosing Spondylitis
Ankylosing Spondylitis
Rheumatoid Arthritis
Arthritis, Rheumatoid
Study Phase
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 2
Recruitment Status
Completed
Completed
Completed
Completed
Suspended
Unknown status
Adalimumab biosimilar (Celltrion)
CT-P17
Phase 3 Clinical
Celltrion
Arthritis, Rheumatoid
NCT Number
NCT04171414
NCT04295356
NCT03970824
Intervention Type
Biological
Biological
Biological
Indications
Rheumatoid Arthritis
Healthy
Healthy
Study Phase
Phase 3
Phase 1
Phase 1
Recruitment Status
Recruiting
Completed
Completed
HMPL-004 (Hutchison Medipharma)
HMPL-004
Phase 3 Clinical
Hutchison Medipharma
Lupus Erythematosus, Systemic, Colitis, Ulcerative, Crohn Disease
NCT Number
NCT01882764
NCT01805791
Intervention Type
Drug
Drug
Indications
Ulcerative Colitis
Ulcerative Colitis
Study Phase
Phase 3
Phase 3
Recruitment Status
Terminated
Terminated
Infliximab biosimilar (Biocad)
BCD-055
Phase 3 Clinical
Biocad
Spondylitis, Ankylosing, Arthritis, Rheumatoid
NCT Number
NCT02762812
NCT02762838
NCT02359903
Intervention Type
Biological
Biological;Drug
Drug
Indications
Ankylosing Spondylitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Study Phase
Phase 3
Phase 3
Phase 1
Recruitment Status
Completed
Completed
Completed
Etanercept biosimilar (Coherus Biosciences)
CHS-0214, BAX-2200
Phase 3 Clinical
Coherus Biosciences
Arthritis, Rheumatoid, Psoriasis
NCT Number
NCT02115750
NCT02486939
NCT02134210
Intervention Type
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis; Plaque Psoriasis
Plaque Psoriasis
Study Phase
Phase 3
Phase 3
Phase 3
Recruitment Status
Completed
Completed
Completed
Adalimumab biosimilar (Danhong Pharma)
BC-002
Phase 3 Clinical
Shandong Danhong Pharmaceutical Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid
Adalimumab biosimilar (Oncobiologics)
ONS-3010
Phase 3 Clinical
Outlook Therapeutics
Psoriasis
CD24-Fc
CD24-Fc-IgG, CD24-Fc, HAS-CD24
Phase 3 Clinical
Oncoimmune
HIV Infections, Leukemia, Graft vs Host Disease, Coronavirus Disease 2019 (COVID-19), Myelodysplastic Syndromes, Dyslipidemias, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Melanoma
NCT Number
NCT04317040
NCT04095858
NCT03960541
NCT02663622
NCT04060407
NCT02650895
Intervention Type
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Indications
Covid19
Hematopoietic Stem Cell Transplantation; Acute Graft Versus Host Disease; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes
HIV Infections; Dyslipidemias
Graft Versus Host Disease; Hematopoietic Stem Cell Transplantation; Leukemia
Metastatic Melanoma
Healthy Volunteers
Study Phase
Phase 3
Phase 3
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Completed
Adalimumab biosimilar (Tonghua Dongbao Pharmaceutical)
Phase 3 Clinical
Tonghua Dongbao Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Psoriasis
Infliximab biobetter (Mabtech/Sorrento)
STI-002
Phase 3 Clinical
Taizhou Maibo Taike Biotechnology Co Ltd, Sorrento Therapeutics
Arthritis, Rheumatoid
Adalimumab biosimilar (LG Life Sciences)
LBAL
Phase 3 Clinical
Mochida, Lg Chem
Arthritis, Rheumatoid
NCT Number
NCT02746380
NCT02206867
Intervention Type
Drug
Biological
Indications
Arthritis, Rheumatoid
Healthy Subjects
Study Phase
Phase 3
Phase 1
Recruitment Status
Unknown status
Completed
Adalimumab biosimilar (Hualan Biological Engineering)
Phase 3 Clinical
Hualan Genetic Engineering Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis
Adalimumab biosimilar (Hetero Drugs)
Phase 3 Clinical
Hetero Drugs
Arthritis, Rheumatoid
Recombinant human TNF-α monoclonal antibody (Sinocelltech)
SCT-630
Phase 3 Clinical
Shenzhou Cell Engineering Co Ltd
Psoriasis
NCT Number
NCT03927352
NCT03917628
Intervention Type
Biological
Drug
Indications
Psoriasis
Healthy
Study Phase
Phase 3
Phase 1
Recruitment Status
Not yet recruiting
Not yet recruiting
Recombinant anti-TNFα monoclonal antibody (Wuhan Institute of Biological Products)
Phase 3 Clinical
Wuhan Institute Of Biological Products Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Plaque psoriasis
Adalimumab biosimilar (CinnaGen)
Phase 3 Clinical
Cinnagen
Arthritis, Rheumatoid
Thykamine
PUR-0110, PCT-233
Phase 3 Clinical
Purgenesis Technologies
Dermatitis, Colitis, Ulcerative, Proctocolitis
NCT Number
NCT01149707
NCT01149694
Intervention Type
Drug
Drug
Indications
Left-Sided Ulcerative Colitis; Proctosigmoiditis
Ulcerative Colitis
Study Phase
Phase 2
Phase 1
Recruitment Status
Completed
Completed
Infliximab biosimilar (Genor Biopharma)
GB-242
Phase 3 Clinical
Genor Biopharma Co Ltd
Arthritis, Rheumatoid
NCT Number
NCT04178850
Intervention Type
Biological
Indications
Rheumatoid Arthritis
Study Phase
Phase 3
Recruitment Status
Recruiting
Tanfanercept
HBM-9036, HL-036
Phase 3 Clinical
Hanall
Dry Eye Syndromes, Xerophthalmia
NCT Number
NCT03846453
NCT04633213
NCT03334539
NCT04092907
NCT02717208
Intervention Type
Biological
Drug
Other;Biological
Drug
Biological
Indications
Dry Eye
Dry Eye
Dry Eye
Dry Eye
Dry Eye
Study Phase
Phase 3
Phase 3
Phase 2
Phase 2
Phase 1
Recruitment Status
Recruiting
Not yet recruiting
Completed
Completed
Completed
Adalimumab biosimilar (Coherus BioSciences)
CHS-1420
Phase 3 Clinical
Coherus Biosciences
Psoriasis
NCT Number
NCT02489227
Intervention Type
Drug
Indications
Plaque Psoriasis
Study Phase
Phase 3
Recruitment Status
Completed
Adalimumab biosimilar (Alvotech)
AVT-02 (Alvotech)
Phase 3 Clinical
Alvotech
Autoimmune Diseases, Psoriasis
NCT Number
NCT04453137
NCT03579823
Intervention Type
Biological
Drug
Indications
Plaque Psoriasis
Healthy Volunteers
Study Phase
Phase 3
Phase 1
Recruitment Status
Active, not recruiting
Completed
Etanercept biosimilar (Clover Biopharmaceuticals)
SCB-808
Phase 3 Clinical
Sichuan Sanyecao Bio-Pharmaceutical Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid
Ozoralizumab
TS-152, ATN-103, PF-5230896, PF-05230896
Phase 3 Clinical
Ablynx
Arthritis, Rheumatoid
NCT Number
NCT04077567
NCT01063803
NCT01007175
NCT00959036
NCT00916110
Intervention Type
Drug
Drug
Biological
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Active Rheumatoid Arthritis
Healthy
Study Phase
Phase 3
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Active, not recruiting
Completed
Completed
Completed
Completed
Adalimumab biosimilar (Genor Biopharma)
GB-232, BCD-100
Phase 2 Clinical
Genor Biopharma Co Ltd
Carcinoma, Renal Cell, Arthritis, Rheumatoid, Lung Neoplasms, Melanoma
NCT Number
NCT03269565
NCT03050047
Intervention Type
Biological
Biological
Indications
Melanoma
Melanoma; Lung Cancer; Renal Cell Carcinoma
Study Phase
Phase 2
Phase 1
Recruitment Status
Active, not recruiting
Unknown status
LP-0058
LP-0058, LEO-32731
Phase 2 Clinical
Leo Pharma Inc
Psoriasis, Dermatitis, Atopic
NCT Number
NCT02888236
NCT02126371
NCT02753218
NCT02496546
NCT03812198
NCT03231124
NCT02514694
NCT03126578
NCT01310049
Intervention Type
Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Drug
Drug
Drug
Indications
Psoriasis Vulgaris
Psoriasis Vulgaris
Psoriasis Vulgaris
Atopic Dermatitis
Healthy
Psoriasis Vulgaris
Psoriasis Vulgaris
Drug Interaction Potentiation
Healthy Subjects
Study Phase
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
EYS-606
EYS-606
Phase 2 Clinical
Eyevensys
Uveitis
NCT Number
NCT03308045
Intervention Type
Biological
Indications
Non-infectious Uveitis
Study Phase
Phase 1/Phase 2
Recruitment Status
Recruiting
Etanercept biosimilar (Suzhou Genemen Biotech)
BF-02, GM-02
Phase 2 Clinical
Suzhou Genemen Biotech. Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis
Hemay-005
Hemay-005
Phase 2 Clinical
Hainan Hailing Chemipharma Corporation Ltd, Tianjin Hemei Pharmaceutical Technology Co Ltd
Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Dermatitis, Atopic, Behcet Syndrome
NCT Number
NCT04609397
NCT04102241
NCT03570346
NCT03577626
NCT03007810
Intervention Type
Other;Drug
Drug
Drug
Drug
Drug
Indications
Behçet Disease
Psoriasis
Psoriasis
Psoriasis
Psoriasis
Study Phase
Phase 2
Phase 2
Phase 1
Phase 1
Phase 1
Recruitment Status
Recruiting
Active, not recruiting
Unknown status
Unknown status
Completed
ABT-122
ABT-122, D2E7-GS10-B6-17
Phase 2 Clinical
Abbvie Inc
Arthritis, Rheumatoid, Rheumatic Diseases, Arthritis, Psoriatic
NCT Number
NCT02429895
NCT02141997
NCT02433340
NCT02349451
NCT01853033
Intervention Type
Drug
Biological
Drug
Biological
Biological
Indications
Psoriatic Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Psoriatic Arthritis
Rheumatoid Arthritis
Study Phase
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1
Recruitment Status
Terminated
Completed
Completed
Completed
Completed
CC-10015
CC-10015
Phase 2 Clinical
Celgene
Sarcoidosis, Multiple Myeloma, Lupus Erythematosus, Systemic
NCT Number
NCT02192489
NCT02185040
NCT03161483
NCT02773030
NCT03294603
NCT01733875
NCT02820935
NCT02034773
NCT03135509
Intervention Type
Drug
Drug
Other;Drug
Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Indications
Sarcoidosis
Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Multiple Myeloma
Healthy Volunteer
Healthy
Pharmacokinetics
Healthy Volunteers
Healthy Volunteers
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Withdrawn
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
OCS-02
OCS-02, ESBA-1622, LME-636
Phase 2 Clinical
Oculis Pharma
Dry Eye Syndromes, Uveitis, Anterior, Xerophthalmia
NCT Number
NCT02482129
NCT02365519
Intervention Type
Drug
Biological
Indications
Acute Anterior Uveitis
Dry Eye
Study Phase
Phase 2
Phase 2
Recruitment Status
Completed
Completed
Recombinant anti-TNFα monoclonal antibody (Livzon Group)
AT-132, LZM-001
Phase 2 Clinical
Livzon Pharmaceutical Group Inc
Arthritis, Rheumatoid
V-565
V-565
Phase 2 Clinical
Vhsquared
Colitis, Ulcerative, Crohn Disease
NCT Number
NCT02976129
NCT03705117
Intervention Type
Drug
Biological
Indications
Crohn's Disease
Ulcerative Colitis
Study Phase
Phase 2
Phase 1
Recruitment Status
Recruiting
Completed
Hemay007
Hemay-007
Phase 2 Clinical
Tianjin Hemay Bio-Tech Co Ltd
Inflammatory Bowel Diseases, Arthritis, Rheumatoid, Colitis, Ulcerative
NCT Number
NCT03977480
NCT02603185
Intervention Type
Drug
Drug
Indications
Ulcerative Colitis
Inflammatory Bowel Disease
Study Phase
Phase 2
Phase 1
Recruitment Status
Recruiting
Unknown status
COVA-322
COVA-322
Phase 2 Clinical
Covagen
Psoriasis
NCT Number
NCT02243787
Intervention Type
Other;Drug
Indications
Plaque Psoriasis
Study Phase
Phase 1/Phase 2
Recruitment Status
Terminated
Certolizumab (Intrexon)
AG-014
Phase 1 Clinical
Intrexon Co
Inflammatory Bowel Diseases
JNJ-63823539
JNJ-63823539
Phase 1 Clinical
Janssen Global Services Llc
Arthritis, Rheumatoid
LY-3114062
LY3114062, LY-3114062
Phase 1 Clinical
Eli Lilly And Company
Arthritis
NCT Number
NCT02144272
Intervention Type
Drug
Indications
Inflammatory Arthritis
Study Phase
Phase 1
Recruitment Status
Completed
Human anti-TNFα monoclonal antibody (DZM Biotech)
Phase 1 Clinical
Daqing Dongzhuming Biotechnology Co Ltd
Arthritis, Rheumatoid
Recombinant human anti-TNFα monoclonal antibody (Qilu Pharmaceutical)
Phase 1 Clinical
Qilu Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing
Recombinant anti-TNFα antibody (Shanghai Xiesheng Medicine)
Phase 1 Clinical
Shanghai Harmony Pharmaceutical Technology Co Ltd
AVX-470
AVX-470, AVX-1350, AVX-470h
Phase 1 Clinical
Avaxia Biologics
Colitis, Ulcerative
NCT Number
NCT01759056
Intervention Type
Drug
Indications
Ulcerative Colitis
Study Phase
Phase 1
Recruitment Status
Completed
Recombinant human anti-TNFα monoclonal antibody (Weimingdamu Biotech)
Phase 1 Clinical
Anhui Weiming Damu Biomedicine Co Ltd
Arthritis, Rheumatoid
Adalimumab biosimilar (Beijing Luzhu Biotechnology)
Phase 1 Clinical
Beijing Lvzhu Biological Technology Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis
Wogonin
Phase 1 Clinical
Shandong Buchang Pharmaceuticals Co Ltd, Hefei Cosource Medicine Technology, Daewoong Pharmaceutical Co Ltd, China Pharmaceutical University
Respiratory Tract Infections, Neoplasms
Anti-tumour necrosis factor alpha (Livzon)
Phase 1 Clinical
Livzon Pharmaceutical Group Inc
Autoimmune Diseases
Recombinant human anti-TNFα monoclonal antibody (Huaota Biopharma)
Phase 1 Clinical
Shanghai Huaao Tai Biopharma Co Ltd
Spondylitis, Ankylosing, Psoriasis, Arthritis
Recombinant human monoclonal antibody specific for human tumor necrosis factor (North China Pharmaceutical)
Phase 1 Clinical
North China Pharmaceutical Corp
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Autoimmune Diseases, Psoriasis
Adalimumab biosimilar (Prestige BioPharma)
PBP-1502
Phase 1 Clinical
Prestige Biopharma
Arthritis
Golimumab biosimilar (Bio-thera)
BAT-2506
Phase 1 Clinical
Bio-Thera Solutions Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Arthritis, Psoriatic, Arthritis
NCT Number
NCT04152759
Intervention Type
Drug
Indications
Psoriatic Arthritis
Study Phase
Phase 1
Recruitment Status
Recruiting
Adalimumab biosimilar (Eastern Biotech)
JY-026
Phase 1 Clinical
Beijing Oriental 100 Tai Biotechnology Co Ltd
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Juvenile, Psoriasis, Crohn Disease
Etanercept (Neurokine Pharmaceuticals)
NP-1, NK-001
Clinical
Pivot Pharmaceuticals
Cognition Disorders
IBPM005IX (Inbiopro Solutions)
Clinical
Inbiopro Solutions
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Arthritis, Juvenile, Arthritis, Psoriatic, Crohn Disease
Tumour necrosis factor alpha kinoid
TNF-K, TNF-K005
Pending
Neovacs
Arthritis, Rheumatoid, Crohn Disease
NCT Number
NCT01291810
NCT01040715
NCT01911234
Intervention Type
Biological
Biological
Other;Biological
Indications
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Study Phase
Phase 2
Phase 2
Phase 2
Recruitment Status
Completed
Completed
Completed
NV-52
NV-52, NV-07β
Pending
Novogen
Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease
Adalimumab biosimilar (Shanghai Maitaiyabo Biotech)
Pending
Shanghai Maitai Yabo Biotechnology Co Ltd
Arthritis, Rheumatoid
AN-0128
AN-0128, CRM-0005, ONT-0001
Pending
Anacor Pharmaceuticals
Dental Plaque, Dermatitis, Atopic
NCT Number
NCT00762151
Intervention Type
Other;Drug
Indications
Dental Plaque
Study Phase
Phase 1
Recruitment Status
Completed
KOB-03
KOB-03
Pending
Rhinitis, Allergic
Recombinant anti-TNFα human monoclonal antibody (Jilin Kanghui Biotech)
Pending
Alphamab Jilin Co Ltd
Etanercept biosimilar (Biotrion)
BT-D001
Pending
Biotrion
Arthritis, Rheumatoid
Adalimumab biosimilar (Dong-A ST/Meiji Seika Pharma)
DA-3113, DMB-3113
Pending
Dong-A Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd
Arthritis, Rheumatoid
NCT Number
NCT02927353
Intervention Type
Drug
Indications
Healthy Volunteer
Study Phase
Phase 1
Recruitment Status
Completed
MCT-475
MCT-475, MCT-485
Pending
Multicell Technologies
Hepatitis, Chronic, Liver Neoplasms
YS-IL6
YS-IL6, YSIL-6, YSIL6-O-RA, YSIL6-T-PS
Pending
Y'S Therapeutics
Arthritis, Rheumatoid
Recombinant human anti-TNFα monoclonal antibody (Taizhou Mabtech)
Pending
Taizhou Maibo Taike Biotechnology Co Ltd
Anti-TNFalpha polyclonal antibody (Verigen)
Pending
Genzyme Corp
Arthritis, Rheumatoid, Crohn Disease
Etanercept biosimilar (Bionovis/The Instituto Vital Brazil)
Pending
The Instituto Vital Brazil, Bionovis
Spondylitis, Ankylosing, Arthritis, Rheumatoid, Psoriasis, Arthritis, Psoriatic
BCD-121
BCD-121
Pending
Biocad
Arthritis, Rheumatoid
NCT Number
NCT03103451
Intervention Type
Other;Drug
Indications
Healthy
Study Phase
Phase 1
Recruitment Status
Completed
Etanercept biosimilar (Zenotech Laboratories)
Pending
Zenotech Laboratories
Arthritis, Rheumatoid
BLX-1002
BLX-1002
Pending
Orchid
Diabetes Mellitus, Type 2
Adalimumab biosimilar (Bionovis/The Instituto Vital Brazil)
Pending
Bionovis, The Instituto Vital Brazil
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Psoriasis, Colitis, Ulcerative, Arthritis, Psoriatic, Crohn Disease
INDUS-83030
INDUS-83030
Pending
Indus Biotech Pvt Ltd
Arthritis, Rheumatoid
MM-A01-01
MM-A01-01
Pending
Myungmoon Pharm
Arthritis, Rheumatoid
PMI-001
PMI-001
Pending
Phytomedics
Lupus Vulgaris, Arthritis, Rheumatoid, Multiple Sclerosis, Psoriasis
NCT Number
NCT00062465
Intervention Type
Drug
Indications
Rheumatoid Arthritis
Study Phase
Phase 2
Recruitment Status
Completed
BIRB-1017
BIRB-1017
Pending
Boehringer Ingelheim Gmbh
Arthritis, Rheumatoid, Psoriasis
PF-5230905
ATN-192, PF-5230905, PF-05230905
Pending
Ablynx
Arthritis, Rheumatoid
OCT-B201
BT-201, OCT-B201
Pending
Oscotec
Osteoarthritis
Recombinant mutant human tumor necrosis factor alpha (State Key Laboratory of Cancer Biology)
Pending
State Key Laboratory Of Cancer Biology
Head and Neck Neoplasms, Stomach Neoplasms, Carcinoma, Renal Cell, Colorectal Neoplasms, Lung Neoplasms
Adalimumab biosimilar (Alphamab)
KN-002
Pending
Suzhou Alphamab Co Ltd
Arthritis, Rheumatoid
GSK-2800528
GSK-2800528
Pending
Glaxosmithkline Plc
Psoriasis, Inflammation
NCT Number
NCT01899755
Intervention Type
Drug
Indications
Psoriasis
Study Phase
Phase 1
Recruitment Status
Completed
YHB-1411-2
YHB-14112, YHB1411-2, YHB-1411-2, MAb YHB1411-2
Pending
Yuhan Corporation
Arthritis, Rheumatoid
Acetylcysteine/Pentoxifylline
PTL-202
Pending
Intelgenx Corp, Ra Chem Pharma
Idiopathic Pulmonary Fibrosis
QR-449
QR-440, QR-443, QR-449
Pending
Prophase Labs
Pain, Metabolic Diseases, Cachexia
Etanercept biosimilar (AvesthaGen)
Pending
Avesthagen
Arthritis, Rheumatoid
tgAAC 94
Pending
Armata Pharmaceuticals
Arthritis, Rheumatoid, Periodontal Diseases
Doramapimod
BIBR-796, BIRB-796, BIRB-0796, BIRB-796-BS
Discontinued
C.H. Boehringer Sohn Ag & Co. Kg
Arthritis, Rheumatoid, Psoriasis
NCT Number
NCT02214888
NCT02209753
NCT02209779
NCT02211144
NCT02208856
NCT02211885
NCT02211157
NCT02209805
Intervention Type
Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Drug
Drug
Indications
Arthritis, Rheumatoid
Psoriasis
Arthritis, Rheumatoid
Healthy
Healthy
Healthy
Healthy
Healthy
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
CDP-571
CDP-571, cb-0010, BAY-10-3356
Discontinued
Celltech
Shock, Septic, Diabetes Mellitus, Type 2, Arthritis, Rheumatoid, Crohn Disease
AME-527
AME-527
Discontinued
Applied Molecular Evolution
Arthritis, Rheumatoid
Adalimumab biosimilar (Momenta Pharmaceuticals)
M-923, BAX-923, BAX-2923
Discontinued
Momenta
Arthritis, Rheumatoid, Autoimmune Diseases, Psoriasis, Inflammation
NCT Number
NCT02722044
NCT02581345
NCT02675023
Intervention Type
Biological;Device
Biological
Biological
Indications
Rheumatoid Arthritis
Chronic Plaque Psoriasis; Psoriasis
Healthy
Study Phase
Phase 3
Phase 3
Phase 1
Recruitment Status
Completed
Completed
Completed
AZD-9773 (BTG)
Discontinued
Btg Plc
Shock, Septic, Sepsis
HP-228
HP-228, ILP-228
Discontinued
Sygnis
Diabetes Mellitus, Type 2, Pain, Postoperative, Obesity, Inflammation
Adalimumab biosimilar (Synermore Biologics)
SYN-060
Discontinued
Lonn Ryonn Pharma Ltd, Xingmeng Biotechnology (Beijing) Co Ltd
Arthritis, Rheumatoid
NCT Number
NCT03254810
Intervention Type
Biological
Indications
Arthritis, Rheumatoid
Study Phase
Phase 1
Recruitment Status
Completed
AMG-548
AMG-548
Discontinued
Amgen Inc
Arthritis, Rheumatoid, Arthritis
ONO-4007
ONO-4007
Discontinued
Ono Pharmaceutical Co Ltd
Neoplasms
NPH-30907
NPH-30907
Discontinued
Piramal Phytocare
Mycoses
Placulumab
ART-621, PN-0621, Dom-0200, CEP-37247
Discontinued
Domantis, Peptech Uk
Arthritis, Rheumatoid, Sciatica, Psoriasis, Inflammation
NCT Number
NCT00928317
NCT00854685
NCT01240876
Intervention Type
Drug
Drug
Drug
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Sciatica
Study Phase
Phase 2
Phase 2
Phase 1/Phase 2
Recruitment Status
Terminated
Completed
Completed
DLX-105
DLX-105, ESBA-105
Discontinued
Esbatech
Dry Eye Syndromes, Psoriasis, Uveitis, Anterior, Osteoarthritis, Xerophthalmia, Uveitis, Crohn Disease
NCT Number
NCT00823173
NCT01338610
NCT01624376
NCT01936337
NCT00819572
NCT01595997
NCT00671619
Intervention Type
Biological
Other;Biological
Drug
Drug
Biological;Drug
Drug
Drug
Indications
Anterior Uveitis
Eyes Dry Chronic
Fistulizing Crohn's Disease
Psoriasis Vulgaris
Osteoarthritis
Mild-to-moderate Psoriasis Vulgaris
Healthy
Study Phase
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Infliximab biosimilar (Shanghai CP Guojian)
Discontinued
Shanghai Cp Guojian Pharmaceutical Co Ltd
Arthritis, Rheumatoid
CC-11050
CC-11050
Discontinued
Celgene
Lupus Erythematosus, Cutaneous
NCT Number
NCT03807362
NCT02968927
NCT01300208
NCT04139226
NCT02652546
Intervention Type
Drug
Drug
Other;Drug
Drug
Drug
Indications
Erythema Nodosum Leprosum; Leprosy
Tuberculosis
Cutaneous Lupus Erythematosus
Healthy Volunteers
HIV, Inflammation
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Recruitment Status
Recruiting
Active, not recruiting
Completed
Completed
Completed
Adalimumab with ENHANZE technology (Abbvie)
Discontinued
Abbvie Inc
REN-1654
CPI-1189, REN-1189, REN-1654
Discontinued
Evotec
Intervertebral Disc Displacement, Peripheral Nervous System Diseases, HIV Infections, Neuralgia, Postherpetic, Sciatica, Radiculopathy, AIDS Dementia Complex, Neuralgia, Herpes Zoster
NCT Number
NCT00107055
NCT00002414
NCT00099528
NCT00002209
Intervention Type
Drug
Drug
Drug
Drug
Indications
Sciatica; Herniated Disc; Radiculopathy
HIV Infections
Neuralgia; Shingles; Peripheral Nervous System Disease
AIDS Dementia Complex; HIV Infections
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1
Recruitment Status
Unknown status
Unknown status
Unknown status
Completed
Genz-29155
Genz-29155
Discontinued
Sanofi
Multiple Sclerosis, Rejection of organ transplantation
MNX-160
LMP-160, MNX-160
Discontinued
Nonindustrial Source
Arthritis, Rheumatoid, Multiple Sclerosis, Respiratory Distress Syndrome, Adult, Psoriasis, Asthma, Cachexia, Diabetes Mellitus
SA-13353
DE-096, SA-13353
Discontinued
Santen Pharmaceutical Co Ltd
Arthritis, Rheumatoid, Diabetic macular oedema
ENMD-0995
S-3APG, ENMD-0995
Discontinued
Boston Children'S Hospital, Celgene Corp
Multiple Myeloma
ISIS-104838
ISIS 104838
Discontinued
Ionis
Arthritis, Rheumatoid, Psoriasis, Inflammation, Crohn Disease
NCT Number
NCT00048321
Intervention Type
Drug
Indications
Rheumatoid Arthritis
Study Phase
Phase 2
Recruitment Status
Completed
Recombinant anti-TNFα antibody (Sailemin Biotech)
Discontinued
Hainan Selemin Biological Technology Co Ltd
Spondylitis, Ankylosing, Arthritis, Rheumatoid
DOM-0215
DOM-0215
Discontinued
Glaxosmithkline Plc
Arthritis, Rheumatoid
Recombinant humanized anti-TNFα monoclonal antibody (Shenzhen Main Luck Pharmaceuticals)
Discontinued
Shenzhen Main Luck Pharmaceuticals Inc
Spondylitis, Ankylosing, Arthritis, Rheumatoid
BB-2275
BB-2275
Discontinued
Vernalis
Cachexia
Lenercept
RO-452081, NFR55-IgG1, TNFR55-Ig1, p55TNFR-Ig
Discontinued
F. Hoffmann-La Roche Ltd
Shock, Septic, Arthritis, Rheumatoid
Golnerminogene pradenovec
ADgvEGR.TNF.11D
Discontinued
Asahi Kasei Corp
Head and Neck Neoplasms, Rectal Neoplasms, Pancreatic Neoplasms, Melanoma
NCT Number
NCT00868114
NCT00261404
NCT00137878
NCT00496535
NCT00496236
Intervention Type
Biological
Drug
Drug
Drug
Drug
Indications
Metastatic Pancreatic Cancer
Melanoma
Rectal Cancer
Head and Neck Cancer; Head and Neck Neoplasms
Head and Neck Cancer; Head and Neck Neoplasms
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Recruitment Status
Terminated
Completed
Completed
Completed
Completed
Human TNF-α monoclonal antibody( Simcere Pharmaceutical)
Discontinued
Nanjing Simcere Pharmaceutical Co Ltd, Shandong Xiansheng Bio-Pharmaceutical Co Ltd, Jiangsu Xiansheng Pharmaceutical Co Ltd
K-832
K-832
Discontinued
Kowa
Arthritis, Rheumatoid
ABBV-257
DVD-1, ABBV-257, DVD-Ig-1
Discontinued
Abbott Laoratories
Arthritis, Rheumatoid
NCT Number
NCT02531178
Intervention Type
Biological
Indications
Rheumatoid Arthritis
Study Phase
Phase 1
Recruitment Status
Completed
MGN-1404
MGN-1404
Discontinued
Mologen
Melanoma
ABX-0401
ABX-0401
Discontinued
Sanofi
Inflammatory Bowel Diseases, Arthritis, Rheumatoid, Inflammation
CYT 007 TNFQb
Discontinued
Cytos
Arthritis, Rheumatoid, Psoriasis
Azacitidine/Lenalidomide
Discontinued
Celgene
Leukemia, Myeloid, Acute
Ro-327315
Ro-327315, Ro-32-7315
Discontinued
F. Hoffmann-La Roche Ltd
Arthritis, Rheumatoid